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ABSTRACT 
The aim of this dissertation is to elucidate age-related patterns in the multidimensional 
experience of cancer pain. Chapter 1 presents a literature review of age-related patterns in 
cancer pain, outlines the methodological limitations of existing literature and highlights 
gaps in our knowledge. Chapter 2 presents the first psychometric analysis of the Short-
Form McGill Pain Questionnaire-2 in older and younger people with cancer pain. The 
weight of the evidence suggests that this tool is valid for use in older and younger people 
with cancer pain. Chapter 3 presents an analysis of age-related patterns in the experience 
of cancer pain across the biopsychosocial spectrum. Pain intensity, qualities, and 
interference did not differ across age groups but older patients were somewhat less likely 
to be prescribed an opioid. Comorbidity was associated with greater pain for younger, but 
not older people, and chronic nonmalignant pain was associated with greater pain for 
older, but not younger people. An age-related pattern in the supportive context of cancer 
pain based on health status factors may also be present. There were no age differences in 
depressive symptoms, but intrusive thoughts were associated with greater pain for 
younger but not older patients, suggesting a unique adaptive advantage of prior 
experience with health limitations among older, but not younger patients. Chapter 4 
presents a preliminary investigation of the role of pain three months after breast cancer 
surgery in the relationship between age and depressive symptoms. In women with 
moderate-to-severe pain, age was not associated with depressive symptoms but in women 
with mild or no pain, younger age was associated with greater depressive symptoms. 
However, in women with neuropathic pain, younger age was associated with greater 
depressive symptoms, but not in women without neuropathic pain. The impact of pain 
was not age-related. High preoperative pain expectations may be a risk factor for pain 
three months after breast cancer surgery, regardless of age. In Chapter 5, results are 
integrated and discussed along with implications for future research and treatment. 
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CHAPTER 1 
Age Differences in the Experience of Cancer Pain: A Literature Review 
2 
Dissertation Synopsis 
Pain is one of the most common and feared symptoms of cancer (Cleeland, 1998). 
It increases in intensity as the disease progresses and significantly impairs quality of life 
(Bruera & Kim, 2003; Castel et al., 2007; Cleeland et al., 1994; M. Z. Cohen et al., 2005; 
Ferreira et al., 2008; McCarthy, Phillips, Zhong, Drews, & Lynn, 2000; Mystakidou et 
al., 2006; Peng, Wu, Sun, Chen, & Huang, 2006; Wells, Murphy, Wujcik, & Johnson, 
2003). Although cancer can occur at any age, it is considered to be a disease of the older 
person (Canadian Cancer Society [CCS], 2013). With the aging population, the numbers 
of older people who will require treatment for cancer pain will grow. Unfortunately, our 
understanding of the experience of cancer pain across the adult life span is limited. We 
urgently need to improve our understanding in order to provide effective prevention and 
palliation of pain for adults of all ages. 
The overall aim of this dissertation is to elucidate age-related patterns in the 
multidimensional experience of cancer pain. The introductory chapter presents an 
overview of the existing literature describing age-related patterns in cancer pain, and 
highlights methodological limitations and gaps in our knowledge. Evidence for the 
biopsychosocial model of pain is reviewed and methodological considerations in the 
study of age-related patterns in cancer pain are discussed. Chapter 2 presents an 
evaluation of the psychometric properties of the Short-Form McGill Pain Questionnaire-2 
(SF-MPQ-2 [Dworkin et al., 2009]), a revised and expanded version of the McGill Pain 
Questionnaire (Melzack, 1975), the most widely used measure of the multidimensional 
qualities of pain. This study represents the first evaluation of the psychometric properties 
3 
of the SF-MPQ-2 in people with cancer pain and the first evaluation of its invariance 
across age groups. This step was necessary prior to commencing the comprehensive 
investigation of age differences in the multidimensional experience of cancer pain and its 
correlates, which is presented in Chapter 3. In Chapter 3, it is also demonstrated that there 
are no age differences in depressive symptoms in people with cancer pain. This finding is 
consistent with studies of people with cancer pain (Green & Hart-Johnson, 2010; Kai-hoi 
Sze, Wong, Lo, & Woo, 2000; Knotkova, Clark, Mokrejs, Padour, & Kuhl, 2004; G. M. 
Williamson & Schulz, 1995), but not with other studies of people with cancer that do not 
consider pain (Compas et al., 1999; Kroenke et al., 2004; Politi, Enright, & Weihs, 2007; 
Schroevers, Ranchor, & Sanderman, 2004; Vinokur, Threatt, Vinokur-Kaplan, & 
Satariano, 1990; Wenzel et al., 1999). Cross-study methodological inconsistencies make 
it difficult to draw conclusions about the role of pain in the relationship between age and 
depressive symptoms in people with cancer. Chapter 4 therefore presents the first 
preliminary investigation of the moderating role of pain in the relationship between age 
and depressive symptoms in women who do and do not experience pain three months 
after surgery for breast cancer. In Chapter 5, the methodological and theoretical 
contributions of these findings are discussed as well as directions for future studies and 
implications for treatment. 
Introduction 
Cancer Pain 
Although cancer can be accompanied by a constellation of disabling and 
distressing symptoms, pain is among the most common and feared symptoms (Cleeland, 
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1998). Over 80% of patients experience pain in the course of the disease (Bruera & Kim, 
2003), with the prevalence and severity increasing as the disease progresses (Bruera & 
Kim, 2003; McCarthy, Phillips, Zhong, Drews, & Lynn, 2000; Peng, Wu, Sun, Chen, & 
Huang, 2006). Cancer pain is highly complex and heterogeneous (Bruera & Kim, 2003; 
Caraceni & Portenoy, 1999). It may be caused by tumor involvement or metastatic spread 
to soft tissue, viscera or bone (Bruera & Kim, 2003; Cleary & Carbone, 1997), 
or treatments, such as radiation, surgery or chemotherapy (Bruera & Kim, 2003; Caraceni 
& Portenoy, 1999; Jacox, Carr, & Payne, 1994; King & Arnold, 2005; McGuire, 2004). 
It may be nociceptive, arising from activation of afferent nerves in somatic tissue or 
viscera (Caraceni & Portenoy, 1999; Portenoy, 1989; Portenoy & Lesage, 1999) or 
neuropathic, arising from damage to the peripheral and/or central nervous systems 
(Backonja, 2003). A substantial number of patients may experience both types of pain 
(Grond et al., 1999). In fact, it has been estimated that 85% of patients experience more 
than one type of pain with 40% experiencing four or more types of pain (Twycross, 
Harcourt, & Bergl, 1996). Similar to nonmalignant pain, there is not a direct relationship 
between the extent of tissue damage and pain severity (Turk, 2002; Turk et al., 1998; Wu, 
Beaton, Smith, & Hagen, 2010). While the psychosocial correlates of nonmalignant pain 
have been well documented (Keefe, Rumble, Scipio, Giordano, & Perri, 2004 ), there has 
been significantly less attention to the role of these correlates in cancer pain. To date, the 
majority of the literature has focused almost exclusively on the biological correlates of 
cancer pain (Keefe, Abernethy, & Campbell, 2005; Turk, 2002). Nonetheless, there is 
emerging evidence that psychosocial factors are important in cancer pain (Keefe, 
Abernethy, & Campbell, 2005; Turk et al., 1998), and the need for further research has 
been recognized (Turk & Fernandez, 1990). 
Age-Related Patterns in Cancer Pain 
Cancer is a disease of the older person (CCS, 2013). It has been estimated that 
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71 % of new cases and 61 % of cancer deaths occurred in people aged 60 and older(CCS, 
2013). By 2031, 25% of Canadians will be aged 65 and older (Statistics Canada, 2007). 
Eighty percent of older cancer patients report pain (Walsh, Donnelly, & Rybicki, 2000), 
with more than half reporting severe pain (M. Z. Cohen, Musgrave, Munsell, Mendoza, 
& Gips, 2005). Unfortunately, older cancer patients may be less likely than younger 
patients to receive adequate pain treatment (Cleeland et al., 1994). There are significant 
gaps in our understanding of age-related patterns in cancer pain. They are outlined below 
in relation to key domains of interest, namely pain intensity, qualities, and interference. 
Cancer Pain Intensity 
Studies of age-related patterns in cancer pain intensity have been inconsistent. 
While some find that cancer pain increases with age (M. Z. Cohen et al., 2005; Yates et 
al., 2002), others find that it decreases (W. Y. Cheung, Le, Gagliese, & Zimmermann, 
2011; Jordhoy et al., 2001; Mohile et al., 2011; Olden, Holloway, Ladwig, Quill, & van 
Wijngaarden, 2011; Soltow, Given, & Given, 2010; Stuver et al., 2012; Wilson et al., 
2009), and still others find no relationship (Caraceni & Portenoy, 1999; Cataldo et al., 
2013; Green & Hart-Johnson, 2010; Kelsen et al., 1995; McMillan, 1996; Rustoen, Fossa, 
Skarstein, & Mourn, 2003; Valeberg, Miaskowski et al., 2008; Vigano, Bruera, & Suarez-
Almazor, 1998; G. M. Williamson & Schulz, 1995). However, these studies suffer from a 
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number of methodological limitations which make it difficult to draw conclusions about 
the relationship between cancer pain and age. Many were not designed a priori to assess 
age-related patterns, thus older people are underrepresented (e.g. Caraceni & Portenoy, 
1999; W. Y. Cheung et al., 2011; Jordhoy et al., 2001; Kelsen et al., 1995; Mohile et al., 
2011; Olden et al., 2011; Stuver et al., 2012; Valeberg, Miaskowski et al., 2008; Wilson 
et al., 2009; Yates et al., 2002). Others used pain assessment tools that may not be valid 
for use across the adult life span (e.g. Kelsen et al., 1995; Olden et al., 2011; Soltow et 
al., 2010; G. M. Williamson & Schulz, 1995; Wilson et al., 2009; Vigano et al., 1998). 
Additionally, many have confounded prevalence with intensity and do not report the 
number of people reporting pain by age group (e.g. Jordhoy et al., 2001; Mohile et al., 
2011; Rustoen et al., 2003; Stuver et al., 2012; G. M. Williamson & Schulz, 1995; 
Wilson et al., 2009). This may be important, as one study found that although there may 
be age-related patterns in pain prevalence, among those who do report cancer pain, 
intensity is not age-related (Cataldo et al., 2013). However, a large systematic review 
found that the prevalence of cancer pain was not associated with age (van den Beuken-
van Everdingen, M.H.J. et al., 2007). Unfortunately, these methodical limitations make it 
impossible to draw conclusions about age-related patterns, and they have hindered our 
understanding of cancer pain across the adult life span. Furthermore, these studies are 
limited in that they only tell us about pain intensity, or how much it hurts. Intensity alone 
insufficiently describes the multidimensional experience of pain (Jensen & Karoly, 
2011). Consequently, extending the investigation of age-related patterns in cancer pain to 
other domains, including pain qualities, and pain-related interference in important life 
domains, has substantial heuristic and clinical importance. This would provide us with a 
more refined understanding of age-related patterns in cancer pain and may contribute to 
tailored treatments. In Chapter 3, age related patterns in cancer pain intensity are 
described. 
Cancer Pain Qualities 
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The qualities of pain, or "how it feels" (Jensen & Karoly, 2011), can provide 
information about its pathophysiology and guide the selection of appropriate treatments 
(Caraceni et al., 2004; Dworkin et al., 2007; Harden & Cohen, 2003; Mercadante, 
Casuccio, Pumo, & Fulfaro, 2000; Vadalouca et al., 2012). Unfortunately, there have 
been no studies designed specifically to investigate age-related patterns in cancer pain 
qualities. In studies that have simply reported on the relationship between age and scores 
on the McGill Pain Questionnaire (MPQ [Melzack, 1975]), younger age has been 
associated with higher scores in one study (Greenwald, 1991), while in another, age was 
not associated with MPQ Pain Rating Index scores (Wilkie, Huang, Reilly, & Cain, 
2001 ). Our understanding of age-related patterns in cancer pain qualities remains 
seriously limited. In people with chronic nonmalignant pain, older people have obtained 
lower Total and Sensory scores on the MPQ or its short-form (Melzack, 1987) than 
younger people (Gagliese & Melzack, 1997a; Gagliese & Melzack, 2003). However, 
cancer pain may differ from chronic nonmalignant pain on a number of domains (Turk et 
al., 1998). It may therefore be inappropriate to generalize across patient populations. 
Studies assessing age-related patterns in the qualities of cancer pain are necessary. 
Chapter 2 reports on the first psychometric evaluation of the Short-Form McGill Pain 
Questionnaire-2 (SF-MPQ-2 [Dworkin et al., 2009]), a revised and expanded version of 
the SF-MPQ, in older and younger people with cancer pain. The study described in 
Chapters 2 and 3 is the first study designed a priori to investigate age-related patterns in 
cancer pain qualities. 
Cancer Pain Interference 
8 
More than one-third of cancer patients report that their pain interferes with 
psychological and physical functioning, including activities such as walking, working and 
socializing (Cleeland et al., 1994). Greater pain interference has been related to 
inadequate pain management, increased distress about pain and other symptoms, 
depression, anxiety, comorbidities and decreased functional status (Castel et al., 2007; 
Cleeland et al., 1994; Ferreira et al., 2008; Mystakidou et al., 2006; Vallerand, Templin, 
Hasenau, & Riley-Doucet, 2007; Wells, Murphy, Wujcik, & Johnson, 2003; G. M. 
Williamson & Schulz, 1995). Age-related patterns in cancer pain interference have 
received limited attention. In the small number of studies that have addressed this, age 
has been unrelated to pain interference (M. Z. Cohen et al., 2005; Green & Hart-Johnson, 
2010; Soltow, Given, & Given, 2010; Wells, Murphy, Wujcik, & Johnson, 2003); 
however, in one study, older adults reported greater pain-related interference with 
walking than younger adults (Mohile et al., 2011). Unfortunately, these studies have not 
always taken into account a broad range of factors, including comorbidities and 
functional status, which may be important to consider when assessing age-related 
patterns. In Chapter 3, age related patterns in cancer pain interference are described. 
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Methodological Considerations 
Several factors must be considered in the design and execution of studies of age-
related patterns in cancer pain in order to maximize internal and external validity. First, 
the lack of a universal age-cutoff that defines older adults has limited cross-study 
comparisons (Gagliese, 2009). An age-group cutoff of 60 has been identified as having 
clinical relevance (Cataldo et al., 2013; Gagliese & Katz, 2003; Gagliese & Melzack, 
2003; Gagliese, Weizblit, Ellis, & Chan, 2005; Green, Ndao-Brumblay, Nagrant, Baker, 
& Rothman, 2004; Green & Hart-Johnson, 2010; Kotkamp-Mothes, Slawinsky, 
Hindermann, & Strauss, 2005). For example, symptom clusters may differ between adults 
aged 60 and older and adults younger than 60 years old, adults aged 60 and older may 
also require longer time to achieve stable pain control than adults younger than 60 years 
old, and adults aged 60 and older may be less likely to be referred to psychosocial 
oncology than younger adults (W. Y. Cheung, Le, Gagliese, & Zimmermann, 2011; Ellis 
et al., 2009; Fainsinger et al., 2009). In this dissertation, adults aged 18 and over will be 
included and an age group cutoff of 60 years old for older adults will be used to 
maximize cross-study comparisons. Second, where possible, measures should be 
validated for use across the adult life span. Older and younger people should be equally 
able to use a tool and its validity and reliability should be similar across age groups 
(Gauthier & Gagliese, 2011). That way, if an age difference is detected, it may be 
interpreted as a possible age-related effect, rather than age differences in the way the tool 
operates. Chapter 2 describes age-related patterns in the use of the SF-MPQ-2. Third, 
missing data and loss-to-follow-up may be more likely with older than younger adults 
due to declining health and functional limitations (Hardy, Allore, & Studenski, 2009). 
These issues may present threats to external validity (Garland, Carlson, Marr, & 
Simpson, 2009; Hardy, Allore, & Studenski, 2009; Mody et al., 2008; Ransom, 
Azzarello, & McMillan, 2006) and it has therefore been suggested that it may be 
necessary to over-sample older adults to obtain the required sample size in order to 
maximize power to detect an age-related effect (Gagliese, 2009). 
Age-Related Patterns in the Correlates of Cancer Pain 
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In addition to assessing age differences in pain outcomes, such as pain intensity, 
qualities, and interference, it is important to consider whether their correlates vary with 
age. For example, in patients with chronic nonmalignant pain, there is emerging evidence 
suggesting that there are age-related patterns in the relationships between factors such as 
pain and depressive symptoms, regardless of age differences in those factors themselves 
(Cook, Brawer, & Vowles, 2006; Edwards, 2006; Mcllvane, Schiaffino, & Paget, 2007; 
Turk, Okifuji, & Scharff, 1995). In one study, pain interference and life control mediated 
the relationship between pain intensity and depression in younger but not older patients 
(Turk, Okifuji, & Scharff, 1995). In a separate study, although younger and older people 
with chronic nonmalignant pain reported similar pain intensity and levels of activity, 
greater pain intensity was more strongly related to reduced functioning in younger than 
older people (Edwards, 2006). Taken together, these data suggest that even if there is no 
age difference in an outcome, there may be age-related variation in its correlates 
(Gagliese, 2009). Chapter 3 presents an analysis of age-related patterns in the correlates 
of cancer pain, including biomedical (e.g., disease and treatment factors, cancer symptom 
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severity, comorbidities, chronic nonmalignant pain, and functional status), psychological 
(e.g., quality of life, depressive symptoms, traumatic stress, spirituality, and pain-related 
acceptance, anxiety, attitudes, and catastrophizing) and social factors (e.g., marital status 
and satisfaction, social support, perceptions of significant others' responses to pain, and 
attachment style). 
Although the correlates of chronic nonmalignant pain have been extensively 
studied across the biopsychosocial spectrum (Gatchel, Peng, Peters, Fuchs, & Turk, 2007; 
Keefe, Rumble, Scipio, Giordano, & Perri, 2004), until recently, the biomedical model of 
cancer pain has predominated (Keefe, Abernethy, & Campbell, 2005; Turk, 2002). This 
lack of attention may reflect the historical understanding of cancer pain as somehow 
unique or distinct from other types of pain. However, this has been increasingly 
challenged in recent years, especially since, like most other types of pain, there is not an 
isomorphic relationship between the extent of tissue damage due to cancer and the 
intensity of pain (Turk et al., 1998; Wu, Beaton, Smith, & Hagen, 2010). Nonetheless, 
our understanding of the role of psychosocial factors in the experience of cancer pain is 
in its infancy (Porter & Keefe, 2011 ), especially in regards to older adults. 
Life span developmental theory may contribute to our understanding of age-
related patterns in correlates of cancer pain outcomes. This theory suggests that adults 
experience a series of gains and losses as they age, with the balance favouring gains in 
younger adulthood and shifting to losses in older adulthood (P. B. Baltes, 1987). It is 
possible that pain due to advanced cancer represents a life course disruption that is 
perceived as developmentally off-time among younger but not older adults (Gagliese et 
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al., 2009; Revenson & Pranikoff, 2005). Consistent with this, a recent qualitative study 
found age-related patterns in responses to living with cancer pain despite similar severity 
and interference across age groups (Gagliese et al., 2009). Older adults employed 
accommodative strategies, such as acceptance, whereas younger adults had difficulty 
accommodating to living with ongoing cancer pain. This was the first study to identify 
age-related patterns in adaptation to cancer pain, despite a lack of age differences in pain 
intensity and interference. 
According to a life span developmental perspective, one's ability to adapt to 
lifecourse disruptions is also affected by a broad range of age-related biopsychosocial 
factors (Aldwin, Spiro, & Park, 2006). For instance, several unique physiological 
characteristics of older people, including greater comorbidity, polypharmacy, declining 
functional status, and the presence of nonmalignant chronic pain (Cancer and aging, 
2007; Curless, French, Williams, & James, 1994; Davis & Srivastava, 2003; Extermann, 
2000a; Mercadante, Casuccio, Pumo, & Fulfaro, 2000; Yancik & Ries, 2000) may 
contribute to pain homeostenosis, the decreased ability to effectively respond to the stress 
of ongoing pain (Karp, Shega, Morone, & Weiner, 2008) and may make older people 
more vulnerable to poor outcomes, such as prolonged recovery and impaired functioning 
(Gagliese, 2009). Thus, these issues must be considered in the examination of the impact 
of cancer pain across the adult life span, as their importance may change based on life 
stage, however to date, these issues have received limited attention. 
The studies included in this dissertation draw on life span developmental theory 
(Aldwin, Spiro, & Park, 2006; Baltes, M. M.,& Carstensen, 1996; P. B. Baltes, 1987; 
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Schulz & Heckhausen, 1996) and the biopsychosocial model of pain (Gatchel, Peng, 
Peters, Fuchs, & Turk, 2007) as well as the cancer and nonmalignant pain research 
literature (Keefe, Rumble, Scipio, Giordano, & Perri, 2004; Keefe, Abernethy, & 
Campbell, 2005; Porter & Keefe, 2011; Turk et al., 1998) to identify the most salient 
factors to the experience of cancer pain across the adult life span. For most of these 
factors, prior research into age-related patterns in their relationship with cancer pain 
intensity, qualities, and interference, is not available. As such, the review of these factors 
below is limited by the available evidence. Each chapter also presents a more focused 
literature review relevant to the particular study. 
Physical and Psychosocial Correlates 
In addition to pain, cancer patients may experience multiple distressing 
symptoms, including fatigue, nausea, anorexia, shortness of breath, depression and 
anxiety (Bruera, Kuehn, Miller, Selmser, & Macmillan, 1991). Predictors of symptom 
distress and intensity include female sex, functional status and pain severity (Wilson et 
al., 2009; Zimmermann et al., 201 Ob). Symptom intensity may mediate the relationship 
between pain intensity and interference (Vallerand, Templin, Hasenau, & Riley-Doucet, 
2007). While one study reported that age was not related to overall symptom intensity 
(Zimmermann et al., 201 Ob), another study reported that younger patients had a higher 
prevalence of distressing symptoms (Kirkova et al., 2010). These studies indicate that the 
severity of other cancer symptoms is important to consider, but it is difficult to draw 
conclusions about age-related patterns in the role of cancer symptoms because of the 
limited research and methodological differences across these studies. 
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Quality oflife (QOL) can be broadly conceptualized as subjective wellbeing in 
the physical, social, and emotional domains (Felce & Perry, 1995; Hickey, Barker, 
McGee, & O'Boyle, 2005). Interestingly, when compared to younger people with chronic 
nonmalignant pain, older people report worse physical but better mental health QOL 
(Wittink et al., 2006). A similar pattern has been found in people with cancer; older 
patients report more physical but less psychological impairment than younger patients 
(Cimprich, Ronis, & Martinez-Ramos, 2002; Greimel, Padilla, & Grant, 1997; Jordhoy et 
al., 2001; Mohamedali et al., 2012; Schroevers, Ranchor, & Sanderman, 2004). In a 
recent study, older people with cancer pain had better emotional functioning but greater 
decline in physical functioning over time than younger people (Green & Hart-Johnson, 
2010). 
From 25 to 50% of patients with cancer pain report depressive symptoms (Hann, 
Winter, & Jacobsen, 1999; Lawrie, Lloyd-Williams, & Taylor, 2004; Lloyd-Williams, 
Dennis, & Taylor, 2004). Its prevalence and intensity increase as the disease progresses 
(Gibson, Lichtenthal, Berg, & Breitbart, 2006). Cancer patients with pain report greater 
depression than pain-free patients (Glover, Dibble, Dodd, & Miaskowski, 1995; Spiegel, 
Sands, & Koopman, 1994). Depression is related to greater cancer pain interference 
(Cleeland, 1984). Although there have been recent mixed findings (Linden, Vodermaier, 
MacKenzie, & Greig, 2012; Mystakidou et al., 2005; Nelson et al., 2009), it has been 
suggested that older adults are less affected by cancer than younger adults, and 
experience less depression, anxiety and distress (Blank & Bellizzi, 2008). In studies that 
do not measure pain, older cancer patients report lower depression than younger patients 
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(Compas et al., 1999; Kroenke et al., 2004; Politi, Enright, & Weihs, 2007; Schroevers, 
Rancher, & Sanderman, 2004; Vinokur, Threatt, Vinokur-Kaplan, & Satariano, 1990; 
Wenzel et al., 1999). However, in the context of cancer pain, younger and older adults 
report comparable levels of depression (Gagliese, Gauthier, & Rodin, 2007; Green & 
Hart-Johnson, 2010; Kai-hoi Sze, Wong, Lo, & Woo, 2000; Knotkova, Clark, Mokrejs, 
Padour, & Kuhl, 2004; G. M. Williamson & Schulz, 1995). Cross-study differences in the 
operationalization of distress and depression (Nelson et al., 2009), or the measurement of 
distress and depression at different time points in the cancer continuum may contribute to 
the mixed findings. It may also be possible that certain symptoms, such as pain, operate 
as risk factors for depressive symptoms similarly across age groups, however, this has yet 
to be investigated. 
Intrusive and avoidant thoughts indicative of clinically relevant traumatic stress 
may be common in cancer patients (Butler, Koopman, Classen, & Spiegel, 1999; Norton 
et al., 2004). Younger patients may report more intrusive thoughts and fewer avoidant 
thoughts than older patients (Butler, Koopman, Classen, & Spiegel, 1999; Hart et al., 
2012; Schroevers, Rancher, & Sanderman, 2004; J. Turner, Kelly, Swanson, Allison, & 
Wetzig, 2005) but these studies did not measure pain. Traumatic stress may be lower in 
older than younger adults with nonmalignant pain (Stalnacke & Ostman, 2010). 
However, the relevance of these findings in the context of cancer pain remains to be 
demonstrated. 
Pain-related anxiety and catastrophizing may also be important to consider. In 
patients with nonmalignant pain, pain anxiety, or fearful and anxious reactions to pain-
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related stimuli, is an important correlate of physical disability and psychological 
wellbeing (Bums, Mullen, Higdon, Wei, & Lansky, 2000; McCracken, Faber, & Janeck, 
1998). Similar to younger adults (McCracken, Zayfert, & Gross, 1992), it has been 
related to worse self-rated health among older community dwelling adults (K. L. Bishop, 
Ferraro, & Borowiak, 2001). Older cancer and nonmalignant pain patients have reported 
lower pain anxiety than younger patients (Cook, Brawer, & Vowles, 2006; Mosher & 
Danoff-Burg, 2005). 
Pain catastrophizing, which is characterized by rumination, magnification, and 
negative appraisals of one's ability to manage pain (Sullivan, Bishop, & Pivik, 1995), 
may also be used to convey distress and elicit support (Sullivan, Thom, Haythomtwaite, 
Keefe, Martin, Bradley, & Lefebvre, 2001). Consistent with this, cancer patients who 
catastrophize report receiving more instrumental, but not emotional support from 
significant others (Keefe et al., 2003). However, in both nonmalignant and cancer pain 
patients, catastrophizing is related to greater pain interference and poorer functional 
wellbeing and QOL (S. Bishop & Warr, 2003; Boothby, Thom, Overduin, & Ward, 2004; 
Novy et al., 2005; Sullivan, Thom, Haythomtwaite, Keefe, Martin, Bradley, & Lefebvre, 
2001 ). The evidence regarding age-related patterns in pain catastrophizing is mixed 
(Keefe & Williams, 1990; Sorkin, Rudy, Hanlon, Turk, & Stieg, 1990; J. A. Turner, 
Mancl, & Aaron, Jul 2004; Watkins, Shifren, Park, & Morrell, 1999). Interestingly, in 
one study, older patients with nonmalignant pain report greater catastrophizing than 
younger patients in the presence of mild but not severe pain (Watkins, Shifren, Park, & 
Morrell, 1999), therefore, pain severity may be an important mediator of these 
relationships. Methodological differences, including different measures used to assess 
catastrophizing, may also account for the inconsistent findings across studies. 
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Pain acceptance involves acknowledging pain while redirecting efforts from 
attempts to control pain toward living a fulfilling life despite pain (McCracken, 1998). In 
patients with nonmalignant pain, it is related to better physical and psychological 
wellbeing (McCracken, 1998; McCracken & Eccleston, 2005; McCracken & Eccleston, 
2006; Vowles, McCracken, & Eccleston, 2007; Vowles, McCracken, & Eccleston, 2008). 
We recently found that pain acceptance was an important correlate of psychological 
wellbeing, but not physical functioning in people with cancer pain (Gauthier et al., 2009). 
Similarly, in a recent qualitative study, acceptance emerged as a key method of positive 
adaptation to cancer pain (Gagliese et al., 2009). Specifically, older adults were more 
likely than younger adults to describe acceptance as a way to modify important activities 
and pursue goals despite cancer pain. In contrast, younger adults were more likely to 
describe being unable or unwilling to accept their pain. Quantitative studies of age-
related patterns in acceptance of cancer pain are not available. 
Spirituality is the meaning and value by which people understand and live their 
lives and it exists separately from religious belief systems (Brady, Peterman, Fitchett, 
Mo, & Cella, 1999; Muldoon & King, 1995). It has been related to both higher and lower 
nonmalignant pain intensity (Rosenstiel & Keefe, 1983; J. A. Turner & Clancy, 1986) 
but not pain interference (Abraido-Lanza, Vasquez, & Echeverria, 2004). While it is 
emerging as an important predictor of better physical and psychological wellbeing in 
patients with cancer (Brady, Peterman, Fitchett, Mo, & Cella, 1999; Canada, Murphy, 
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Fitchett, Peterman, & Schover, 2008; Lo et al., 2010), its role in adaptation to cancer pain 
is less understood. In older cancer pain patients, greater spirituality has been related to 
greater pain interference, but not intensity (M. Z. Cohen, Musgrave, Munsell, Mendoza, 
& Gips, 2005). Age-related patterns in spirituality and its relation to cancer pain remain 
to be elucidated. 
Social support is an important predictor of wellbeing in cancer patients across age 
groups (Baider et al., 2003). In older patients, greater perceived support reduces feelings 
of uncertainty, anxiety and depression (Lien, Lin, Kuo, & Chen, 2009). Its relationship to 
cancer pain is less clear, with some studies finding it is related to lower pain and others 
finding no relationship (Kelsen et al., 1995; Koopman, Hermanson, Diamond, Angell, & 
Spiegel, 1998). While younger cancer patients have reported worse social functioning 
than older patients (Lintz et al., 2003), threatened social support has been associated with 
greater pain interference in both middle-aged and older adults (Peat, Thomas, Handy, & 
Croft, 2004). It is difficult to draw conclusions about age-related patterns in support and 
its impact on cancer pain because of the different definitions of support across studies 
(Zaza & Baine, 2002). 
With specific regard to supportive responses to pain, perceptions of solicitous, 
distracting or negative or punishing responses to pain from significant others may be 
important correlates of cancer pain. In chronic nonmalignant pain patients, more 
frequently perceived solicitous responses predicts greater pain, pain-related disability and 
social support and more frequently perceived negative responses predicts lower pain and 
pain-related disability (Boothby, Thom, Overduin, & Ward, 2004; Kerns, 
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Haythornthwaite, Southwick, & Giller, 1990; J.M. Romano, Turner, Jensen, & 
Friedman, 1995). However, a unique social context of cancer pain has been suggested 
whereby cancer patients are more likely than people with chronic nonmalignant pain to 
perceive more frequent solicitous responses from their significant others (Turk et al., 
1998), therefore it may be inappropriate to generalize findings from people with chronic 
nonmalignant pain to people with cancer pain. Age-related patterns in perceptions of 
supportive responses to cancer pain have not been investigated. 
The effectiveness of support depends on the extent to which one is able to elicit 
and respond to support (Mikulincer & Shaver, 2003). The attachment system is activated 
in response to perceived stressful situations, such as advanced disease (Mikulincer & 
Shaver, 2003; Rholes, Simpson, & Stevens, 1998). In studies of chronic nonmalignant 
pain, insecure attachment is associated with higher pain, depression and disability 
(Ciechanowski, Sullivan, Jensen, Romano, & Summers, 2003; Davies, Macfarlane, 
McBeth, Morriss, & Dickens, 2009; L. A. Mc Williams, Cox, & Enns, 2000). In patients 
with advanced cancer, attachment anxiety buffered the effects of symptom distress on 
depressive symptoms and attachment security was associated with increasing age (Lo et 
al., 2009; Rodin et al., 2007). It is possible that age-related patterns in attachment security 
may impact on perceptions of support in relation to cancer pain; however, this has yet to 
be investigated. 
1 Marital satisfaction is an important mediator of the relationships between pain and 
responses to pain. For example, negative responses are related to lower pain interference 
in non-maritally distressed patients only (Flor, Turk, & Rudy, 1989). Marital satisfaction 
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and collaborative coping may increase with advancing age (Dixon & Gould, 1996; Flor, 
Turk, & Rudy, 1989). For example, in a recent qualitative study, more older than younger 
patients described strengthened marital relationships arising from their partner's 
expressions of support and empathy. In contrast, more younger than older patients 
described marital strain and conflict related to their ongoing pain (Gagliese et al., 2009). 
These provocative results suggest age-related patterns in marital and relational 
functioning in the context of cancer pain, but large-scale, quantitative studies are needed. 
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BRIDGE FROM CHAPTER 1 TO CHAPTER 2 
As described in Chapter 1, to date, the majority of studies of age-related patterns in 
cancer pain have focused on pain intensity (e.g. W. Y. Cheung, Le, Gagliese, & 
Zimmermann, 2011; Olden, Holloway, Ladwig, Quill, & van Wijngaarden, 2011; Stuver 
et al., 2012; Valeberg, Miaskowski et al., 2008). However, pain is multidimensional 
(Melzack & Casey, 1968) and intensity alone may not sufficiently describe its experience 
(Jensen & Karoly, 2011). Moreover, proper pain assessment is fundamentally important 
to pain management. The McGill Pain Questionnaire is the most widely used measure of 
the multidimensional qualities of pain. It has recently been expanded and revised but the 
validity and reliability of this revised tool, the Short-Form McGill Pain Questionnaire-2, 
in people with cancer pain and in people of different age groups has not been examined. 
This is necessary in order to ensure that the tool measures what it is supposed to measure 
the same way for older and younger people. In Chapter 2, the validity and reliability of 
this measure was investigated in older and younger people with cancer pain. 
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Introduction 
Although cancer can occur at any age, it is a disease of older people (Canadian 
Cancer Society [CCS], 2013). Pain is among the most common symptoms (Cleeland, 
1998), and increases in prevalence and severity as the disease progresses (Bruera & Kim, 
2003; McCarthy, Phillips, Zhong, Drews, & Lynn, 2000; Peng, Wu, Sun, Chen, & 
Huang, 2006). With the aging of the population (Statistics Canada, 2007), there will be 
increasing numbers of older people who will require treatment for cancer pain. 
Unfortunately, it remains poorly understood and undertreated in older people (Bernabei et 
al., 1998; Cleeland et al., 1994; Gao, Gulliford, & Higginson, 2011; Higginson & Gao, 
2012; Yun et al., 2004). Proper treatment requires assessment methodologies that are 
appropriate for use in people of all ages. However, some pain assessment scales have not 
been validated in older cancer patients. This is necessary to ensure that scales function 
similarly across age groups (G. W. Cheung & Rensvold, Apr 2002; G. W. Cheung & 
Lau, Apr 2012). 
The McGill Pain Questionnaire (MPQ [Melzack, 1975]) and its short-form, the 
SF-MPQ (Melzack, 1987), are the most widely used measures of the sensory and 
affective qualities of pain (Jensen, 2003b ). There is a strong body of evidence supporting 
their validity and reliability in people with cancer (Jensen, 2003b; Ngamkham et al., 
2012). In people with chronic nonmalignant pain, the validity, reliability and feasibility 
of the MPQ and SF-MPQ are not age-related (Fuentes, Hart-Johnson, & Green, 2007; 
Gagliese & Melzack, 1997a; Gagliese & Katz, 2003; Gagliese & Melzack, 2003; 
Gagliese, Weizblit, Ellis, & Chan, 2005). Although older and younger adults report the 
same pain intensity and choose the same words most frequently to describe their pain, 
older adults choose fewer sensory and affective words than younger adults (Gagliese & 
Melzack, 1997a; Gagliese & Melzack, 2003). 
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A revised version of the SF-MPQ, the SF-MPQ-2, has been published (Dworkin 
et al., 2009). It retains the sensory and affective qualities of the original SF-MPQ with 
additional neuropathic pain qualities. This is especially relevant to the assessment of 
cancer pain, which may be nociceptive (e.g. activation of afferent nerves in somatic tissue 
or viscera [Caraceni & Portenoy, 1999; Portenoy, 1989; Portenoy & Lesage, 1999]) or 
neuropathic (e.g. pain and sensory symptoms from damage to the peripheral and/or 
central nervous systems [Backonja, 2003]) or both (Grond et al., 1999). The 4-point 
intensity rating scale of the SF-MPQ was expanded to 11-point Numeric Rating Scales 
(NRS) to increase responsiveness (Dworkin et al., 2009). This response format is 
acceptable for use across the adult life span (Gauthier & Gagliese, 2011). The SF-MPQ-2 
was validated initially in people with chronic pain and with diabetic neuropathy 
(Dworkin et al., 2009). Four subscales have been identified, including the original 
Affective subscale and three sensory subscales measuring Continuous, Intermittent and 
Neuropathic pain qualities. The SF-MPQ-2 has demonstrated good convergent validity 
with measures of pain and quality of life' (QOL [Dworkin et al., 2009]). Its psychometric 
properties for assessment of cancer pain have yet to be investigated. Although the four-
factor structure recently was confirmed in veterans with chronic nonmalignant pain 
(Lovejoy, Turk, & Morasco, 2012), the age range of the sample was restricted and 
analyses by age were not included. Thus, our understanding of the appropriateness of the 
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scale for older people remains limited. The objective of this study was to evaluate age-
related patterns in the use of the SF-MPQ-2 and compare its psychometric properties in 
younger and older people with cancer pain. We hypothesized that, similar to people with 
chronic nonmalignant pain, (la) older patients would choose fewer words than younger 
patients, but (1 b) the most commonly chosen words would be selected by a similar 
proportion of older and younger patients and ( 1 c) there would be no age related patterns 
in the intensity of each chosen word. (2) Construct and (3) convergent validity and ( 4) 
internal consistency reliability would not be age-related. 
Methods 
Participants 
People attending outpatient clinics at a comprehensive cancer centre and those 
receiving home palliative care in Toronto, Canada, were recruited between May, 2006 
and August, 2012 for a larger study of cancer pain (previously we have published 
separate analyses with smaller subsets of this sample that did not focus on the SF-MPQ-2 
[Gauthier et al., 2009; Gauthier et al., 2012]). Patients who were 2'.:18 years of age, who 
had advanced cancer (metastatic or non-resectable disease [American Cancer Society, 
2012a; National Cancer Institute, 2005]) and pain due to the disease or treatment, and 
sufficient English language ability to provide informed consent and complete the 
questionnaires were eligible for this study. Those with documented cognitive impairment 
as identified by their healthcare provider or medical chart, or those who scored below the 
cutoff score on our cognitive screen (Katzman et al., 1983), were not eligible to 
participate. Ethical approval was obtained from the Research Ethics Boards of the 
University Health Network (UHN), York University and Mount Sinai Hospital. 
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Outpatients who reported pain to their healthcare providers were informed of the 
research study by clinic staff. Physicians providing home palliative care identified 
potentially eligible participants. The Research Assistant (RA) approached patients in the 
outpatient clinics or telephoned them if they were receiving home palliative care, then 
explained the study and obtained written informed consent from those who wished to 
participate. Following consent, the RA administered the Short Orientation Memory 
Concentration Test (SOMC [Katzman et al., 1983]). Those who scored <20 were 
withdrawn from the study. This cutoff has been shown to discriminate patients with and 
without cognitive impairment (Katzman et al., 1983) and has been used in studies of 
patients with similar disease characteristics (Rodin et al., 2007). The RA then collected 
demographic, disease and treatment-related information from eligible participants. They 
were provided with a questionnaire package which they completed with the help of the 
RA or took home to complete. Those who took the questionnaire home were provided 
with postage-paid, addressed envelopes and telephoned two weeks following recruitment 
if they had not returned the questionnaire package. Reasons for participant withdrawal 
were recorded. 
Two age groups were formed, consisting of younger (aged 18-59) and older 
patients (aged 2'.:. 60 years old). These age groupings are consistent with previous studies 
of age differences in chronic nonmalignant, postoperative and cancer pain as well as 
psychological adjustment to cancer (Cataldo et al., 2013; Gagliese & Katz, 2003; 
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Gagliese & Melzack, 2003; Gagliese, Weizblit, Ellis, & Chan, 2005; Green, Ndao-
Brumblay, Nagrant, Baker, & Rothman, 2004; Green & Hart-Johnson, 2010; Kotkamp-
Mothes, Slawinsky, Hindermann, & Strauss, 2005). Initially, older patients were matched 
to younger patients based on sex and primary tumor type in a 1 : 1 matching system. When 
there were more older or younger patients in a given sex and primary tumor group (e.g. 
there were more older than younger men with genitourinary cancers; Figure 1 ), these 
additional patients were included in the analysis in order to maximize power to detect an 
age-related effect. This resulted in a sample of 244 patients (105 older and 139 younger 
patients) available for the analyses. Age groups were matched on these variables based on 
research suggesting possible sex and primary tumor type differences in cancer pain 
(Dobratz, 2008; Fillingim, King, Ribeiro-Dasilva, Rahim-Williams, & Riley, 2009; 
Grond, Zech, Diefenbach, Radbruch, & Lehmann, 1996; Miaskowski, 2004; Vainio & 
Auvinen, 1996). 
Twenty-five patients (5 older men and 4 older women; 7 younger men and 9 
younger women) could not be matched because their cancer types did not match across 
gender and age. For instance, there was one older man with breast cancer but no younger 
men with breast cancer. These participants did not differ from the other 244 participants 
on demographic, disease or treatment factors (all p 2:.08). They were excluded from the 
analyses. 
Measures 
Pain Qualities. The Short-Form McGill Pain Questionnaire-2(SF-MPQ-2 [Dworkin et al., 
2009]) was used to measure the qualities of pain. The initial version of the SF-MPQ-2 
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included items that assess 24 qualities of pain and the intensity of each quality on 11-
point numeric rating scales (NRS). Participants were instructed to choose the number 
that best described the intensity of the pain and related symptoms they felt during the past 
week or to select zero if the word did not describe their pain or related symptoms. In the 
initial validation of the scale, the Total score was calculated from the mean of 22 items 
and scores for Continuous (throbbing pain, cramping pain, gnawing pain, aching pain, 
heavy pain, tender), Intermittent (shooting pain, stabbing pain, sharp pain, splitting pain, 
electric-shock pain, piercing), Neuropathic (hot-burning pain, cold-freezing pain, pain 
caused by light touch, itching, tingling or "pins and needles", numbness), and Affective 
(tiring-exhausting, sickening, fearful, punishing-cruel) subscales were calculated from the 
mean of the items included in each subscale. Two items, dull pain and squeezing-
pressure, were not included in the final version of the SF-MPQ-2 because they did not 
differentiate people with and without neuropathic pain (Dworkin et al., 2009). We 
provide descriptive data for these items but do not include them in the psychometric 
analyses to remain consistent with the original validation study and subsequent studies 
validating the SF-MPQ-2 (Adelmanesh et al., 2012; Lovejoy, Turk, & Morasco, 2012). 
Pain Intensity and Interference. The Brief Pain Inventory (BPI [Cleeland & Ryan, 1994]) 
was used to assess pain intensity and interference from pain. The BPI includes four items 
that assess Worst, Least and Average pain intensity in the last 24 hours and Current pain 
intensity on 11-point NRSs anchored with the words "no pain" and "pain as bad as you 
can imagine. The Average pain question was used as the measure of pain intensity. The 
BPI also includes seven 11-point NRSs, anchored with the words "does not interfere" and 
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"completely interferes", which assess interference from pain in general activity, mood, 
walking ability, work, relations with others, sleep and enjoyment of life. The Pain 
Interference score is calculated from the average of these seven items. The BPI has been 
used extensively in people with cancer pain and has good psychometric properties (Ger, 
Ho, Sun, Wang, & Cleeland, 1999; Radbruch et al., 1999). 
Pain Relief and Analgesic Adequacy. Pain Relief was assessed with the BPI item that 
assesses relief from pain treatments or medications ranging from 0% (no relief) to 100% 
(complete relief). The adequacy of analgesia was assessed with the Pain Management 
Index (PMI [Cleeland et al., 1994]). This index is calculated by categorizing participants' 
scores on the BPI Worst Pain NRS into 4 categories (0: no pain; 1-3: mild; 4-7: moderate; 
8-10: severe). This value is then subtracted from the score assigned to the highest level of 
analgesic prescribed (Breitbart et al., 1996; Cleeland et al., 1994) according to the World 
Health Organization's (WHO) Analgesic Ladder (World Health Organization, 1990). 
Comorbidities. The Charlson Comorbidity Index (CCI [Charlson, Pompei, Ales, & 
MacKenzie, 1987]) was used to assess comorbidity load from 19 co-occurring conditions. 
The CCI is valid for use across the adult life span and with cancer patients (Extermann, 
2000a). Higher scores indicate greater comorbidity. The RA completed the CCI by 
reviewing medical charts. 
Functional Status. The Kamofsky Performance Status Scale (KPS [Kamofsky & 
Burchenal, 1949]) was used to assess functional status. It is an observer rated measure of 
patient functional autonomy and ability to participate in normal activities and self-care. 
Patient functional status is assessed on a scale ranging from I 00 (normal activity, no 
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evidence of disease) to 0 (dead). Consistent with the typical methodology for completing 
the KPS (Abernethy, Shelby-James, Fazekas, Woods, & Currow, 2005; Mor, Laliberte, 
Morris, & Wiemann, 1984), it was completed by one rater through observation and by 
asking brief questions. It has good psychometric properties in people with cancer (Yates, 
Chalmer, & McKegney, 1980), including good interrater reliability (Yates, Chalmer, & 
McKegney, 1980; Zimmermann et al., 2010a). The KPS was completed by the RA at the 
time of recruitment. 
Anticholinergic Load The Anticholinergic Drug Scale (ADS [Carnahan, Lund, Perry, 
Culp, & Pollock, 2002; Carnahan, Lund, Perry, Pollock, & Culp, 2006]) was used to 
assess the cumulative anticholinergic load of all medications. The ADS assigns a score to 
medications based on their anticholinergic potency. A score is derived by summing the 
scores assigned to all medications prescribed and taken by patients. The ADS has been 
validated against serum anticholinergic activity in older people (Carnahan, Lund, Perry, 
Culp, & Pollock, 2002). 
Depressive symptoms. The Center for Epidemiologic Studies- Depression Scale (CES-D 
[Radloff, 1977]) is a 20-item measure of current depressive symptoms and their 
frequency over the last week. It has been used extensively in people with cancer (Hann, 
Winter, & Jacobsen, 1999) and has excellent validity and reliability in people across the 
adult life span (Beeber, Shea, & McCorkle, 1998; Coyle & Roberge, 1992; Gauthier & 
Gagliese, 2011; Pasacreta, 1997). 
Physical and Mental Health Quality of Life. The Medical Outcomes Study Short Form-
36(SF-36 [Ware Jr. & Sherbourne, 1992]) Physical (PHC) and Mental (MHC) Health 
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Component Scores were used to assess physical and mental health quality oflife (QOL). 
The SF-36 is the most commonly used measure of health-related QOL (Gauthier & 
Gagliese, 2011) and has been used in diverse patient populations with good reliability 
(Ware et al., 1995). 
Data Analysis 
Age differences in demographic, disease, and treatment characteristics were 
calculated with i, Mann-Whitney U tests of medians and independent samples t-tests, 
where appropriate. 
Items that were left blank were coded as missing. The count and percentage of 
missing data for each item on the SF-MPQ-2 was calculated. Age differences in the 
proportion of missing data on each item and the number of missing items were tested 
with i analyses and independent samples t- tests. 
To test hypothesis (la-c), the number of words chosen (responses 2: 1110) on the 
SF-MPQ-2, the proportion of patients choosing each item, the severity of each chosen 
item and the proportion of patients with moderate-to-severe (2:5/10 on NRS) responses on 
each item were compared in older in younger patients using independent samples t-tests 
and i analyses. For this item analysis, a Bonferroni-corrected p value was used to 
control for multiple comparisons (adjusted a= .05/24 = .002). 
To test hypothesis (2), Confirmatory Factor Analysis (CF A) using Structural 
Equation Modeling (SEM) with Maximum Likelihood Estimation was used to test the 
construct validity of the SF-MPQ-2 according to the four subscales identified in previous 
validation studies (Dworkin et al., 2009; Lovejoy, Turk, & Morasco, 2012). Data were 
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first screened for outliers and violations of normality {Tabachnick & Fidell, 2012). Model 
fit was assessed with the standardized root mean square residual (SRMR < .08), root 
mean square of approximation (RMSEA < .10), comparative fit and Tucker-Lewis 
indices (CFI, TLI > .90) and the Akaike information criterion (AIC [Tabachnick & Fidell, 
2012; Ullman, 2006]). Using multigroups analysis procedures (G. W. Cheung & Lau, 
2012; Sass, 2011), the CFI difference test (~CFI) was evaluated to assess measurement 
invariance across age groups (G. W. Cheung & Rensvold, 2002). If ~CFI::; -0.01, then 
the null hypothesis of invariance should be retained (G. W. Cheung & Rensvold, 2002). 
The ~CFI test has been recommended over other~ Goodness-of-fit Indices (GFI) as it is 
not dependent on model complexity or sample size and is less stringent than other ~GFis 
(G. W. Cheung & Rensvold, 2002). A baseline configural model was fit simultaneously 
for both age groups in order to test whether the factor structure was a reasonable fit and 
to compare to future, more constrained models. A measurement invariance model was 
then fit in order to determine whether the factor loadings were invariant across age 
groups. Finally, structural invariance was tested by constraining the correlations between 
the latent variables to determine whether the latent factor intercorrelations were similar 
across age groups (G. W. Cheung & Rensvold, 1999; Sass, 2011). Interscale correlations 
were then calculated separately for younger and older patients using Pearson's correlation 
coefficients. Fisher's Z-transformation was calculated to compare the significance of the 
difference of each interscale pairwise correlation between younger and older patients. 
To test hypothesis (3), convergent validity was calculated using Pearson's 
correlation coefficients to assess associations between the Total and subscales of the SF-
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MPQ-2 and measures of pain intensity (BPI Average Intensity), interference (BPI 
Interference), analgesic treatment factors (PMI, Relief from pain treatments), physical 
functioning (KPS, SF-36 PHC), depressive symptoms (CES-D) and mental health quality 
oflife (SF-36 MHC). Analyses were conducted separately for younger and older patients 
and the magnitude of the correlations was compared with Fisher's Z-tests. 
Finally, to test hypothesis (4), Cronbach's Alpha was calculated separately for younger 
and older patients. The internal consistency of the Total and subscale scores was then 
compared across age groups (Feldt, Woodruff, & Salih, 1987; Lautenschlager & Meade, 
2008). All data were analyzed with SPSS or Analysis of Moment Structures (AMOS 
[Arbuckle, 1994]) version 20. 
Results 
Patient Characteristics 
Five hundred and thirty-eight patients were approached between May 2006 and 
August 2012. Three hundred and ninety-seven (73.8%) patients consented to participate 
and 141 (26.2%) refused to participate. Reasons for refusal to participate were lack of 
interest (n=55, 39.0%), lack of time (n=30, 21.3%), illness/fatigue (n=20, 14.2%), lack of 
pain despite reporting pain to healthcare providers (n=18, 12.8%), patient reported 
language, comprehension or memory issues (n=6, 4.3%), and inability to answer 
emotional questions (n=l, 0.7%). Seven (5.0%) people did not provide a reason, and the 
family caregivers of four (2.8%) patients refused access to the patient. There were no sex 
differences between those who consented to participate and those who refused, but those 
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receiving home palliative care were more likely to refuse to participate (84.0%) than 
those who attended outpatient clinics (23.4%; i(l) = 45.30,p :S .0001). The recruitment 
rate in home palliative care patients is consistent with previous studies (Husain et al., 
2007) and reflects the severity of illness in this population. Eighty older people (80/538; 
14.9%) refused to participate and 46 younger people (46/538; 8.6%) refused to 
participate. Age information was unavailable for 15 people (15/538; 2.8%) who refused 
to participate. 
Of those who consented to participate, three participants ( 1.1 % ) ~ 60 years old 
scored <20 on the SOMC and two participants (0.5%) < 60 years old reported that their 
pain was not cancer-related. These participants were withdrawn. One hundred and 
twenty-three people who initially consented to participate (123/397; 31.0%; 72 patients~ 
60 years old, 51 patients < 60 years old) did not return the questionnaire package. 
Reasons for failing to return the questionnaire package were illness due to disease 
progression (n=44; 35.8%), death (n=38; 30.9%) and lack of interest in continuing to 
participate (n=l 7; 13.8%). Three participants (2.4%) said they returned their 
questionnaire package via mail however it did no.t arrive, and 21 participants (17. l %) did 
not return the questionnaire package for unknown reasons. 
Compared to those who did not return the questionnaire package, those who 
returned the questionnaire package (n=269) were younger (57.56 ± 11.74 vs. 61.10 ± 
13.55,p =.01), more likely to identify as Caucasian than non-Caucasian (73.9% vs. 
56.4%,p =.001) and report that their primary language was English (72.1 % vs. 55.9%,p 
=.01). Although gender was not associated with return of the questionnaire (p = .26), 
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more participants with breast (80% vs. 20%, p =.05) and gynecologic cancers (94.1 % vs. 
5.9%,p =.001) returned the questionnaire package and fewer participants with other 
cancers (e.g. unknown primary tumor, hematologic, skin, endocrine, central nervous 
system cancers; 46.2% vs. 53.8%,p =.001) returned the questionnaire package compared 
to those who did not. Those who returned the questionnaire package had higher KPS 
(79.33 ± 10.48 vs. 75.16 ± 12.75,p =.001) and SOMC scores (Mann-Whitney-U test of 
medians: 26 (IQR: 24, 28) vs. 26 (IQR: 24, 27.50),p =.001) than those who did not. 
Demographic, disease and treatment characteristics of participants who matched 
on sex and primary tumor type and who were included in this analysis (n=244; see 
Participants) are presented in Table 1. The proportion of men and women in each age 
group did not differ. There were fewer older than younger single patients (11.4% vs. 
20.9,p = .05), more older than younger widowed patients (15.2% vs . . 7%,p = .001), 
more older than younger patients with elementary or high school as the highest level of 
education attained (45.7 vs. 29.5,p = .01), and fewer older than younger patients 
completing a college or bachelor's degree (38.l vs. 51.1,p = .04). 
There were more older than younger patients with genitourinary cancers (24.8% 
vs. 12.9%,p =.02), which is consistent with the incidence of some of these cancers in 
older adults (American Cancer Society, 2012b). There were no age differences in the 
duration of cancer or pain or the proportion of patients undergoing chemotherapy, 
radiation or hormone treatment. A similar proportion of older and younger patients 
reported concurrent chronic nonmalignant pain in addition to cancer pain. Although older 
and younger patients did not differ on anticholinergic load or polypharmacy, fewer older 
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than younger patients were prescribed an opioid (84.8% vs. 95.0%,p = .007). More older 
than younger patients had CCI scores >O (49.5 vs. 24.5,p =~.001), and older patients had 
worse KPS functional status (76.00 ± 10.52 vs. 81.22 ± 10.25,p ~ .001) than younger 
patients. 
Seven (2.9%; 5 [3.6%] younger and 2 [l.9%] older,p = .69) participants 
completed the questionnaire with the help of the RA. These participants reported better 
SF-36 MH QOL than those who did not complete the questionnaires with the RA (55.06 
± 10.86 vs. 43.11±11.33,p = .02). There were no other differences between these two 
groups (allp?:. .10). The proportion of patients with missing SF-MPQ-2 data did not 
differ between those who completed the questionnaires with the RA and those who did 
not (28.6% vs. 22.1 %, p =.65). 
Detailed Analysis of the SF-MPQ-2 
Missing data. In total, 54 participants (22.l %) had some missing data on the SF-
MPQ-2. Of these, 36 (66.7%) had missing data on one or more items and selected ?:.0/10 
on the remaining items. Sixteen (29 .6%) had missing data on one or more items and 
selected ?:.1110 on the remaining items. Only two participants (3.7%, 1 older and 1 
younger) left all 24 items blank. 
Participants with missing data were compared to those without missing data 
(n=l 90) on demographic, disease and treatment factors. Although those with missing data 
were older than those without missing data (60.57 ± 11.00 vs. 57.01 ± 11.55,p = .04), 
Cohen's d indicated this difference was small (Cohen's d = .3). There were no age group 
differences between those with complete versus missing data (Older: 26.7% vs. Younger: 
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18.7%,p = .14), or the median number of missing items (older: 2 vs. younger: 6,p = .18). 
An examination of the frequency of missing items revealed that the proportion of older 
and younger patients missing one item only versus 2:2 items did not differ (missing 1 
item: 11.4% vs. 5.0%; missing 2:2 items: 15.2% vs. 13.7%,p =.16). There were no 
differences on other demographic, disease or treatment factors or study measures (all p 
2:.08). Importantly, the older and younger patients did not differ on the highest level of 
education obtained (elementary or high school: 18.0% vs. college or bachelor's degree: 
23.4% vs. postgraduate degree: 27.3%,p =.4) or SOMC scores (Mann-Whitney-U test of 
medians: 26 (IQR: 24, 28) vs. 26 (IQR: 24,28),p =.7). 
Table 2 presents the proportion of missing data for each SF-MPQ-2 item for the 
total sample and for each age group. The amount of missing data for each item was low 
and ranged from 4.9% (Tiring-exhausting) to 9.8% (Piercing). There were no age 
differences in the proportion of those with missing data on each item. 
Age differences in pain, depressive symptoms and QOL. Older and younger 
patients did not differ on BPI Average Pain Intensity (3.70 ± 2.12 vs. 4.00 ± 2.12,p = 
.28), Pain Interference (4.67 ± 2.48 vs. 4.93 ± 2.37,p = .40), PMI <O (16.2% vs. 13.7%,p 
= .58), Relief from treatments or medications (66.28 ± 24.41 vs. 68.72 ± 24.54,p = .51), 
CES-D depressive symptoms (19.89 ± 11.06 vs. 21.60 ± 10.15,p = .21) or SF-36 
physical (29.40 ± 7.86 vs. 29.03 ± 7.39,p = .71 or mental health QOL (44.28 ± 11.66 vs. 
42.83 ± 10.54,p = .31). 
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Testing Hypothesis I: Age-related patterns in the number and severity of words 
chosen. 
Partially consistent with hypothesis (la), that older patients would choose fewer 
words to describe their pain, older patients chose fewer Affective words than younger 
patients (l.77 ± 1.37 vs. 2.13 ± 1.28,p = .04). Cohen's d indicated this difference was 
small (Cohen's d = -.3). There were no age differences in the number of words chosen 
from the Continuous (older: 3.29 ± 1.87 vs. 3.51±1.63, p=.34), Intermittent (older: 2.49 
± 2.05 vs. younger: 2.65 ± 1.97,p = .52) or Neuropathic subscales (older: 2.10 ± 1.62 vs. 
younger 2.39 ± 1.67,p = .17) or the overall number of words chosen (older: 10.60 ± 6.35 
vs. younger: 11.62 ± 5.68,p =.19). 
Consistent with hypothesis (1 b ), there were no age differences in the proportion 
of older and younger patients selecting each word (Figure 2; all p ~ .02). However, 
although their order differed, the same four words were selected by ~2/3 of older and 
younger patients. Older patients selected aching pain (83.8%), tiring-exhausting (77.0%), 
sharp pain (72.0%) and dull pain (69.7%) most often, while younger patients selected 
tiring-exhausting (87.1 %), aching pain, (79.2%), dull pain (76.3%) and sharp pain 
(67.7%) most often. Consistent with hypothesis (le), there were no age differences in the 
severity of each word selected. Also, there were no age differences in the proportion of 
older and younger patients with NRS scores~ 5/10 on each item (Table 4). 
Testing Hypothesis 2: Age-related patterns in construct validity. Four items were 
significantly skewed (splitting pain, electric-shock pain, cold-freezing pain and itching). 
A logarithmic transformation (In+ 1) normalized the distributions and these transformed 
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items were included in the SEM. Using the 22-item scale, Confirmatory Factor Analysis 
tested the factor structure previously described (Dworkin et al., 2009; Lovejoy, Turk, & 
Morasco, 2012) in people with complete data (n=190). 
Evaluation of the Mahalanobis distance revealed no multivariate outliers. A 
baseline configural model fit for both groups simultaneously demonstrated a reasonable 
fit, although the incremental fit indices, which may be sensitive to the magnitude of the 
correlations within the data ( Kenny & McCoach, 2003 ), are just below the cutoff criteria 
(SRMR = .08, RMSEA = .07, CFI = .78, TLI = .75, AIC = 972.90). A fully constrained 
measurement invariance model was then fit (SRMR = .09, RMSEA = .07, CFI = .77, TLI 
= .74, AIC = 927.39). The ~CFI test (~CFI = -0.01) indicated that this fully constrained 
measurement model was invariant across age groups, indicating that the overall fit of the 
model was the same for younger and older patients. In other words, consistent with 
hypothesis 2, younger and older patients associated the same SF-MPQ-2 items with the 
same latent factors or constructs (G. W. Cheung & Rensvold, 2002). The smaller AIC 
value in this model as compared to the baseline model suggests a better fit to the data 
(Ullman, 2006). Table 4 displays the standardized path coefficients for the final 22-items 
of the SF-MPQ-2 and the intercorrelations among the four latent factors for younger and 
older patients. Interestingly, itching had the lowest path coefficient for both younger and 
older patients. Finally, a structural invariance model was fit (SRMR = .10, RMSEA = 
.07, CFI = .76, TLI = .75, AIC = 970.44). The ~CFI test (~CFI = -0.02) just failed to 
make the cutoff of:::; -0. 01 for invariance of the intercorrelations between the latent 
factors. Consistent with this, Fisher's Z-tests revealed that the strength of the correlation 
between the Continuous and Intermittent and Continuous and Affective subscales was 
significantly stronger among older than younger patients (Table 5). There were no 
significant differences in the strength of the remaining interscale correlations. 
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A sensitivity analysis was conducted with data from the total sample (n=244), 
regardless of missing data. To retest the factor structure of the SF-MPQ-2 in younger and 
older patients regardless of missing data, full information maximum likelihood (FIML) 
model estimation was used to account for the missing data. The overall pattern of results 
was the same as with patients with complete data. 
Testing hypothesis 3: Age-related patterns in convergent validity. Table 6 
presents the tests of convergent validity among older and younger patients (n=244). The 
Total and subscales of the SF-MPQ-2 were correlated with more intense BPI Average 
pain. These correlations were positive and in the moderate-to-strong range suggesting 
that the SF-MPQ-2 and its subscales measure a dimension of pain that is closely related 
to pain intensity but sufficiently distinct to suggest that these may not be identical 
constructs. The SF-MPQ-2 was also associated with higher BPI Pain Interference and 
CES-D depressive symptoms, and lower Pain Relief and SF-36 Physical Health QOL and 
worse KPS functional status, further supporting the convergent validity of the SF-MPQ-2 
in people with cancer pain. 
Importantly, consistent with hypothesis 3, there were no age-related differences in 
the magnitude of most of the correlations when tested with a Fisher's Z-transformation. 
However, the correlations between the SF-MPQ-2 Continuous subscale and the SF-36 
MHC, a measure of mental health QOL, were significantly stronger among older than 
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younger patients. Interestingly, there were moderate, significant correlations between the 
PMI and most of the subscales of the SF-MPQ-2 in younger, but not older patients and 
the correlation between the PMI and the SF-MPQ-2 Continuous subscale was 
significantly stronger in younger than older patients. 
Testing Hypothesis 4: Age-related patterns in internal consistency reliability. 
Table 7 presents Cronbach's alpha for older and younger patients. It ranged from 
acceptable to excellent in each age group (Nunnally, 1978). In agreement with hypothesis 
4, there were no age differences in the internal consistency reliability of the subscales of 
the SF-MPQ-2. Cronbach's alpha for the Total score was significantly greater for older 
than younger patients Ci(l) = 4.06,p = .04). 
Discussion 
This study presents the first examination of the psychometric properties of the SF-
MPQ-2 for the assessment of cancer pain, including the first comparison of its use and 
psychometric properties in older and younger people. We found no age differences in 
missing data, suggesting that older and younger people with cancer pain are equally able 
to complete the scale. They chose the same words to describe their pain with the same 
level of intensity, suggesting that there are no age differences in the way the scale is used 
or in the predominant qualities of cancer pain. We found evidence for good internal 
consistency reliability and convergent validity, which were similar across age groups. 
Consistent with previous reports (Dworkin et al., 2009; Lovejoy, Turk, & Morasco, 
2012), a four-factor solution fit the data. Importantly, the same items loaded on each 
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factor across age groups, providing evidence for measurement invariance. Overall, the 
weight of the evidence suggests that the scale is appropriate for use- in younger and older 
people with cancer pain. 
The first consideration in determining the utility of an assessment tool is whether 
it can be completed by the group for whom it was designed (Streiner & Norman, 2008). 
Although it has been suggested that the MPQ is overwhelming for older people (Herr & 
Mobily, 1991; Herr & Garand, 2001), data supporting this claim are lacking. Instead, 
consistent with the majority of previous studies using the MPQ and SF-MPQ (Fuentes, 
Hart-Johnson, & Green, 2007; Gagliese & Melzack, 1997a; Gagliese & Katz, 2003; 
Gagliese & Melzack, 2003; Gagliese, W eizblit, Ellis, & Chan, 2005), we found no age-
related patterns in the ability to complete the SF-MPQ-2. Most participants with missing 
data left three or fewer items blank. There were no age differences in the percentage of 
missing data overall or by individual item. Importantly, missing data was not associated 
with education, which is consistent with previous studies using the full MPQ (Cook et al., 
2004; Gagliese, Weizblit, Ellis, & Chan, 2005; Wilkie et al., 2003). Given the available 
evidence, older and younger adults appear to be equally able to complete the SF-MPQ-2. 
In studies of adults with chronic nonmalignant pain, while the most commonly 
chosen descriptors of pain are the same across age groups, older people choose fewer 
sensory and affective items than younger people (Gagliese & Melzack, 1997a; Gagliese 
& Melzack, 2003). Partially consistent with this, we found that older people chose fewer 
affective words to describe their pain. However, the effect size of this difference was 
small. Moreover, older people chose the same number of sensory qualities as younger 
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people. There are two possible explanations for these discrepant findings across patient 
populations: One involves the revised construction of the SF-MPQ-2, which may elicit a 
similar pattern of responding across age groups. Consistent with studies using the NRS, 
which have demonstrated a lack of age differences in pain intensity (Gagliese & Melzack, 
1997a; Gagliese & Melzack, 2003; Gagliese, Weizblit, Ellis, & Chan, 2005; Green & 
Hart-Johnson, 2010; Valeberg, Miaskowski et al., 2008), we found no age differences in 
the intensity of each chosen quality. It is therefore possible that the use ofNRSs on the 
SF-MPQ-2 may account for the present findings. A second possibility may be that the 
qualities of cancer pain override the previously documented parsimonious response style 
of older people with chronic nonmalignant pain. For example, because a substantial 
minority of cancer patients experience neuropathic pain (Bennett et al., 2012; Caraceni & 
Portenoy, 1999; Grond, Zech, Diefenbach, Radbruch, & Lehmann, 1996), the addition of 
neuropathic qualities to the SF-MPQ-2 may influence responding in a similar way across 
age groups. Future studies of age differences in the use of the SF-MPQ-2 in people with 
chronic nonmalignant or acute pain may clarify these discrepancies across patient groups. 
In this sample of cancer patients reporting pain, we did not find support for the 
suggestion that older people are more reluctant to report pain (Yong, Bell, Workman, & 
Gibson, 2003) or less likely to endorse intense pain than younger people (Greenwald, 
1991; Nicholas, Asghari, & Blyth, 2008; Oberle, Paul, Wry, & Grace, 1990). Instead, we 
found no age differences in the selection or intensity of each pain quality. These data are 
consistent with studies of people with chronic nonmalignant pain that have shown that 
older and younger people choose the same words most frequently to describe their 
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pain(Gagliese & Melzack, 2003). Taken together, there is little evidence to suggest that in 
clinical samples of patients seeking symptom management, older people are reluctant to 
report pain or endorse intense pain. 
Construct validity, a critical component of psychometric evaluation, tests the 
extent to which a tool measures what it purports to measure (Jensen, 2003a). 
Confirmatory factor analysis is one method of assessing construct validity (Jensen, 
2003a). It tests how observed, measured variables converge on one or more unobserved, 
latent factors (Ullman, 2006). There is ongoing debate about the factor structure of 
earlier versions of the MPQ (Fernandez & Boyle, 2002; Holroyd et al., 1992; Holroyd et 
al., 1996; J. Katz & Melzack, 2011; Turk, Rudy, & Salovey, 1985; Wright, Asmundson, 
& McCreary, 2001), but the relevance of this to the SF-MPQ-2 is unclear. Our findings 
support the same four-factor solution- Continuous, Intermittent, Neuropathic, and 
Affective - that was previously found in diverse patient populations (Dworkin et al., 
2009; Lovejoy, Turk, & Morasco, 2012) and extend it to the assessment of cancer pain. 
Importantly, we found that the items that made up each latent factor were the 
same in older and younger patients with cancer pain. Related to this, the internal 
consistency reliability of the subscales, which estimates the degree to which a set of items 
are related to an underlying factor (Jensen, 2003a), did not differ across age groups. This 
is consistent with the evidence demonstrating a lack of age-related patterns in the factor 
structure of the MPQ (Fuentes, Hart-Johnson, & Green, 2007; Gagliese & Melzack, 
1997a; Gagliese & Katz, 2003; Gagliese & Melzack, 2003; Gagliese, Weizblit, Ellis, & 
Chan, 2005). While the strength of the interscale correlations were in the moderate-to-
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strong range for older and younger patients, the interscale correlations were somewhat 
stronger between the Continuous and Intermittent subscales and Continuous and 
Affective subscales in older than younger patients. The magnitude of the correlations in 
older patients was similar to those previously published (Lovejoy, Turk, & Morasco, 
2012). Future, larger scale studies are required to further investigate the importance of 
these small age-related differences. 
Convergent validity is an element of construct validity. It tests how well a scale 
correlates with other, known measures of the same construct (Jensen, 2003a). Consistent 
with the initial validation of the SF-MPQ-2 (Dworkin et al., 2009), tests of convergent 
validity revealed moderate-to-strong correlations with measures of pain intensity, pain 
interference, relief from pain medications or treatments, and functional status as well as 
small-to- moderate correlations with measures of physical health QOL and depressive 
symptoms. In further support of the convergent validity of the subscales, the correlations 
between the Affective subscale and the CES-D and SF-36 MHC were somewhat stronger 
than the correlations between the sensory subscales and these two measures of 
psychological functioning. There were no age-related patterns in the magnitude of most 
of these correlations. However, the SF-36 MHC was correlated with the sensory 
subscales of the SF-MPQ-2 in older, but not younger patients. Moreover, the correlation 
between the SF-MPQ-2 Continuous subscale and the SF-36 MHC was significantly 
stronger for older than younger patients. This may reflect age-related variation in the 
relationships between pain and some indices of emotional wellbeing (Cook, Brawer, & 
Vowles, 2006; Turk, Okifuji, & Scharff, 1995). For example, Turk et al.,(1995) found a 
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different relationship between pain and depression in older than younger patients with 
chronic nonmalignant pain. Interestingly, the PMI was correlated with most of the 
subscales of the SF-MPQ-2 in younger, but not older patients and the correlation between 
the PMI and the SF-MPQ-2 Continuous subscale was significantly stronger for younger 
than older patients. Although the PMI is the most widely used index of pain management 
adequacy (Deandrea, Montanari, Moja, & Apolone, 2008), its validity has been 
questioned (Russell, A veyard, & Oxenham, 2006). Thus, the meaning of this finding 
remains unclear and requires further investigation. Since the majority of correlations were 
similar across age groups, we may conclude that the convergent validity of the SF-MPQ-
2 is not age-related but that the relationship between pain and emotional wellbeing may 
be stronger in older than younger patients. This requires testing in future studies. 
In summary, these preliminary data suggest that the SF-MPQ-2 is appropriate for 
use in older and younger people with cancer pain. However, several limitations must be 
considered in the interpretation of these findings. Patients completed the SF-MPQ-2 only 
once. Thus it was not possible to investigate age-related patterns in test-retest reliability 
of the SF-MPQ-2. It will be important for future studies to do this. The majority of 
participants in this study were receiving specialized symptom management at a 
comprehensive cancer center, therefore the generalizability of these data to patients not 
receiving such care remains to be tested. It will also be important to investigate the 
psychometric properties of this version of the scale in different patient populations, 
including those at different points in the disease trajectory, including the end oflife. 
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In conclusion, these data demonstrate that the factor structure of the SF-MPQ-2 is 
equivalent across age groups and that older and younger patients who report cancer pain 
endorse the same words with the same intensity to describe their pain. Notably, they 
show that older people are not reluctant to endorse severe pain. There is emerging 
evidence of the sensitivity of the SF-MPQ-2 in people with chronic nonmalignant pain 
(Curtis, Osadchuk, & Katz, 2011). This should also be evaluated in people with cancer 
pain. Another important future direction would be to evaluate age-related patterns in the 
correlates of neuropathic and non-neuropathic sensory and affective pain qualities, 
separately. This would further our understanding of the predictive validity of the SF-
MPQ-2 (Lovejoy, Turk, & Morasco, 2012), contribute to the identification of age- or life-
stage-specific profiles of factors that are important to different pain qualities, and 
improve our understanding of cancer pain across the adult life span. 
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Table 1. Participant Characteristics 
Mean± SD; N (%) 
Total (n=244) Younger Older (n=l 05) p~ 
(n=139) 
Age (years) 57.79 ± 11.51 49.83 ± 7.19 68.34 ± 6.61 .0001 
(range: 21-87) 
18-29 3 (1.2) 
30-39 9 (3.7) 
40-49 46 (18.9) 
50-59 81 (33.2) 
60-69 62 (25.4) 
70-79 34 (13.9) 
80-89 9 (3.7) 
Sex (Female) 142 (58.2) 87 (62.6) 55 (52.4) .11 
Ethnicity (Caucasian) 191 (78.3) 106 (76.3) 85 (81.0) .38 
Primary Language (English) 206 (84.8) 120 (87.0) 86 (81.9) .28 
Marital Status 
Single 41 (16.8) 29 (20.9) 12 (11.4) .05 
Married/Partnered 159 (65.2) 94 (67.6) 65 (61.9) .35 
Separated/Divorced 27(11.1) 15 (10.8) 12 (11.4) .88 
Widowed 17 (7.0) 1 (.7) 16 (15.2) <.001 
Highest level of education 
completed 
Elementary or High 89 (36.5) 41 (29.5) 48 (45.7) .01 
School 
College or Bachelor's 111 (45.5) 71 (51.1) 40 (38.1) .04 
degree 
Postgraduate degree 44 (18.0) 27 (19.4) 17 (16.2) .52 
Primary Tumor Type 
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Gastrointestinal 60 (24.6) 35 (25.5) 25 (23.8) .81 
Breast 47 (19.3) 31 (22.3) 16 (15.2) .17 
Lung 45 (18.4) 22 (15.8) 23 (21.9) .23 
Genitourinary 44 (18.0) 18 (12.9) 26 (24.8) .02 
Gynecological 32 (13.1) 23 (16.5) 9 (8.6) .07 
Head& Neck 16 (6.6) 10 (7.2) 6 (5.7) .64 
Site of recruitment .41 
Palliative care 189 (77.5) 112 (80.7) 77 (73.3) 
Pain 19 (7.8) 11 (7.9) 8 (7.6) 
Temmy Latner Centre 3 (1.2) 1 (.7) 2 (1.9) 
Other solid tumor clinics 33 (13.5) 15 (10.8) 18 (17.1) 
Cancer duration (median 23.5 (11, 49.8) 24 (9, 48) 23 (11,50.5) .63 
(IQR) months) 
Pain duration (median (IQR) 11 (4.5, 22) 12 (5, 24) 9.5 (4, 19) .15 
months) 
Concurrent chronic 66 (27.0) 34 (24.5) 32 (30.5) .41 
nonmalignant pain 
Prescribed an opioid 221 (90.6) 132 (95.0) 89 (84.8) .007 
ADS 2.47 ± 2.07 2.58 ± 2.24 2.32 ± 1.82 .35 
Polypharmacy (count of 6.89 ± 3.91 6.87 ± 4.00 6.91±3.82 .93 
medications taken) 
Count of analgesics taken 2.54 ± 1.14 2.65 ± 1.21 2.39 ± 1.03 .09 
Chemotherapy, radiation or 132 (54.1) 82 (59.0) 50 (47.6) .08 
hormone treatment 
Nonpharmacological pain 142 (58.2) 81 (58.3) 61 (58.1) .98 
treatment 
CCI>O 86 (35.2) 34 (24.5) 52 (49.5) <.001 
KPS 78.98 ± 10.67 81.22 ± 10.25 76.00 ± 10.52 <.001 
SOMC (median [IQR]) 26 (24, 28) 26 (24, 28) 26 (24, 28) .24 
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Note. ADS, Anticholinergic Drug Scale; CCI, Charlson Comorbidity Index; KPS, 
Karnofsky Performance Status Scale; SOMC, Short Orientation Memory Concentration 
Test; IQR, Interquartile Range. 
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Table 2. SF-MPQ-2 missing data by item 
N (%) Missing 
Total Younger Older p~ 
(n=244) (n=139) (n=105) 
1. Throbbing pain 14 (5.7) 9 (6.5) 5 (4.8) .57 
2. Shooting pain 14 (5.7) 9 (6.5) 5 (4.8) .57 
3. Stabbing pain 16 (6.6) 9 (6.5) 8 (7.6) .56 
4. Sharp pain 14 (5.7) 9 (6.5) 5 (4.8) .57 
5. Cramping pain 14 (5.7) 9 (6.5) 5 (4.8) .57 
6. Gnawing pain 19 (7.8) 11 (7.9) 8 (7.6) .93 
7. Hot-burning pain 14 (5.7) 8 (5.8) 6 (5.7) .99 
8. Aching pain 15 (6.1) 9 (6.5) 6 (5.7) .81 
9. Heavy pain 21 (8.6) 13 (9.4) 8 (7.6) .63 
10. Tender 22 (9.0) 11 (7.9) 11 (10.5) .49 
11. Splitting pain 21 (8.6) 12 (8.6) 9 (8.6) .99 
12. Tiring-exhausting 12 (4.9) 7 (5.0) 5 (4.8) .92 
13. Sickening 16 (6.6) 9 (6.5) 7 (6.7) .95 
14. Fearful 19(7.8) 9 (6.5) 10(9.5) .38 
15. Punishing-cruel 19 (7.8) 10 (7.2) 9 (8.6) .69 
16. Dull pain* 14 (5.7) 8 (5.8) 6 (5.7) .99 
17. Electric-shock pain 21 (8.6) 12 (8.6) 9 (8.6) .99 
18. Squeezing-pressure* 21 (8.6) 11 (7.9) 10 (9.5) .66 
19. Cold-freezing pain 23 (9.4) 13 (9.4) 10 (9.5) .96 
20. Piercing 24 (9.8) 1~ (9.4) 11 (10.5) .77 
21. Pain caused by light touch 18 (7.4) 10 (7.2) 8 (7.6) .90 
22. Itching 19(7.8) 10 (7.2) 9 (8.6) .69 
23. Tingling or "pins and needles" 17 (7.0) 11 (7.9) 6 (5.7) .50 
24. Numbness 15 (6.1) 11 (7.9) 4 (3.8) .19 
*Excluded from the final scale by Dworkin et al., (2009) 
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Table 3. Item Analysis. Severity of individual SF-MPQ-2 items among those who chose each item (responses 2:1110) and the 
proportion of patients with moderate-to-severe pain (responses 2:5110) 
Severity of each item chosen N (%) with responses 2:5110 
Younger Older Younger Older 
Mean±SD Range Mean±SD Range p N(%) N(%) p 
Throbbing pain 4.90 ± 2.35 1-10 5.13 ± 2.71 1-10 .62 44 (33.8) 26 (26.0) .20 
Shooting pain 5.37 ± 2.64 1-10 5.16 ± 2.48 1-10 .66 44 (33.8) 27 (27.0) .27 
Stabbing pain 5.84 ± 2.55 1-10 4.95 ± 2.45 1-10 .06 48 (36.6) 26 (26.8) .12 
Sharp pain 5.64 ± 2.66 1-10 5.13 ± 2.44 1-10 .21 57 (43.1) 41 (41.0) .67 
Cramping pain 5.31±2.37 1-10 5.39 ± 2.43 1-10 .86 43 (33.1) 24 (24.0) .13 
Gnawing pain 5.23 ± 2.47 1-10 4.97 ± 2.36 1-10 .56 38 (29.7) 29 (29.9) .97 
Hot-burning 5.67 ± 2.71 1-10 5.42 ± 2.20 1-10 .64 35 (26.7) 21 (21.2) .34 
pain 
Aching pain 5.24 ± 2.49 1-10 5.16 ± 2.39 1-10 .83 61 (46.9) 45 (45.5) .83 
Heavy pain 5.67 ± 2.60 1-10 5.25 ± 2.63 1-10 .38 42 (33.3) 32 (33.0) .96 
Tender 5.07 ± 2.60 1-10 4.75 ± 2.39 1-10 .47 42 (32.8) 29 (30.9) .76 
Splitting pain 5.03 ± 2.54 1-10 4.72 ± 2.97 1-10 .65 21 (16.5) 17 (17.7) .82 
Tiring- 5.90 ± 2.67 1-10 5.93 ± 2.56 1-10 .93 77 (58.3) 53 (53.0) .42 
exhausting 
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Sickening 4.29 ± 2.76 1-10 4.65 ± 2.77 1-10 .50 28 (21.5) 20 (21.1) .82 
Fearful 4.63 ± 2.95 1-10 5.24 ± 2.58 1-10 .32 29 (22.3) 20 (21.1) .82 
Punishing- 5.76 ± 3.24 1-10 5.43 ± 2.62 1-10 .62b 30 (23.3) 19 (19.8) .53 
cruel 
Dull pain a 4.39 ± 2.22 1-10 4.63 ± 2.30 1-10 .50 48 (36.6) 33 (33.3) .60 
Electric-shock 5.76 ± 2.81 1-10 4.63 ± 2.45 1-9 .14 30 (23.6) 12 (12.5) .04 
pain 
Squeezing 5.32 ± 2.63 1-10 5.49 ± 2.52 1-10 .76 39 (30.5) 25 (26.3) .50 
pressure a 
Cold-freezing 4.06 ± 2.38 1-8 5.25 ± 2.14 1-8 .15 6 (4.8) 11 (11.6) .08 
pain 
Piercing 5.48 ± 2.78 1-10 4.68 ± 2.20 1-10 .13b 32 (25.4) 20 (21.3) .48 
Pain caused by 4.95 ± 2.59 1-10 4.27 ± 2.61 1-10 .17 37 (28.7) 19 (19.6) .12 
light touch 
Itching 3.86 ± 2.53 1-10 3.81±2.37 1-9 .94 15 (11.6) 10 (10.4) .78 
Tingling or 4.96 ± 2.80 1-10 4.65 ± 2.48 1-10 .54 40 (31.2) 22 (22.2) .13 
"pins and 
needles" 
Numbness 4.73 ± 2.67 1-10 4.96 ± 2.49 1-10 .64 42 (32.8) 27 (26.7) .32 
a Excluded from calculations of the Total and subscale scores by Dworkin et al 
b Levine's test indicated unequal variances, p value for equal variances not assumed 
Table 4. 22-item SF-MPQ-2 standardized path coefficients for younger and older 
patients (n=190). 
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~~~~~~~~~~~~~~~~~~~~~~~~~ 
Continuous Intermittent Neuropathic Affective 
Younger Older Younger Older Younger Older Younger Older 
Throbbing 
pam 
Cramping 
pam 
Gnawing pain 
Aching pain 
Heavy pain 
Tender 
Shooting pain 
Stabbing pain 
Sharp pain 
Splitting 
pain* 
Electric-
shock pain* 
Piercing 
Hot-burning 
pam 
Cold-freezing 
pain* 
.61 
.50 
.66 
.65 
.72 
.47 
Pain caused by light 
touch 
Itching* 
Tingling or "pins and 
needles" 
Numbness 
Tiring-
exhausting 
Sickening 
Fearful 
.67 
.60 
.67 
.66 
.73 
.52 
.69 
.63 
.69 
.70 
.55 
.68 
.78 
.69 
.69 
.75 
.65 
.71 
.65 
.57 
.56 
.25 
.49 
.48 
.71 
.46 
.58 
.25 
.54 
.46 
.73 .68 
.65 .65 
.63 .74 
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Punishing- .67 .78 
cruel 
Latent factor 
intercorre lations 
Continuous 1 1 
Intermittent .66 .88 1 1 
N europathic .74 .87 .63 .67 1 1 
Affective .82 .86 .67 .83 .78 .76 1 1 
* log transformed 
Table 5. SF-MPQ-2 Interscale Correlations for Younger and Older Patients (n=190). 
Younger Intermittent N europathic Affective 
Continuous .50*6 .52* .58*a 
Intermittent .47* .51 * 
N europathic .50* 
Older Intermittent Neuropathic Affective 
Continuous .74*6 .61 * .75*a 
Intermittent .62* .69* 
N europathic .55* 
* P ~ .01 two-tailed Pearson Correlation Coefficient 
a P ~ .05 for Fisher's Z-test comparison of correlations between younger and older 
patients 
b P ~ .01 for Fisher's Z-test comparison of correlations between younger and older 
patients 
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Table 6. Convergent validity for Younger and Older Patients. 
BPI BPI Pain PMic,a Pain KPS SF-36 CES-D SF-36 
Average Interference Relief PHC MHC 
Pain 
Intensity 
Younger 
Total .61** .63** -.32** -.34** -.25° -.23** .27** -.13 
Continuous .60** .49** -.32** a -.21 * -.26** -.19* .19* .01 b 
Intermittent .55** .54** -.13 -.2s·· -.25° -.35** .18* -.07 
N europathic .53** .51 ** -.32** -.34** -.17* -.20* .34** -.17 
Affective .57° .62** -.30** -.31 ** -.20* -.18* .42** -.32** 
Older 
Total .55** .56° -.13 -.30** -.29° -.32° .35** -.36** 
Continuous .51** .52** -.07 a -.28* -.26° -.29** .2s* -.30** b 
Intermittent .45** .44** -.07 -.3 7** -.27** -.21** .29** -.26** 
N europathic .42** .36° -.12 -.18 -.14 -.25* .30** -.25** 
Affective .43** .60** -.04 -.24* -.36° -.30* .38° -.46** 
* P ~ .05 two-tailed 
** P ~ .01 two-tailed 
a P ~ .05 for Fisher's Z-test comparison of correlations between younger and older patients 
b P ~ .01 for Fisher's Z-test comparison of correlations between younger and older patients 
c PMI <O versus ~ 0 
d Spearman's rho 
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Note: BPI, Brief Pain Inventory; PMI, Pain Management Index; KPS, Karnofsky Performance Status Scale; SF-36 PHC, SF-36 
Physical Health Component Score; CES-D, Center for Epidemiologic Studies Depression Scale; SF-36 MHC, SF-36 Mental 
Health Component Score 
Table 7. Cronbach's alpha for SF-MPQ-2 Subscale and Total scores for Younger and 
Older Patients. 
Younger n=ll3 
Total score 
Continuous 
Intermittent 
Neuropathic 
Affective 
Older n=77 
Total score 
Continuous 
Intermittent 
N europathic 
Affective 
Cronbach's 
Alpha 
.74 
.84 
.69 
.73 
.83 
.85 
.66 
.81 
a P ~ .05 for Cronbach's Alpha comparison between age groups 
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Figure 1. Number of participants in each sex/primary tumor group. 
Note: BR, Breast; GY, Gynecologic; GI, Gastrointestinal; LU, Lung; GU, Genitourinary; 
HN, Head and Neck 
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Figure 2. Proportion of Older and Younger patients selecting each SF-MPQ-2 item. 
*Excluded from calculations of the Total and subscale scores by Dworkin et al. (2009) 
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BRIDGE FROM CHAPTER 2 TO CHAPTER 3 
Existing studies of age-related patterns in cancer pain have primarily relied on the 
biomedical model (Keefe, Abernethy, & Campbell, 2005; Turk, 2002). However, there is 
not a direct relationship between the extent of injury and pain intensity (Turk et al., 1998; 
Wu, Beaton, Smith, & Hagen, 2010). There is also converging evidence that, consistent 
with chronic nonmalignant pain, biopsychosocial factors play a role in cancer pain 
(Keefe, Abernethy, & Campbell, 2005; Porter & Keefe, 2011; Turk, 2002). Moreover, 
studies of age-related patterns in cancer pain have mainly focused on pain intensity, a 
unidimensional construct. However, pain is multidimensional (Melzack & Casey, 1968) 
and therefore, investigations of age-related patterns in cancer pain should acknowledge 
this. In Chapter 2, we established that the Short-Form McGill Pain Questionnaire-2 is 
valid for use in older and younger adults with cancer pain. Now that we have established 
that the SF-MPQ-2 is appropriate for use in older and younger adults with cancer pain, in 
Chapter 3, we investigate age differences in the multidimensional experience of cancer 
pain using validated tools. Data described in Chapters 2 and 3 are derived from the same 
larger study of age-related patterns in cancer pain. 
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Introduction 
Pain is one of the most common and feared symptoms of cancer (Cleeland, 1998). 
It is associated with impairments in multiple domains of physical and psychosocial 
wellbeing (Castel et al., 2007; Cleeland et al., 1994; M. Z. Cohen, Musgrave, Munsell, 
Mendoza, & Gips, 2005; Ferreira et al., 2008; Keefe, Abernethy, & Campbell, 2005; 
Mystakidou et al., 2006; Turk et al., 1998; Wells, Murphy, Wujcik, & Johnson, 2003; G. 
M. Williamson & Schulz, 1995). Because the majority of new cases and deaths occur in 
people over the age of 60, cancer is considered a disease of older people (Canadian 
Cancer Society (CCS), 2013). While a number of age-related factors, including 
comorbidity, chronic nonmalignant pain, impaired functional status, and polypharmacy 
(Davis & Srivastava, 2003; Extermann, 2000a; Mercadante, Casuccio, Pumo, & Fulfaro, 
2000; Yancik & Ries, 2000) may be associated with vulnerability to cancer pain, few 
studies have been designed to investigate age-related patterns in cancer pain or the impact 
of age-related factors. When age is considered, it is generally investigated as one of a 
number of other background demographic variables (Knudsen et al., 2009), rather than as 
the primary focus of the study. Consequently, our understanding of cancer pain across the 
adult life span remains limited. This information is urgently needed in order to provide 
effective palliation of pain to people across the adult life span. 
Age-Related Patterns in Cancer Pain 
There have been inconsistent findings of age-related patterns in the intensity of 
cancer pain, with reports of increases (M. Z. Cohen et al., 2005; Yates et al., 2002), 
decreases (W. Y. Cheung, Le, Gagliese, & Zimmermann, 2011; Jordhoy et al., 2001; 
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Mohile et al., 2011; Olden, Holloway, Ladwig, Quill, & van Wijngaarden, 2011; Soltow, 
Given, & Given, 2010; Stuver et al., 2012; Wilson et al., 2009) and no relationship with 
age (Caraceni & Portenoy, 1999; Cataldo et al., 2013; Green & Hart-Johnson, 2010; 
Kelsen et al., 1995; McMillan, 1996; Rustoen, Fossa, Skarstein, & Mourn, 2003; 
Valeberg, Miaskowski et al., 2008; Vigano, Bruera, & Suarez-Almazor, 1998; G. M. 
Williamson & Schulz, 1995). Unfortunately, it is difficult to draw conclusions due to 
several methodological limitations. For instance, prevalence often has been confounded 
with intensity. Other methodological limitations include use of assessment tools that have 
not been validated for use in older people as well as the underrepresentation of older 
people. Moreover, much of the research has been limited to pain intensity (Caraceni & 
Portenoy, 1999; W. Y. Cheung, Le, Gagliese, & Zimmermann, 2011; Olden, Holloway, 
Ladwig, Quill, & van Wijngaarden, 2011; Stuver et al., 2012; Valeberg, Miaskowski et 
al., 2008). Extending our understanding of age-related patterns beyond this 
unidimensional construct is important, because intensity alone insufficiently describes the 
multidimensional nature of pain (Jensen & Karoly, 2011). 
There has been substantially less investigation of age-related patterns in other 
dimensions of cancer pain, including the multidimensional qualities of pain and its 
interference in important daily activities and psychosocial wellbeing. There have been no 
studies designed specifically to investigate age-related patterns in cancer pain qualities. In 
studies that have simply examined age as one of a number of other background 
demographic variables and its relationship to scores on the McGill Pain Questionnaire 
(MPQ), the data are mixed. One study found that younger age was associated with higher 
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MPQ Sensory scores (Greenwald, 1991), while another found no age differences in MPQ 
Pain Rating Index scores (Wilkie, Huang, Reilly, & Cain, 2001). Most studies of pain 
interference find no age-related patterns (M. Z. Cohen et al., 2005; Green & Hart-
Johnson, 2010; Soltow, Given, & Given, 2010; Wells, Murphy, Wujcik, & Johnson, 
2003); however one study found that older adults reported greater pain-related 
interference with walking than younger adults (Mohile et al., 2011). Unfortunately, many 
of these studies suffer from the methodological weaknesses described above and have not 
taken into account a broad range of biopsychosocial, age-related factors. In studies of 
people with chronic nonmalignant pain that overcome these weaknesses, there were age-
related patterns in pain qualities, but not intensity (Gagliese & Melzack, 1997a; Gagliese 
& Melzack, 2003). However, because cancer pain may differ from nonmalignant pain on 
a number of domains (Turk et al., 1998), it may be inappropriate to generalize across 
patient populations. Studies assessing age-related patterns in the multidimensional 
experience of cancer pain are therefore necessary. 
Age-Related Patterns in Adaptation to Cancer Pain 
Similar to people with chronic nonmalignant pain, in people with cancer, there is 
not a direct relationship between the degree of tissue damage and the intensity of pain 
experienced (Turk et al., 1998; Wu, Beaton, Smith, & Hagen, 2010). The biopsychosocial 
correlates of chronic nonmalignant pain have been well documented (Gatchel, Peng, 
Peters, Fuchs, & Turk, 2007; Keefe, Rumble, Scipio, Giordano, & Perri, 2004). Although 
there is emerging evidence of their importance (Keefe, Abernethy, & Campbell, 2005; 
Porter & Keefe, 2011 ), the biomedical model of cancer pain has continued to dominate 
(Keefe, Abernethy, & Campbell, 2005; Turk, 2002), limiting our understanding of the 
role of psychosocial factors in the experience of cancer pain. 
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The chronic nonmalignant pain literature may guide our understanding. For 
example, older people with chronic nonmalignant pain have reported worse physical 
health quality oflife (QOL), but better mental health QOL than younger people (Wittink 
et al., 2006). While the evidence regarding pain catastrophizing is mixed (Keefe & 
Williams, 1990; Sorkin, Rudy, Hanlon, Turk, & Stieg, 1990; J. A. Turner, Mancl, & 
Aaron, Jul 2004; Watkins, Shifren, Park, & Morrell, 1999), older people with chronic 
nonmalignant pain have reported lower pain anxiety than younger people (Cook, Brawer, 
& Vowles, 2006; Mosher & Danoff-Burg, 2005). Cross-study methodological 
differences, including sample differences and different measures used to assess 
catastrophizing, may account for the mixed findings. 
Studies of adaptation to cancer that do not consider pain may also have heuristic 
value. Interestingly, similar to people with chronic nonmalignant pain, older cancer 
patients report worse physical health QOL, but better mental health QOL, than younger 
cancer patients (Cimprich, Ronis, & Martinez-Ramos, 2002; Greimel, Padilla, & Grant, 
1997; Mohamedali et al., 2012; Schroevers, Ranchor, & Sanderman, 2004). Older cancer 
patients have also reported lower traumatic stress and greater spirituality than younger 
patients (Baider et al., 2003; Lo et al., 2010; Schroevers, Ranchor, & Sanderman, 2004; 
Stalnacke & Ostman, 2010). Greater attachment security (Lo et al., 2009) and social 
support (Berg & Upchurch, 2007; Lintz et al., 2003) have been associated with older age, 
although the data are not always consistent, and relational quality may be an important 
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factor (Berg & Upchurch, 2007; Hunter, Davis, & Tunstall, 2006). Interestingly, although 
older cancer patients without pain may experience fewer depressive symptoms than 
younger patients (Compas et al., 1999; Kroenke et al., 2004; Politi, Enright, & Weihs, 
2007; Schroevers, Ranchor, & Sanderman, 2004; Vinokur, Threatt, Vinokur-Kaplan, & 
Satariano, 1990; Wenzel et al., 1999), in the context of cancer pain, older and younger 
patients report comparable levels of depressive symptoms, suggesting that cancer pain 
may override the age differences found in depression when pain is not present (Gagliese, 
Gauthier, & Rodin, 2007). This illustrates the possible limitations of generalizing from 
other populations and the need to measure age-related patterns in people with cancer 
pam. 
Age-Related Patterns in the Correlates of Cancer Pain 
In addition to age differences in outcomes, it is also important to assess whether 
the pathways to those outcomes, or the correlates of those outcomes, vary with age 
(Gagliese, 2009). Specifically, there is an emerging literature that has demonstrated that 
despite a lack of age differences in factors such as pain intensity, pain interference, and 
depressive symptoms, there are age differences in the relationships between those factors 
in people with chronic nonmalignant pain (Cook, Brawer, & Vowles, 2006; Edwards, 
2006; Mcllvane, Schiaffino, & Paget, 2007; Turk, Okifuji, & Scharff, 1995). For 
example, although there were no age differences in pain intensity or activity, the 
relationship between pain intensity and functioning was stronger in older than younger 
people with chronic nonmalignant pain (Edwards, 2006). Similarly, in a recent qualitative 
study of people with advanced cancer and pain, age differences in pain intensity and 
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interference were not found, but there were age-related patterns in adaptation to cancer 
pain (Gagliese et al., 2009). On the one hand, older patients adapted by accepting pain 
and its associated limitations, pursued important life goals by modifying or pacing 
activities, and described strengthened relationships. On the other hand, younger patients 
described relational strain, and reacted to cancer pain with fear, anger, and grief at the 
loss of pre-pain identities and roles (Gagliese et al., 2009). Although a host of 
biopsychosocial factors have been associated with greater cancer pain intensity and 
interference, including female sex, longer disease duration, comorbidities, greater 
symptom severity, depression, pain catastrophizing, and worse physical functioning, 
quality oflife, spirituality, and social support (Bernabei et al., 1998; S. Bishop & Warr, 
2003; Caraceni & Portenoy, 1999; Castel et al., 2007; Cleeland et al., 1994; M. Z. Cohen 
et al., 2005; Ferreira et al., 2008; C. W. Given, Given, Azzouz, Kozachik, & Stommel, 
2001; Green & Hart-Johnson, 2010; Kelsen et al., 1995; Mystakidou et al., 2006; Novy et 
al., 2005; Peat, Thomas, Handy, & Croft, 2004; Porter & Keefe, 2011; Soltow, Given, & 
Given, 2010; Stuver et al., 2012; Turk et al., 1998), age-related patterns in the 
interrelationships of many of these factors and their relationships to multidimensional 
pain outcomes, including pain intensity, qualities, and interference remain unknown. 
By extending our investigation beyond pain intensity and adopting a 
biopsychosocial framework, we can obtain a richer understanding of the experience of 
cancer pain across the adult life span. Thus, our aims were to I) examine age differences 
in the experience of cancer pain and 2) determine age-related patterns in the correlates of 
cancer pain intensity, qualities and interference. We hypothesized that (la) there would 
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be no age differences in pain intensity or pain interference, but pain qualities would differ 
between older and younger patients; (I b) older patients would have more comorbidities 
and worse functional status, lower physical health QOL, traumatic stress, and pain 
anxiety, and higher mental health QOL, pain catastrophizing, pain acceptance, 
spirituality, social support and marital satisfaction than younger patients, but there would 
be no age differences in depressive symptoms; and (2) some of the correlates of pain 
outcomes would be similar across age groups, but unique correlates would also be 
evident within each age group. Specifically, in both age groups, female sex, 
comorbidities, functional status, symptom severity, depressive symptoms, pain anxiety, 
catastrophizing and social support would be related to pain outcomes. Pain acceptance 
and spirituality would be unique correlates of lower pain in older patients. Insecure 
attachment, less frequent solicitous and more frequent punishing responses, and lower 
marital satisfaction would be unique correlates of higher pain intensity, qualities and 
interference in younger patients. Since there is no evidence available to guide the 
development of hypotheses about outcome-specific profiles of correlates, we made no a 
priori hypotheses about this. 
Methods 
Participants 
Data described in Chapter 2 and the present chapter are derived from the same 
study of age-related patterns in the experience of cancer pain. We have also previously 
examined different research questions using smaller subsets of these participants 
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(Gauthier et al., 2009; Gauthier et al., 2012). Patients attending outpatient clinics at a 
comprehensive cancer centre in Toronto, Canada and patients receiving home palliative 
care were recruited between May 2006 and August 2012. Inclusion criteria were age~ 18 
years, advanced cancer, cancer-related pain, sufficient English to provide informed 
consent and complete questionnaires. Exclusion criteria included documented cognitive 
impairment as identified by healthcare provider or medical chart and scores below 
predetermined cutoff on a cognitive screening instrument (Katzman et al., 1983). Ethics 
approval for the study was obtained from the Research Ethics boards of the University 
Health Network, Mount Sinai Hospital and York University. 
Healthcare providers of patients attending outpatient clinics and reporting pain 
determined their desire to be approached about the study by a Research Assistant (RA). 
Physicians providing home palliative care identified potentially eligible patients. The RA 
approached patients in person in the outpatient clinics or telephoned patients receiving 
home palliative care and explained the study. Patients agreeing to participate provided 
informed consent. The RA then administered the Short Orientation Memory 
Concentration Test (SOMC [Katzman et al., 1983]). Patients scoring <20 were 
withdrawn. The RA then collected demographic and clinical information from remaining 
participants. They were then provided with a questionnaire package which they could 
complete with the help of the RA or take home to complete. Those who chose to take the 
questionnaire package home were provided with a stamped, addressed envelope. 
Participants who had not returned their questionnaire were telephoned after two weeks 
with a reminder. 
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Measures 
Demographic and clinical information. Demographic information collected 
included age, sex, ethnicity, marital status, and education. Clinical information included 
primary tumor type, cancer and pain duration, presence of chronic nonmalignant pain, 
and information regarding all modalities of treatment (pharmacologic and 
nonpharmacologic; see Chapter 2). The Anticholinergic Drug Scale (ADS [Carnahan, 
Lund, Perry, Culp, & Pollock, 2002; Carnahan, Lund, Perry, Pollock, & Culp, 2006]) was 
used to assess the cumulative anticholinergic load of all medications. A score is assigned 
to each medication based on its anticholinergic potency. Scores are summed to provide a 
total ADS score. The ADS has been validated against serum anticholinergic activity in 
older people (Carnahan, Lund, Perry, Culp, & Pollock, 2002). 
Cognitive Screen. The Short Orientation-Memory-Concentration Test (SOMC 
[Katzman et al., I 983]) was used as a short cognitive screen. It is a 6-item screening 
measure of cognitive impairment and orientation to time, person and place, and memory. 
It has been validated for use among older adults (Katzman et al., I 983) and has been used 
in samples of patients with similar disease characteristics (Rodin et al., 2007). 
Pain Measures. The Brief Pain Inventory (BPI [Cleeland & Ryan, 1994]) was 
used to measure pain intensity and its interference in 7 important life domains. It includes 
I I-point Numeric Rating Scales (NRS) anchored with the words "no pain" and "pain as 
bad as you can imagine" to assess Average, Worst, Least and Current Pain Intensity. The 
Average Pain Intensity question was used as our outcome measure of Pain Intensity 
because Current Pain may be unstable (Serlin, Mendoza, Nakamura, Edwards, & 
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Cleeland, 1995) and Worst Pain is not standardized for time across patients. BPI Average 
Pain Intensity has been used as an outcome measure (Langford et al., 2011; Valeberg, 
Miaskowski et al., 2008). The BPI also includes NRSs anchored with the words "does not 
interfere" and "completely interferes" to assess pain-related interference in general 
activity, mood, walking ability, work, relations with others, sleep and enjoyment of life. 
A Pain Interference score was calculated from the average of these questions. Internal 
consistency reliability in the present study was .91 in older patients and .91 in younger 
patients. The BPI has been validated in people with cancer pain (Ger, Ho, Sun, Wang, & 
Cleeland, 1999; Klepstad, Loge, Borchgrevink, Mendoza, & Cleeland, 2002). The BPI is 
also used to calculate the Pain Management Index (PMI [Cleeland et al., 1994 ]), an index 
of analgesic adequacy, based on the patient's report of worst pain and the highest level of 
analgesic prescribed, according to the World Health Organization's Analgesic Ladder 
(World Health Organization, 1986). Patients prescribed a strong opioid (e.g. morphine or 
fentanyl) were assigned a score of 3, patients prescribed a weak opioid (e.g. oxycodone) 
were assigned a score of 2, patients prescribed acetaminophen, acetylsalicylic acid, a 
nonsteroidal anti-inflammatory, or adjuvant drug (e.g. tricyclic antidepressant or 
gabapentin) were assigned a score of 1 and patients not prescribed any analgesic received 
a score of 0 (Breitbart et al., 1996; Cleeland et al., 1994). Patients reporting severe BPI 
Worst pain intensity (8-10) received a score of 3, patients reporting moderate BPI Worst 
pain (4-7) received a score of2, patients reporting mild BPI Worst pain (1-3) received a 
score of 1 and patients reporting 0 on the BPI Worst pain item received a score of 0. BPI 
Worst pain category scores are subtracted from the Analgesic Ladder score to obtain a 
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score for the PMI. PMI scores <Oare considered inadequate analgesia (Cleeland et al., 
I994). The Short-Form McGill Pain Questionnaire 2 (SF-MPQ 2 [Dworkin et al., 2009]) 
was used to measure the qualities of pain. It includes 22 items that measure Continuous, 
Intermittent, Neuropathic and Affective pain qualities on I I-point NRSs. It has very good 
psychometric properties in patients with diverse pain conditions (Adelmanesh et al., 
20I2; Dworkin et al., 2009; Lovejoy, Turk, & Morasco, 2012). We have demonstrated 
that the SF-MPQ-2 has an equivalent factor structure in older and younger patients with 
cancer pain. See Chapter 2 for detailed analysis of the construct and convergent validity 
and internal consistency reliability in younger and older patients. 
Physical Functioning Measures. The Charlson Comorbidity Index (CCI 
[Charlson, Pompei, Ales, & MacKenzie, 1987]) was used to measure comorbidities. The 
CCI predicts mortality based on the presence of I 9 co-occurring conditions. It has been 
used extensively among cancer patients (Extermann, 2000a). Higher scores indicate 
greater comorbid load. The RA completed the CCI by reviewing medical charts. The 
Karnofsky Performance Status Scale (KPS [Kamofsky & Burchenal, 1949]) is an 
observer rated measure of functional status. The RA rated patient functional autonomy 
and ability to participate in their own care and regular activities on a scale ranging from 
100 (normal activity, no evidence of disease) to 0 (dead) through observation and by 
asking brief questions at the time of recruitment. It has good psychometric properties in 
people with cancer (Yates, Chalmer, & McKegney, I 980), including good interrater 
reliability (Yates, Chalmer, & McKegney, I980; Zimmermann et al., 2010a). 
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The Edmonton Symptom Assessment Scale (ESAS [Bruera, Kuehn, Miller, 
Selmser, & Macmillan, 1991]) measures the intensity of 9 cancer-related symptoms with 
11-point NRSs. It has good validity and reliability in people with cancer (Bruera, Kuehn, 
Miller, Selmser, & Macmillan, 1991). The ESAS has demonstrated a 2 factor structure: 
One that includes physical symptoms (pain, tiredness, nausea, drowsiness, appetite, 
wellbeing, shortness of breath) and one that includes psychological symptoms 
(depression and anxiety) (W. Y. Cheung, Le, & Zimmermann, 2009). Since the 
psychological symptom cluster may have poor validity (Richardson & Jones, 2009; 
Teunissen, S. C. C. M, de Graeff, Voest, & de Haes, Jun 2007), we constructed an 
average score of the items assessing physical symptoms. We excluded the pain item in 
order to reduce the amount of shared variance between other measures of pain intensity 
and qualities. Internal consistency reliability in the present study was . 77 in older patients 
and .80 in younger patients, and did not differ between the groups. The Medical 
Outcomes Study Short Form-36 (SF-36 [Ware Jr. & Sherboume, 1992]) Physical Health 
Component Score (PHC) measures subjective physical wellbeing in four domains, 
including physical functioning, role limitations caused by physical health, bodily pain, 
and general health perceptions. Scores are transformed to a 0 to 100 scale and higher 
scores reflect better physical health QOL. The SF-36 has demonstrated good 
psychometric properties in diverse samples of people (Ware et al., 1995). Internal 
consistency reliability in the present study was .68 and .69 in older and younger patients, 
and did not differ between the groups. 
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Psychological Wellbeing Measures. The SF-3 6 (Ware Jr. & Sherbourne, 1992) 
Mental Health Component Score (MHC) measures subjective mental health and 
wellbeing in four domains, including mental health, vitality, social functioning, and role 
limitations caused by emotional health. Scores are transformed to a 0 to 100 scale and 
higher scores reflect better mental health QOL. Internal consistency reliability in the 
present study was .71 and .66 in older and younger patients, and did not differ between 
the groups. The Center for Epidemiologic Studies-Depression Scale (CES-D [Radloff, 
1977]) was used to measure depressive symptoms. It is a 20-item measure of current 
depressive symptoms and their frequency over the last week. Scores range from 0 to 60 
and higher scores reflect greater depressive symptoms. It has been used extensively and 
has excellent psychometric properties for use across the adult life span (Beeber, Shea, & 
McCorkle, 1998; Coyle & Roberge, 1992; Gauthier & Gagliese, 2011; Pasacreta, 1997). 
Internal consistency reliability in the present study was .89 and .88 in older and younger 
patients, and did not differ between the groups. The Impact of Event Scale (IES 
[Horowitz, Wilner, & Alvarez, 1979]) was used to measure symptoms of traumatic stress. 
It includes two factors that measure intrusive thoughts and avoidance of thoughts and 
ideas (Horowitz, Wilner, & Alvarez, 1979; Zilberg, Weiss, & Horowitz, 1982). It is the 
most common measure of traumatic stress symptoms in cancer patients (Gurevich, 
Devins, & Rodin, 2002). The total score ranges from 0 to 75 and higher scores reflect 
greater traumatic stress symptoms. It has good reliability among cancer patients with pain 
(Kaasa et al., 1993). Internal consistency reliability was .77 and .80 for the Avoidance 
subscale, .84 and .84 for the Intrusion subscale, and .88 and .90 for the Total, in older and 
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younger patients, and did not differ between the groups. The Short Form Pain Anxiety 
Symptoms Scale (PASS-20 [McCracken & Dhingra, 2002]) was used to measure anxiety 
reactions to pain-related stimuli. It includes four factors that measure fear of pain, 
physiological anxiety, escape and avoidant thoughts, and cognitive anxiety. The total 
score ranges from 0 to 100 and higher scores reflect greater pain-related anxiety. It has 
good validity and reliability in people with chronic nonmalignant pain (Roelofs et al., 
2004). Internal consistency reliability was .84 and .77 for the Fear subscale, .73 and .76 
for the Escape-Avoidance subscale, .80 and .77 for the Physiological Anxiety subscale, 
.86 and .87 for the Cognitive Anxiety subscale and .93 and .91 for the Total, in older and 
younger patients, and did not differ between the groups. The Pain Catastrophizing Scale 
(PCS [Sullivan, Bishop, & Pivik, 1995]) was used to measure excessive attention to pain-
related thoughts and negative evaluations of painful sensations. Three factors have been 
identified that measure rumination about pain, a helplessness attitude toward managing 
pain, and exaggerated negative appraisals of painful sensations. The total score ranges 
from 0 to 52 and higher scores reflect greater pain catastrophizing. It has good 
psychometric properties in people with chronic nonmalignant pain and has been used to 
measure catastrophizing in people with cancer pain (S. Bishop & Warr, 2003; Buck & 
Morley, 2006). Internal consistency reliability was .90 and .89 for the Rumination 
subscale, .81 and .86 for the Magnification subscale, .90 and .88 for the Helplessness 
subscale, and .95 and .93 for the Total, in older and younger patients, and did not differ 
between the groups. The Chronic Pain Acceptance Questionnaire (CP AQ [McCracken, 
Vowles, & Eccleston, 2004]) measures the acceptance of pain. Two factors have been 
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identified that measure the activity engagement, or the degree to which people with pain 
participate in valued life activities despite pain, and pain willingness, or the willingness 
to experience pain without controlling it. The total score ranges from 0 to 120 and higher 
scores reflect greater acceptance of pain. Its validity has been demonstrated in people 
with chronic nonmalignant pain (McCracken, Vowles, & Eccleston, 2004). We have 
previously demonstrated that greater acceptance is associated with better psychological 
wellbeing in a smaller subset of this sample (Gauthier et al., 2009). Internal consistency 
reliability was .87 and .89 for the Activity Engagement subscale, .84 and .81 for the Pain 
Willingness subscale, and .85 and .89 for the Total, in older and younger patients, and did 
not differ between the groups. The Pain Attitudes Questionnaire - Cancer (P AQ-C [Tran 
et al., 2013; Yong, Gibson, Home, & Helme, 2001; Yong, Bell, Workman, & Gibson, 
2003]) was used to measure attitudes toward pain. In a smaller subset of this study, two 
factors were identified that measure pain-related Stoicism and Cautiousness to label 
sensations as painful (Tran et al., 2013). We have previously shown that Stoicism is 
related to greater CPAQ Activity Engagement, IES Avoidance and SF-MPQ-2 
Neuropathic pain, and Cautiousness is associated with greater IES Avoidance and less 
satisfaction with pain control (Tran et al., 2013). The total scores for Stoicism and 
Cautiousness range from 1 - 5 and higher scores reflect greater pain-related stoicism and 
cautiousness. Internal consistency reliability was .87 and .90 for the Stoicism subscale, 
.88 and .84 for the Cautiousness subscale, in older and younger patients, and did not 
differ between the groups. The Functional Assessment of Chronic Illness Therapy -
Spiritual Wellbeing 12 (F ACIT-Sp 12 [Peterman, Fitchett, Brady, Hernandez, & Cella, 
2002]) was used to measure spirituality. It includes two factors that measure a sense of 
meaning, peace, and purpose in life; and comfort and strength derived from faith. The 
total score ranges from 0 to 48 and higher scores reflect greater spirituality. It has good 
validity and reliability with cancer patients (Peterman, Fitchett, Brady, Hernandez, & 
Cella, 2002). Internal consistency reliability was .91 and .87 for the Meaning-peace 
subscale, .87 and .88 for the Faith subscale, and .88 and .88 for the Total, in older and 
younger patients, and did not differ between the groups. 
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Social/Relational Measures. The Medical Outcomes Study Social Support Survey 
(MOS-SS [Sherbourne & Stewart, 1991]) measures perceptions of social support 
regardless of source. It includes four factors that measure perceptions of emotional, 
informational, tangible and affectionate support, and positive social interaction. It also 
queries the number of close friends and family; a measure of structural support. Scores 
are transformed to a 0 to 100 scale and higher scores reflect greater perceived support. It 
has good psychometric properties in patients with various chronic diseases (Sherbourne 
& Stewart, 1991). Internal consistency reliability was .91 and .90 for the Emotional 
Information subscale, .91 and .90 for the Tangible subscale, .90 and .88 for the 
Affectionate subscale, .89 and .89 for the Positive Social Interaction subscale, and .96 
and .97 for the Total in older and younger patients, and did not differ between the groups. 
The Multidimensional Pain Inventory (MP!) Caregiver Responses Scale (Kerns, Turk, & 
Rudy, 1985) was used to measure patients' perceptions of their significant others' 
solicitous, distracting, and punishing responses to their pain. Scores for each subscale 
range from 0 to 6 and higher scores reflect more frequent perceptions of these responses. 
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The MPI has been validated with patients with chronic nonmalignant pain (Flor, Kerns, 
& Turk, 1987; Kerns, Turk, & Rudy, 1985; Kerns, Haythornthwaite, Southwick, & 
Giller, 1990). Internal consistency reliability was .80 and .81 for the Punishing responses 
subscale, .79 and .76 for the Solicitous responses subscale, and .73 and .72 for the 
Distracting responses subscale, in older and younger patients, and did not differ between 
the groups. The Experiences in Close Relationships Inventory (ECR [Brennan, Clark, & 
Shaver, 1998]) was used to measure adult attachment avoidance, the extent to which 
individuals are uncomfortable with closeness and dependence on others, and attachment 
anxiety, the extent to which individuals fear rejection and abandonment. Higher scores 
reflect greater attachment anxiety and avoidance. The ECR has good reliability in people 
with cancer and chronic nonmalignant pain (Mc Williams & Asmundson, 2007; Rodin et 
al., 2007). Internal consistency reliability was .90 and .90 for the Avoidance subscale and 
.90 and .91 for the Anxiety subscale, in older and younger patients, and did not differ 
between the groups. The Kansas Marital Satisfaction Scale (KMS [Schumm, Paff-
Bergen, & Hatch, 1986; Schumm et al., 1985]) was used to measure marital satisfaction. 
It is a three-item measure of satisfaction with the partner and relationship. Scores range 
from 3 to 21 and higher scores reflect greater satisfaction. It demonstrates good 
psychometric properties (Schumm, Paff-Bergen, & Hatch, 1986; Schumm et al., 1985). 
Internal consistency reliability was .98 and .98 in older and younger patients. 
Data Analysis 
Missing Data. SPSS Missing Value Analysis (MV A) was run to identify the 
number and percent of participants with missing data on each scale and the relationship 
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between missingness and other variables included in the study (Tabachnick & Fidell, 
2012). The relationship between missing data on each scale and demographic (age, sex, 
ethnicity, primary language, marital status, education) and clinical factors (cancer type, 
cancer duration, pain duration, concurrent chronic nonmalignant pain, ADS, 
polypharmacy, treatment variables, CCI, KPS, WHO analgesic ladder level, PMI) was 
calculated with SPSS MV A. Little's Missing Completely at Random test (MCAR [Little, 
1988]) is a likelihood ratio test of whether the data are missing completely at random 
(MCAR). It is a global test statistic that uses all available data to determine whether 
missing data on a given scale is associated with other variables in a dataset (Little, 1988). 
It overcomes the problems associated with multiple tests comparing the means of each 
variable between those with missing data and those without missing data (Little, 1988). 
A Bonferroni correction was applied to this analysis based on the number of tests of 
association between missingness on a given scale and the demographic and clinical 
variables and the remaining questionnaires (adjusted a= .05164 = .0007). Data were 
considered MCAR if missingness on a given scale was not associated with other 
variables that were measured in this study (Little, 1988). Data were considered Missing at 
Random (MAR) if missing data on a given scale was associated with other variables 
measured in this study. MCAR and MAR are considered ignorable conditions and allow 
for missing data estimation techniques to be employed (Heitjan & Basu, 1996). Data 
were considered Missing Not at Random (MNAR) if missing data was associated with 
itself (Resseguier, Giorgi, & Paoletti, 2011). For example, data would be MNAR if 
participants with missing data on items about pain, such as pain catastrophizing and 
anxiety, had higher pain intensity than those without missing data on these items. 
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In order to identify age-related patterns in missingness, the count and percent of 
younger and older participants with missing data were calculated for each questionnaire. 
i analyses determined age differences in the proportion of younger and older participants 
with missing data. A Bonferroni correction was also applied to this analysis based on the 
number of tests of age differences in the proportion of patients with missing data on each 
scale (adjusted a= .05/48 = .001). 
For data that were MCAR and MAR, expectation maximization (EM) was used to 
impute missing data. EM is an iterative procedure that consists of two steps: In the first 
step, expected values are substituted for missing values based on the available data and 
current estimates of the parameters. In the second step, maximum likelihood, model 
parameters are re-estimated using the data from the first step (Tabachnick & Fidell, 
2012). EM assumes a multivariate normal distribution of the data and that data is MCAR 
or MAR (Tabachnick & Fidell, 2012). Benefits of EM include lack of overfitting the data 
such that models converge better than they should, and less disturbance to variances than 
with other methods of imputation, such as mean substitution imputation (Tabachnick & 
Fidell, 2012). Data were not imputed for the MPI Caregiver Responses scale questions 
about the primary caregiver' s identity and living arrangements, the structural support 
questions on the MOS (number of close family and friends variables) and KMS responses 
in unpartnered people that are completely missing. Missing PMI scores were calculated 
from the imputed value of the BPI Worst pain item. A comparison of analyses using the 
imputed and nonimputed data revealed the same pattern of findings, therefore analyses 
from imputed data are presented. 
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Testing the study aims. Data were screened for assumptions of normality, 
linearity, and homogeneity of variance using grouped data screening procedures 
(Tabachnick & Fidell, 2012). To test age differences, independent-samples t-tests, Mann-
Whitney U tests of medians and i analyses compared older and younger patients on 
demographic and clinical variables, and pain, physical and psychosocial factors. For the 
analysis, a Bonferroni-corrected p value was used to control for multiple comparisons 
(adjusted a= .05/44 = .001). 
A number of steps were taken to identify candidate correlates of BPI Average 
Pain Intensity, SF-MPQ-2 Continuous, Intermittent, Neuropathic and Affective subscales 
and BPI Interference. First, variables that differed between younger and older patients at 
p :S .05 were retained for inclusion in each model. Second, candidate correlates that were 
associated with a given outcome variable in bivariate testing at p :S .01, using the total 
sample (n=244), were considered for inclusion. Those that were highly associated with 
each other (r 2:.6 [Tabachnick & Fidell, 2012]) were examined for associations with the 
outcome variable. Where two or more highly correlated variables were identified, the 
variable that was more strongly related to the outcome variable was retained for entry 
into the model. These rigorous steps were taken in order to prevent multicollinearity and 
overfitting the models. Multivariate regression models, using backward elimination 
procedures, were fit separately for younger and older patients for each of the outcome 
variables, with the same candidate correlates in each age group. Criterion for removal of 
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variables was p ~. l 0. The level of significance for correlates and model fit was set at p ~ 
.05. Model fit was evaluated, and VIF klO) and Tolerance(~ .10) values were examined 
for evidence of multicollinearity (M. H. Katz, 1999; Tabachnick & Fidell, 2012). The 
strength of common correlates for a given outcome variable were compared between 
older and younger patients using the formula (Brame, Paternoster, Mazerolle, & Piquero, 
1998; Clogg, Petkova, & Haritou, 1995; Field, 2009): 
SE b-difference = -.J (SEbGt2 + SEbG2 2) 
and 
z = 
where: Z ~ ( +/-) 1.645, a = .05 
Z ~ (+/-) 1.96, a= .025 
Z ~ (+/-) 2.33, a= .01 
Z ~ (+/-) 2.58, a= .005 
In order to identify age differences in the moderating role of common and unique 
correlates identified in the multivariate regression models, simple interaction models 
were fit with the age group variable, the identified correlate and the relevant outcome 
variable. Continuous variables were grand-mean centered and product terms were created 
with the age group variable. Variables were entered in blocks, with age group, the 
centered correlate, then the two-way interaction between age group and the correlate 
(Aiken & West, 1991; Holmbeck, 2002). Significant interactions (p ~ .05) indicated that 
the correlate was significantly stronger for older or younger patients. Interactions were 
investigated graphically by plotting the simple slopes of age group and the other 
variable(s) (Holmbeck, 2002). Only significant interactions are reported below. 
Results 
Participant Characteristics 
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Recruitment statistics for this study have been previously described (Chapter 2). 
Three hundred and ninety-seven (73.8%) patients who were approached about the study 
consented to participate. Three participants ( 1.1 % ) who consented were subsequently 
withdrawn because they did not meet the inclusion criteria. One hundred and twenty-
three (31 % ) participants did not return the questionnaire package due to disease 
progression (35.8%), death (30.9%) and lack of interest in continuing to participate 
(13.8%). Two-hundred and sixty-nine participants returned the questionnaire package 
(Chapter 2). 
As previously described (Chapter 2), two age groups were formed. Older (~60 
years old) and younger ( <60 years old) patients were matched based on sex and primary 
tumor type. This resulted in a sample consisting 105 older and 139 younger participants 
(total n=244). Twenty-five participants could not be matched based on sex and primary 
tumor type. As reported in Chapter 2, they did not differ from the matched sample 
(n=244) on demographic or clinical factors. 
Demographic and clinical characteristics of the matched sample (n=244) have 
been previously described (Chapter 2). Briefly, older participants were 68.34 ± 6.61 years 
old and younger participants were 49.83 ± 7.19. Fewer older than younger patients were 
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single (11.4% vs. 20.9%,p =.05) and more older than younger patients were widowed 
(15.2% vs . . 7%,p =.001) but there were no differences in the proportion of 
married/partnered (61.9% vs. 67.6%,p =.35) or separated/divorced (11.4 vs. 10.8%,p 
=.88) participants. Fewer older than younger patients had completed elementary or high 
school (45.7% vs. 29.5%,p =.01) or a post-secondary degree (38.l % vs. 51.1%,p =.04). 
There were minimal age differences in clinical characteristics. Older and younger patients 
did not differ on BMI (24.99 ± 5.72 vs. 24.74 ± 5.51,p = .73). There were more older 
than younger patients with genitourinary cancers (24.8% vs. 12.9%, p =.02), but the 
distribution of patients with other primary tumor types did not differ (breast: 15 .2% vs. 
22.3%; lung: 21.9% vs. 15.8%; gynecological: 8.6% vs. 16.5%; head and neck: 5.7% vs. 
7.2%, allp ~.07). Fewer older than younger patients were prescribed an opioid (87.0% 
vs. 95.6%, p =.03). There were no other age differences in demographic or clinical 
characteristics (see Chapter 2 for detailed description of demographic and clinical data by 
age group). 
Missing Data 
Overall, the percentage of patients with missing data on each scale was low. On 
most scales, <15% of patients had some missing data, except for the ECR Anxiety 
subscale (15.7%). Little's Missing Completely at Random test revealed that missing data 
on the KMS was associated with the MOS Tangible, Affectionate and Positive Social 
Interaction subscales (all p ~.0006). Those with missing data on the KMS had lower 
Tangible (67.48 ± 29.84 vs. 83.07 ± 20.25), Affectionate 73.96 ± 30.00 vs. 89.19 ± 
19.35) and Positive Social Interaction scores (70.77 ± 24.37 vs. 83.46 ± 20.03). Missing 
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data on the KMS can be considered Missing at Random because this pattern of missing 
responses may be explained by the marital status of those who did not complete the 
questionnaire. While it is possible that people who considered their marriages 
unsatisfactory left KMS items blank, it is also be possible that those who were partnered 
perceived greater social support than those who were not partnered. Data were MCAR for 
the rest of the scales (allp :S.01). 
Twenty-one percent of older patients and 7. 7% of younger patients left one or 
more items blank (missing items) on the PASS-20 Cognitive Anxiety subscale (p =.001). 
However, there were no age differences in the proportion of patients who left all of the 
items blank on this subscale (3.5% vs. 3.2%,p =.9), and older and younger patients did 
not differ on the number of missing items within this subscale (1.71±1.45 vs. 2.45 ± 
2.02,p = .24). There were no other age differences in the proportion of patients with 
missing data on the rest of the questionnaires (all p 2: .03). 
Data Screening 
Grouped data screening procedures (Tabachnick & Fidell, 2012) revealed that 
KMS, MOS-SS subscales and MPI Punishing responses subscale were skewed for both 
age groups. A square root transformation normalized the MPI Punishing Responses 
distribution, but did not normalize the distributions of the MOS Total and subscales and 
the KMS. Various transformations were attempted with the MOS Total and subscales and 
the KMS, but they did not improve the distributions; therefore, the untransformed values 
were used for analyses. There were no other violations to assumptions of univariate and 
multivariate normality and homogeneity of variance in each age group. There were no 
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cubic or quadratic relationships between age (measured in years) and any of the variables. 
This was tested in order to ensure the appropriateness of the age groupings for the 
analysis. 
Testing Aim 1. Age Differences in Physical Functioning, Psychosocial Wellbeing and 
Pain 
The majority of patients (n=l59; 65.2%) had CCI scores= 0. They ranged from 0-
8 in older patients and 0-5 in younger patients. Since the CCI was positively skewed, it 
was collapsed to a dichotomous variable, representing no comorbidities (CCI= 0) and 
comorbidities (CCI> 0), to stabilize the distribution. Consistent with hypothesis (1 b ), 
older patients were more likely than younger patients to have CCI scores >O ( 49 .5% vs. 
24.5%, p:S.001). The most common comorbidities on the CCI were diabetes (n=30; 
12.3%), chronic pulmonary disease (n=27; 11.1 %), ulcer disease (n=13; 5.3%) and 
secondary solid tumor in the last 5 years (n=13; 5.3%). More older than younger patients 
had diabetes (18.l % vs. 7.9%,p = .03) and chronic pulmonary disease (20% vs. 4.3%,p 
= .0003) but there were no age differences in the proportion of people with ulcer disease 
(4.8% vs. 5.8%,p =.99) or secondary tumor (7.6% vs. 3.6%,p =.27).There were no age 
differences in the proportion of older and younger people reporting chronic nonmalignant 
pain of any type (30.5% of older patients vs. 24.5% of younger patients,p = .41; Chapter 
2). Among older people, 50.0% attributed the pain to osteoarthritis, 9.4% to lower back 
pain, 3.1 % to fibromyalgia and 37.5% to mixed causes. Among younger people, 32.4% 
attributed the pain to osteoarthritis, 23.5% to lower back pain, 8.8% to fibromyalgia and 
35.3% to mixed causes. 
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There was further partial support for hypothesis (1 b ). Older patients had worse 
functional status than younger patients (KPS: 76.00 ± 10.52 vs. 81.22 ± 10.25,p:::; .001; 
Chapter 2). Older people also had lower JES Intrusion than younger people, but the 
proportion of older and younger people scoring >35 on the JES, a score that has been 
associated with possible post-traumatic stress (Thulesius, Alveblom, & Hakansson, 
2004), did not differ (17% vs. 26%,p = .10). Also, there were no age differences in 
depressive symptoms (Table 1 ). 56% of older patients and 65% of younger patients 
scored ~16 on the CES-D (p = .14), a cutoff that has been associated with clinically-
relevant levels of depressive symptoms (Radloff, 1977). Inconsistent with the rest of the 
hypothesis, there were no age differences in SF-36 PHC and MHC, PASS-20, PCS, 
CPAQ, FACIT-Sp-12, MOS-SS and KMS. (Table 1; allp ~ .03). 
Partially consistent with hypothesis (la), there were no age differences in BPI 
Average Pain Intensity or Interference. A similar proportion of older and younger 
patients reported moderate-to-severe (~5/10) BPI Worst (60.0% vs. 64.7%,p = .45) and 
Average (32.4% vs. 41.0%,p = .17) Pain Intensity and Pain Interference (48.6% vs. 
46.8%,p = .78). However, inconsistent with this hypothesis, there were no age 
differences on SF-MPQ-2 Continuous, Intermittent, Neuropathic or Affective subscales 
(allp ~ .11). 
Testing Aim 2. Age Differences in the Correlates of Pain Outcomes: Multivariate Linear 
Regression Models 
Model building. All multivariate models included the variables that differed 
between older and younger patients at p:::; .05. These were marital status 
(married/partnered, separated/divorced, widowed; single was reference category), 
education (post-secondary, post-graduate; elementary or high school was reference 
category), CCI> 0, KPS, receipt of an opioid, PASS-20 Cognitive Anxiety, IES 
Intrusion, and PAQ-C Cautiousness (Chapter 2 and Table 1, this Chapter). Table 2 lists 
additional candidate correlates of each outcome variable identified in bivariate testing. 
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Summary of final multivariate linear regression models. Table 3 presents a 
summary of the significant (p:::; .05) correlates across all final multivariate regression 
models. Partially consistent with hypothesis (2), functional status, symptom severity, and 
depressive symptoms were common correlates of pain outcomes. However, inconsistent 
with this hypothesis, pain willingness was a common correlate and gender and the social 
support measures did not emerge as correlates for older or younger patients. Also, 
comorbidity was important only for younger patients and there were age-related patterns 
in relationships between pain anxiety and catastrophizing and the pain outcomes. A 
detailed description of each final multivariate linear regression model follows below. 
BPI Average Pain Intensity. Common correlates of higher BPI Average Pain 
Intensity in both older and younger patients were no concurrent chemotherapy, radiation 
or hormone therapy and higher ESAS Physical symptoms. There were no significant 
differences in the regression weights of the common correlates (allp > .05). Unique 
correlates of higher BPI Average Pain Intensity in older patients were education (post-
graduate vs. elementary or high school) and lower KPS. Unique correlates of higher BPI 
Average pain intensity in younger patients were CCI >O, lower CP AQ Pain Willingness 
and higher IES Intrusion. An examination of the Tolerance and VIF values revealed no 
91 
multicollinearity. Both models were significant (p :S .001) and accounted for 39.4% of the 
variance in older patients and 22.2% of the variance in younger patients (R2 =.394 & 
.222; Table 4). 
In the regression models, BPI Average Pain Intensity and PASS-20 Cognitive 
Anxiety were not significantly associated in older patients, but negatively associated in 
younger patients. A number of diagnostic steps were taken to determine why the 
direction of the association changed to negative only in the regression model for younger 
patients. First, an examination of Pearson's correlation coefficients separately in older 
and younger patients revealed PASS-20 Cognitive Anxiety and BPI Average Pain 
Intensity were correlated in older (r = .27,p = .006) but not younger patients (r = .05,p = 
.56). Second, the multivariate analysis was repeated using stepwise entry of PASS-20 
Cognitive Anxiety, common correlates, and unique correlates. This analysis revealed that 
for younger patients, the direction of the relationship between BPI Average Pain Intensity 
and PASS-20 Cognitive Anxiety became negative when ESAS Physical symptom 
severity was entered into the model, suggesting a possible suppressor effect (J. Cohen & 
Cohen, 1983; MacKinnon, Krull, & Lockwood, 2000) in the model for younger patients. 
SF-MPQ-2 Continuous Pain subscale. There were no common correlates of the 
SF-MPQ-2 Continuous pain subscale. In older patients, higher SF-MPQ-2 Continuous 
pain was associated with having chronic nonmalignant pain, no concurrent 
chemotherapy/radiation or hormone therapy and higher ESAS Physical symptoms. In 
younger patients, higher SF-MPQ-2 Continuous pain was associated with CCI >O, lower 
KPS and SF-36 PHC, and higher IES Intrusion. An examination of the Tolerance and 
VIF values revealed no multicollinearity. Both models were significant (p:::; .001) and 
accounted for 29% of the variance in older patients and 24% of the variance in younger 
patients (R2 =.293 & .242; Table 5). 
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There was a significant interaction between age and CCI on SF-MPQ-2 
Continuous pain subscale scores (B = -1.365 (SE= .584), p = -.314, t= -2.337,p = .02). 
Post-hoc probing of simple slopes revealed that comorbidity was associated with greater 
SF-MPQ-2 Continuous pain subscale scores for younger, but not older patients (Figure 
1). 
SF-MPQ-2 Intermittent Pain subscale: There were also no common correlates of 
the SF-MPQ-2 Intermittent pain subscale. In older patients, higher SF-MPQ-2 
Intermittent pain was associated with higher ESAS Physical symptoms and lower CP AQ 
Pain Willingness. In younger patients, higher SF-MPQ-2 Intermittent pain was associated 
with education (post-graduate degree vs. elementary or high school), CCI>O, lower SF-36 
PHC and higher IES Intrusion. An examination of the Tolerance and VIF values revealed 
no multicollinearity. Both models were significant (p:::; .001) and accounted for 20.6% of 
the variance in older patients and 28.6% of the variance in the younger patients (R2 =.206 
& .286; Table 6). 
Similar to the SF-MPQ-2 Continuous pain subscale findings above, there was a 
significant interaction between age and CCI on SF-MPQ-2 Intermittent pain subscale 
scores (B = -1.273 (SE= .626), P = -.229, t = -2.033, p = .04). Post-hoc probing of simple 
slopes revealed that comorbidity was associated with greater SF-MPQ-2 Intermittent pain 
subscale scores for younger, but not older patients (Figure 2). 
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SF-MPQ-2 Neuropathic Pain subscale. Common correlates of higher SF-MPQ-2 
Neuropathic pain in both older and younger patients were lower SF-36 PHC and higher 
CES-D. There were no significant differences in the regression weights of the common 
correlates (all p > .05). There were no other significant correlates for older patients. 
Unique correlates for younger patients were longer disease duration, no opioid treatment 
and higher ESAS Physical symptoms. An examination of the Tolerance and VIF values 
revealed no multicollinearity. Both models were significant (p::::; .0001) and accounted for 
16.5% of the variance in older patients and 33.7% of the variance in younger patients (R2 
=.165 & .337; Table 7). 
SF-MPQ-2 Affective Pain subscale. Common correlates of higher SF-MPQ-2 
Affective pain in both older and younger patients were higher ESAS Physical symptoms 
and IES Intrusion. There were no significant differences in the regression weights of the 
common correlates (allp > .05). In older patients, the only unique correlate was lower 
CP AQ Pain Willingness. In younger patients, unique correlates were lower KPS and 
higher PCS Total. An examination of the Tolerance and VIF values revealed no 
multicollinearity. Both models were significant (p::::; .001) and accounted for 43% of the 
variance in older patients and 36% of the variance in younger patients (R2 =.433 & .363; 
Table 8). 
BPI Pain Interference. Common correlates of higher BPI Interference in both 
older and younger patients included lower KPS and higher ESAS Physical symptoms. 
There were no significant differences in the regression weights of these correlates (all p > 
.05). Unique correlates in older patients included being prescribed an opioid and higher 
94 
PASS-20 Cognitive Anxiety. Unique correlates in younger patients included taking more 
analgesics, lower SF-36 PHC and higher JES Intrusion. An examination of the Tolerance 
and VIF values revealed no multicollinearity. Both models were significant (p :S .001) 
and accounted for 49% of the variance in older patients and 44% of the variance in 
younger patients (R2 =.493 & .440; Table 9). 
In the regression models, BPI Interference was associated with lower PCS Total 
in older patients but higher PCS Total in younger patients. The regression weight was 
significantly different between older and younger patients (SE b-difference = .025, Z = 3.436, 
p :S .005). A number of diagnostic steps were taken to determine why the direction of the 
association was different between older and younger patients. First, an examination of 
Pearson's correlation coefficients between BPI Interference and PCS Total revealed that 
they were positively correlated in older (r = .24,p = .01) and younger patients (r = .40,p 
= .001). Second, the multivariate analysis was repeated using stepwise entry of PCS 
Total, followed by common correlates, then unique correlates. This analysis revealed that 
for older patients, the direction of the relationship changed once the common correlates, 
ESAS Physical symptoms and KPS, were entered into the model. 
In order to explore the impact of ESAS Physical symptoms and KPS on the 
relationship between PCS Total and BPI Interference in older and younger patients, 
Structural Equation Modelling using multigroups analysis procedures (G. W. Cheung & 
Lau, 2012; Sass, 2011) was used. This analytic technique was used in order to model 
KPS and ESAS Physical symptoms in the same model, rather than fitting 2 separate 
models for each mediator (Frazier, Tix, & Baron, 2004). Model fit was evaluated with the 
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root mean square of approximation (RMSEA < .10), comparative fit and Tucker-Lewis 
indices (CFI, TLI > .90 [Tabachnick & Fidell, 2012; Ullman, 2006]). In the first step, 
invariance across age groups was assumed by fitting a fully constrained model. This 
model was an excellent fit to the data (RMSEA = .000; CFI = 1.000; TLI = 1.007). In the 
second step, coefficients for paths al-2, bl-2 and c (Figure 3) were allowed to vary. This 
model was also an excellent fit to the data with minor deterioration of fit (RMS EA = 
.062; CFI = .994; TLI = .933). The results of this model were similar to the results of the 
regression models. PCS Total and BPI Interference were positively associated in younger 
patients, but negatively associated in older patients, suggesting a possible suppressor 
effect ofESAS Physical symptoms and KPS on the relationship between PCS Total and 
BPI Interference for older but not younger patients. 
The CFI difference test (~CFI:S .001 [G. W. Cheung & Rensvold, 2002]) was 
used to compare the constrained and unconstrained models. ~CFI was below the cutoff 
for retaining the null hypothesis of invariance (G. W. Cheung & Rensvold, 2002), 
therefore the fit of the model did not differ for older and younger patients. Further 
exploration of indirect effects using bootstrapping ( 500 random samples) and the bias-
corrected confidence interval (CI: 95% [G. W. Cheung & Lau, 2008; MacKinnon, 
Lockwood, & Williams, 2004; MacKinnon, Lockwood, Hoffman, West, & Sheets, 
2002]) revealed that ESAS Physical symptoms significantly mediated the relationship 
between PCS Total and BPI Interference for older (Bindirect = .036, Standard Error (SE)= 
.011, 95% CI= .017-.063,p = .003) and younger patients (Bindirect = .025, Standard Error 
(SE)= .008, 95% CI= .012-.048,p = .001). Examination of the indirect effects for KPS 
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revealed that it also mediated the relationship for older patients (Bindirect = .014, Standard 
Error (SE)= .009, 95% CI= .002-.079, p = .004). The indirect effect for younger patients 
was just significant (Bindirect = .008, Standard Error (SE) = .006, 95% CI = .000-.024, p = 
.051), suggesting that the impact of KPS on the relationship between PCS and BPI 
Interference was somewhat stronger among older than younger people. 
Discussion 
This study improves our understanding of the experience of cancer pain across the 
adult life span by investigating a broad range of biopsychosocial correlates of the 
multidimensional experience of cancer pain and elucidating how these factors operate 
together in relation to cancer pain in older and younger patients. There were no age 
differences in the intensity of cancer pain or its interference in important aspects of daily 
living, but older patients were less likely than younger patients to be prescribed an opioid. 
Despite the lack of age differences in pain outcomes, consistent with emerging literature 
demonstrating age differences in the correlates of chronic nonmalignant pain (Cook, 
Brawer, & Vowles, 2006; Edwards, 2006; Mcllvane, Schiaffino, & Paget, 2007; Turk, 
Okifuji, & Scharff, 1995), we identified unique age-related patterns in the correlates of 
cancer pain. Specifically, this is the first study to identify comorbidities as a risk factor 
for pain outcomes in younger but not older patients and chronic nonmalignant pain as a 
risk factor in older but not younger patients. It is also the first study to identify possible 
unique roles of cancer symptoms and functional status in the relationship between pain 
catastrophizing and interference among older but not younger patients. These findings 
suggest that age-tailored multimodal assessments and treatments for cancer pain may be 
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necessary and they may inform the development of interventions that consider the unique 
needs of adults at different life stages. 
There were no age differences in pain intensity, qualities or interference from 
pain. Despite this, although not statistically significant based on a stringent alpha level 
adjusted for multiple comparisons, older patients were somewhat less likely to be 
prescribed an opioid than younger patients. Unfortunately, this trend is consistent with 
data from two decades ago (Cleeland et al., 1994) and more recent studies documenting 
the undertreatment of cancer pain in older people (Bernabei et al., 1998; Gao, Gulliford, 
& Higginson, 2011; Higginson & Gao, 2012; Yun et al., 2004). Interestingly, there were 
subtle age-related patterns in the relationships of treatment factors to pain interference. In 
the regression model for younger, but not older people, taking more analgesics of any 
class was associated with greater pain interference, while in in the regression model for 
older, but not younger people, receipt of an opioid prescription was associated with 
greater pain interference. Although previous studies have identified associations between 
healthcare provider treatment choices and patient age (Green, Wheeler, & LaPorte, 2003; 
McCaffery & Ferrell, 1991 ), this is the first study to document these subtle age-related 
treatment differences within people with cancer pain. One possible explanation may be 
that there are age-related patterns in healthcare providers' responses to outward displays 
or reports of pain-related impairment. In older people, who may be less likely than 
younger people to be prescribed an opioid, greater pain interference may be an important 
factor in the decision to prescribe an opioid, while in younger people, greater pain 
interference may be associated with provision of more analgesic treatment overall. This 
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might suggest that healthcare providers may act on cues about the impact of pain 
differently in older than younger people. Patient-related barriers to treatment may also be 
relevant, such as fears of addiction and the beliefs that good patients do not complain 
about pain and that reporting pain may distract healthcare providers from cancer 
treatment (Ward et al., 1993). Future research is needed to investigate whether greater 
displays or reports of pain interference elicit somewhat different treatment based on age, 
as this may have important implications for improving the undertreatment of cancer pain 
in older people. 
Comorbidity was less common in younger than older patients. However, younger 
patients with comorbidities experienced worse non-neuropathic sensory pain qualities 
than younger patients without comorbidities. In contrast, in the regression models for 
older patients, comorbidity did not emerge as an important correlate of any of the pain 
outcomes. Age-related patterns in the impact of comorbidities on the experience of 
cancer pain have received limited attention to-date. In one study, comorbidity was 
associated with lower activity restriction in younger than older people (G. M. Williamson 
& Schulz, 1995). Unfortunately, a nonvalidated measure of comorbidity was used; 
therefore, it is difficult to integrate these findings. While comorbidity is associated with 
increasing age (Dominick, Blyth, & Nicholas, 2012; Extermann, 2000b ), it is not 
exclusively a problem of older people. However, studies of comorbidity in people with 
cancer and chronic nonmalignant pain have largely focused on older, rather than younger 
people and have excluded younger people altogether (Blyth et al., 2008; Extermann, 
2000a; C. W. Given, Given, Azzouz, Kozachik, & Stommel, 2001; Leong, Farrell, 
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Helme, & Gibson, 2007; Yancik, Ganz, Varricchio, & Conley, 2001). Consequently, our 
understanding of the impact of comorbidity on younger people with cancer pain has 
remained limited. The present data suggest that comorbidity may put younger people at 
risk for poor cancer pain outcomes and that this factor should not be ignored when 
assessing cancer pain and its impact in younger people. 
Moreover, although there were no age differences in the proportion of older and 
younger people with chronic nonmalignant pain, this health status factor was associated 
with greater non- neuropathic pain qualities for older, but not younger patients. Chronic 
nonmalignant pain has been identified as a risk factor for the undertreatment of cancer 
pain (V aleberg, Rustoen et al., 2008), but this is the first study to identify chronic 
nonmalignant pain as a risk factor for poor pain outcomes specifically in older cancer 
patients. These results demonstrate that future studies of people with cancer pain should 
also assess the presence and impact of chronic nonmalignant as it may represent a risk 
factor for poor cancer pain outcomes among older people. 
There was also an age-related pattern in the relationship of physical health quality 
of life and pain outcomes. In younger patients it was associated with lower pain 
interference, and non-neuropathic and neuropathic pain qualities. In contrast, in older 
patients, while it was associated with lower neuropathic pain qualities, it was not 
associated with non-neuropathic pain qualities or pain interference. These data 
complement and extend findings from an earlier study which demonstrated that despite a 
lack of age differences in perceptions of global health QOL and pain intensity, the 
100 
correlation between these two factors was stronger in younger than older postoperative 
patients (Mangione et al., 1993). 
Additionally, although two other health status factors - functional status and 
cancer symptom severity - were common correlates of pain outcomes in both older and 
younger patients, there was evidence of age-related patterns in their role in the 
relationship between pain catastrophizing and pain interference. In older, but not younger 
patients, cancer symptom severity and functional status acted as a suppressor of this 
relationship, changing the direction of the relationship from positive, which has been 
consistently demonstrated (Hanley, Raichle, Jensen, & Cardenas, 2008; Hirsh, Bockow, 
& Jensen, 2011; Sullivan, Thom, Haythomtwaite, Keefe, Martin, Bradley, & Lefebvre, 
2001), to negative. The Communal Coping Model of Catastrophizing (CCM) suggests 
that catastrophizing is enacted to elicit support (Sullivan, Thom, Haythomtwaite, Keefe, 
Martin, Bradley, & Lefebvre, 2001). There is emerging support for this model in people 
with chronic nonmalignant pain (Buenaver, Edwards, & Haythomthwaite, 2007; Cano, 
2004; Giardino, Jensen, Turner, Ehde, & Cardenas, 2003; Pence, Cano, Thom, & Ward, 
2006). In people with cancer pain, catastrophizing has been associated with tangible, but 
not emotional support (Keefe et al., 2003). We have also demonstrated that 
catastrophizing is related to more frequently perceived solicitous and distracting support 
with a smaller subset of this sample (Gauthier et al., 2012). The present data suggest that 
the communication value of catastrophizing may be age-related: older people with severe 
cancer symptomatology and impaired functional status may experience a unique 
supportive context that is not available to younger people. In support of this idea, while 
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older people with advanced cancer described strengthened relationships as a result of 
pain, younger people described relational strain, and that their partners did not understand 
their pain (Gagliese et al., 2009). Although very preliminary, these intriguing findings 
require further investigation. 
Taken together, it appears that there are certain health status factors that are 
uniquely important to cancer pain outcomes based on age group, like comorbidities in 
younger patients and chronic nonmalignant pain in older patients, while other factors, like 
physical health quality of life, cancer symptom severity and functional status, are 
important to pain outcomes in both age groups, but in somewhat different ways. Through 
the investigation of relationships between multiple measures of health status and 
multidimensional pain outcomes, we have uncovered a much more comprehensive profile 
of risk factors for cancer pain in older and younger patients than has been available 
previously. Future studies should incorporate these details in order to fully understand the 
complex nature of the relationships between multidimensional pain outcomes and health 
status across the adult life span. 
It has been suggested that older people are less psychologically affected by cancer 
than younger people (Blank & Bellizzi, 2008) and some studies of cancer patients that do 
not consider pain have found older age to be associated with fewer depressive symptoms 
or less distress (Compas et al., 1999; Kroenke et al., 2004; Mosher & Danoff-Burg, 2005; 
Lo et al., 2010; Politi, Enright, & Weihs, 2007; Schroevers, Ranchor, & Sanderman, 
2004; Vinokur, Threatt, Vinokur-Kaplan, & Satariano, 1990; Wenzel et al., 1999). We 
did not find support for this suggestion in the context of cancer pain: A similar proportion 
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of older and younger patients scored above cutoffs for clinically-relevant distress on 
measures of depressive symptoms and traumatic distress, and more than half of older and 
younger patients reported depressive symptoms in a range suggestive of possible clinical 
depression (Radloff, 1977). Moreover, depressive symptoms were associated with 
neuropathic pain in older and younger patients, suggesting that, in both age groups, 
interventions designed to alleviate neuropathic pain may be equally important for 
improving distress, and vice versa, interventions designed to alleviate distress may be 
equally important for improving neuropathic pain. However, consistent with previous 
studies (Butler, Koopman, Classen, & Spiegel, 1999; Hart et al., 2012; Schroevers, 
Ranchor, & Sanderman, 2004; J. Turner, Kelly, Swanson, Allison, & Wetzig, 2005), 
older patients had fewer intrusive thoughts than younger patients. More interestingly, in 
the regression models, intrusion was associated with greater pain intensity, non-
neuropathic sensory pain qualities, and interference in younger but not older patients. In a 
qualitative study, more younger than older patients described "waiting to live". They 
reacted to the loss of their pre-pain identities and activities with anger and grief and 
described feeling overwhelmed by pain (Gagliese et al., 2009), reactions which may be 
related to intrusive thoughts about the experience of cancer pain. In contrast, more older 
than younger patients described "living despite pain" (Gagliese et al., 2009). They 
discussed the importance of maintaining their activities and refusing to let pain control 
their lives. 
Together with that study (Gagliese et al., 2009), and previous research 
demonstrating age-related patterns in adaptation to chronic illness (Aldwin, Sutton, 
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Chiara, & Spiro, 1996; Diamond & Aspinwall, 2003; Felton & Revenson, 1987; Stanton, 
Revenson, & Tennen, 2007) these findings suggest that the adaptive value of prior health 
limitations may differ across the adult life span (Gagliese et al., 2009). Although older 
people may be faced with a constellation of factors which may be associated with 
vulnerability to negative pain outcomes (Davis & Srivastava, 2003; Extermann, 2000a; 
Mercadante, Casuccio, Pumo, & Fulfaro, 2000; Yancik & Ries, 2000), the experience of 
adapting to comorbidities may be associated with a unique repertoire of accommodative 
strategies whose development may be facilitated by observing age-related health 
limitations among peers (Gagliese et al., 2009; Schulz & Heckhausen, 1996). A related 
explanation may be response shift or cognitive reappraisal (Diamond & Aspinwall, 2003; 
Stanton, Revenson, & Tennen, 2007), which suggest that adaptation to other chronic 
conditions may result in a recalibration of responses on self-report measures (Daltroy, 
Larson, Eaton, Phillips, & Liang, 1999; Ubel, Jankovic, Smith, Langa, & Fagerlin, 2005). 
In contrast, among younger people, cancer pain may be inconsistent with normative 
health expectations, and may be perceived as threatening to future life goals (Gagliese et 
al., 2009). Rather than providing an adaptive advantage, the presence of comorbidities 
along with cancer pain may instead represent further lifecourse violations and additional 
vulnerability to poor outcomes. Taken together with the qualitative study described above 
(Gagliese et al., 2009), it is possible that there are age-related patterns in the cognitive-
affective dimension of cancer pain. In further support of this possibility, pain-related 
cognitive anxiety was associated with greater pain interference in older, but not younger 
people. Intriguingly, it was correlated with greater pain intensity only in older patients. 
This is the first study to document this age-related pattern in the relationship between 
pain-related cognitive anxiety and cancer pain outcomes. 
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Despite the age-related patterns in the cognitive-affective dimension noted above, 
pain willingness, an element of pain acceptance (McCracken, 1998) which may represent 
another component of this dimension, was a common correlate of pain outcomes across 
both age groups. Pain acceptance has been related to lower pain intensity and better 
physical and psychosocial wellbeing in people with chronic nonmalignant pain 
(McCracken & Eccleston, 2005; McCracken, 2005a; McCracken, 2005b; McCracken & 
Eccleston, 2006; Viane et al., 2003). In a smaller subset of this sample, we found that 
pain willingness was related to lower pain catastrophizing as well as parental status, 
which may have operated as a proxy for life stage (Gauthier et al., 2009). Specifically, 
parents living with children had much lower pain willingness than people who were not 
parents. In the qualitative study described above, more older than younger people with 
cancer pain described acceptance as an important method of positive adaptation to pain 
(Gagliese et al., 2009). Based on the present findings, it is possible that enhancing 
patients' willingness to accept pain while encouraging letting go of futile efforts to 
control pain would be important to improving pain and wellbeing regardless of age or life 
stage. 
Although the individual correlates differed slightly, most of the regression models 
demonstrated that physical and psychological factors were associated with pain outcomes 
in both older and younger patients. There were two noteworthy findings that emerged 
with regard to the models predicting neuropathic pain. First, depressive symptoms 
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emerged as a correlate of neuropathic pain, but not other pain outcomes. This is 
surprising, given the extensive literature demonstrating the relationship between 
depression and cancer pain (Laird, Boyd, Colvin, & Falon, 2009). Although some studies 
have attempted to compare psychological wellbeing in cancer patients with nociceptive 
and neuropathic pain (Burrows, Dibble, & Miaskowski, 1998; Tofthagen& McMillan, 
2010; Wilkie et al., 2001), the findings have been mixed and age-related patterns in these 
relationships have not been evaluated. It is difficult to integrate the inconsistent findings 
due to the wide variation in classification criteria for neuropathic pain across studies. One 
possible explanation may be that neuropathic pain is highly distressing regardless of life 
stage because it may be refractory to treatment (Dworkin et al., in press; Mercadante & 
Portenoy, 200 I). Future studies should investigate differences in the biopsychosocial 
predictors of neuropathic and nociceptive cancer pain using validated methods. The 
second noteworthy finding relates to the age-related pattern that emerged in the profile of 
correlates of neuropathic pain. Although physical health QOL and depressive symptoms 
emerged for both age groups, disease duration, receipt of an opioid, and symptom 
severity emerged for younger, but not older patients. We have shown that the 
psychometric properties of the SF-MPQ-2 are not age-related (Chapter 2), therefore these 
findings are likely not due to age differences in the psychometric properties of the 
measure. Future studies investigating age-related patterns in the psychosocial correlates 
of neuropathic pain are warranted. 
To date, much of the literature describing age-related patterns in cancer pain has 
been hindered by methodological limitations, narrow scope in the operationalization of 
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cancer pain, and a persistent reliance on the biomedical model. With the aging population 
(Statistics Canada, 2007), it is increasingly important to improve our understanding in 
order to enhance pain palliation for adults across the life span. A recent literature review 
of older people's experience of cancer pain concluded that the existing literature is "scant 
and heterogeneous" (Dunham, Ingleton, Ryan, & Gott, 2013, p. 2108). Unfortunately, 
this review excluded younger people, and therefore did not contribute to an improved 
understanding of the experience of cancer pain across the adult life span. By excluding 
younger people, we have no idea whether the "themes" uncovered by the authors are 
unique among older people and should therefore guide the development of treatments 
tailored to older people, or if these are common experiences to older and younger people. 
The present study provides important evidence describing the experience of cancer pain 
across the adult life span. In summary, although there were no age differences in cancer 
pain, older people were somewhat less likely than younger people to receive an opioid 
and there were age differences in the relationship of treatment factors and pain 
interference. We identified a number of unique health status risk factors for older and 
younger patients as well as a possible unique role of health status factors in the 
relationship between catastrophizing and pain interference for older but not younger 
patients, which may represent age-related patterns in the supportive context of cancer 
pain. Finally, although a similar number of older and younger patients reported levels of 
distress indicative of clinically relevant symptomatology, age-related patterns in the 
relationships of intrusive thoughts and pain outcomes may be suggestive of a unique 
adaptive advantage of some health status factors in older but not younger patients. 
107 
This study improves on the methodological limitations of the existing literature in 
a number of ways. First, the inclusion criteria of people reporting cancer pain prevented 
confounding prevalence with intensity. Second, the measure of pain qualities is valid for 
use across the adult life span (Chapter 2), which increases confidence in our 
interpretation of age-related patterns as actual patterns, and not age differences in the 
psychometric properties of the scale. Third, the matching procedure used in this study is a 
particular strength. No prior studies of age-related patterns in cancer pain have matched 
participants on sex and primary tumor type. This is important, as these factors have been 
associated with cancer pain (Dobratz, 2008; Fillingim, King, Ribeiro-Dasilva, Rahim-
Williams, & Riley, 2009; Grond, Zech, Diefenbach, Radbruch, & Lehmann, 1996; 
Miaskowski, 2004; Vainio & Auvinen, 1996). Despite these important strengths, there 
are several limitations which must be taken into account when interpreting the findings. 
The majority of participants were well-educated, predominantly Caucasian patients 
receiving specialized symptom management at a comprehensive tertiary cancer care 
centre (Chapter 2). Additionally, those who completed the questionnaires were younger 
and had better functional status than those who failed to return the questionnaires. 
Although poor performance status is often associated with withdrawal from studies 
(Garland, Carlson, Marr, & Simpson, 2009; Gilbertson-White, Aouizerat, Jahan, & 
Miaskowski, 2011; Hardy, Allore, & Studenski, 2009; Mody et al., 2008; Ransom, 
Azzarello, & McMillan, 2006), future studies should endeavor to include older people 
with severe functional impairments who are not receiving specialized symptom 
management. The cross-sectional design of this study precludes statements of causality. 
108 
Longitudinal studies are required to assess the trajectory of pain and its correlates in older 
and younger patients as they approach the end of life. 
A number of significant future research directions are evident based on the results 
of this study. First, cancer pain is dynamic and may fluctuate with treatment changes or 
as the disease progresses. The health status factors that operated differently in older and 
younger patients may be impacted by disease progression (Harris et al., 2013; Kang, 
Kwon, Hui, Yennurajalingam, & Bruera, 2013; Visovsky, Berger, Kosloski, & Kercher, 
2008), by the process of aging (B. Chen, Covinsky, Stijacic Cenzer, Adler, & Williams, 
2012; Inouye, Studenski, Tinetti, & Kuchel, 2007; Miller, Longino, Anderson, James, & 
Worley, 1999), or by an interactive process of disease progression and aging (Dale et al., 
2012), and may therefore impact on pain outcomes differently over time in older and 
younger patients. Longitudinal studies of age-related patterns in cancer pain that consider 
these factors are necessary. Second, studies that include caregivers are necessary to 
investigate the possibility of a unique supportive context in older patients, especially 
those who are burdened by severe cancer symptoms and compromised functional status. 
These studies would provide important information about caregivers' supportive 
responses to older and younger patients' catastrophizing, based on patients' symptom 
severity and functional status. Since receipt of an opioid was associated with greater pain 
interference, it might be possible that the presence of a unique supportive context that 
mitigates pain interference may also have implications for the receipt of analgesia among 
older people. Vignette studies with healthcare providers may be useful to test this 
possibility (Burgess, van Ryn, Crowley-Matoka, & Malat, 2006; Green, Wheeler, & 
LaPorte, 2003; McCaffery & Ferrell, 1991; Weisse, Sorum, Sanders, & Syat, 2001). 
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In the end, the age differences uncovered in this study were subtle. Importantly, 
despite the fact that older people were somewhat less likely than younger people to 
receive an opioid, may experience a unique supportive context, and may adapt differently 
based on experience with certain health limitations, cancer pain was equally distressing in 
both age groups. It felt the same, hurt just as much, and interfered in important aspects of 
daily living to the same extent in older and younger patients. As a result, there is no 
reason to think that older people are less affected by cancer pain than younger people. 
These data have heuristic and clinical value. They will contribute to future studies that 
will further refine the biopsychosocial model of cancer pain across the adult life span. 
They will also contribute to studies that will and design and test interventions tailored to 
the unique needs of older and younger people. These studies are urgently needed in order 
to reduce suffering at the end of life in adults of all ages. 
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Table 1. Study measures by age group 
Mean± SD; N (%) 
Total (n=244) Younger (n=l 39) Older (n=l 05) PS. 
BPI Average Pain Intensity 3.82 ± 2.02 4.00 ± 2.12 3.70 ± 2.12 .28 
BPI Pain Interference 4.82 ± 2.41 4.93 ± 2.37 4.67 ± 2.48 .40 
PMI<O 36 (14.8) 19 (13.7) 17 (16.2) .58 
SF-MPQ-2 Continuous 3.29 ± 2.16 3.39 ± 2.15 3.15 ± 2.17 .38 
SF-MPQ-2 Intermittent 2.47 ± 2.30 2.67 ± 2.43 2.20 ± 2.12 .11 
SF-MPQ-2 Neuropathic 1.93 ± 1.73 2.06 ± 1.81 1.76 ± 1.60 .18 
SF-MPQ-2 Affective 2.79 ± 2.33 2.94 ± 2.32 2.59 ± 2.35 .25 
SF-MPQ-2 Total 2.59 ± 1.74 2.74 ± 1.74 2.39 ± 1.72 .12 
ESAS Physical symptoms 4.03 ± 1.74 3.99 ± 1.69 4.08 ± 1.82 .68 
SF-36 PHC 29.19 ± 7.58 29.03 ± 7.39 29.40 ± 7.86 .71 
SF-36MHC 43.45 ± 11.04 42.83 ± 10.54 44.28 ± 11.66 .31 
CES-D 20.86 ± 10.56 21.60 ± 10.15 19.89 ± 11.06 .21 
IES Avoidance 13.40 ± 9.01 13.72 ± 9.41 12.99 ± 8.47 .53 
IES Intrusion 10.66 ± 7.86 12.24 ± 7.99 8.58 ± 7.21 .0001 
IES Total 24.07 ± 15.24 25.96 ± 15.75 21.56 ± 14.23 .03 
P AQ-C Stoicism 3.04 ± 0.81 3.02 ± 0.85 3.07 ± 0.76 .64 
P AQ-C Cautiousness 2.39 ± 0.93 2.28 ± 0.88 2.53 ± 0.99 .04 
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CP AQ Activity Engagement 34.14 ± 12.58 33.50 ± 12.91 34.98 ± 12.14 .37 
CP AQ Pain Willingness 21.45 ± 9.65 21.58 ± 9.60 21.29 ± 9.76 .82 
CPAQ Total 55.59 ± 18.14 55.08 ± 19.10 56.27 ± 16.86 .61 
PASS-20 Fear 8.65 ± 5.72 9.04 ± 5.43 8.13 ± 6.06 .22 
P ASS-20 Escape-Avoidance 13.37 ± 5.66 13.78 ± 5.59 12.84 ± 5.75 .20 
P ASS-20 Physiological Anxiety 6.97 ± 5.24 7.20 ± 4.97 6.65 ± 5.58 .42 
PASS-20 Cognitive Anxiety 13.33 ± 6.15 14.02 ± 5.91 12.42 ± 6.37 .04 
PASS-20 Total 42.32 ± 19.32 44.05 ± 17.90 40.03 ± 20.92 .11 
PCS Rumination 7.54 ± 4.40 7.56 ± 4.26 7.52 ± 4.59 .94 
PCS Magnification 4.04 ± 3.04 3.93 ± 2.91 4.18 ± 3.22 .53 
PCS Helplessness 8.41±5.80 8.36 ± 5.51 8.49±6.19 .87 
PCS Total 20.00 ± 12.09 19.86 ± 11.41 20.19 ± 12.98 .83 
FACIT-Sp-12 Meaning-Peace 22.49 ± 6.82 22.45 ± 6.36 22.55 ± 7.41 .91 
F ACIT-Sp-12 Faith 8.97 ± 5.04 8.60 ± 5.06 9.47 ± 4.98 .18 
FACIT-Sp-12 Total 31.47 ± 9.84 31.05 ± 9.62 32.02 ± 10.15 .44 
MPI Punishing Responses 1.07 ± 1.26 1.12 ± 1.27 1.00 ± 1.27 .48 
MPI Solicitous Responses 4.54 ± 1.22 4.59 ± 1.16 4.48 ± 1.29 .48 
MPI Distracting Responses 2.94 ± 1.38 2.85 ± 1.39 3.04 ± 1.37 .30 
MOS-SS # of Close Friends and 6.61±4.79 6.59 ± 4.28 6.63 ± 5.41 .96 
Relatives 
MOS-SS Emotional Information 
MOS-SS Tangible 
MOS-SS Affectionate 
MOS-SS Positive Social 
Interaction 
MOS-SS Total 
ECR Avoidance 
ECRAnxiety 
KMS Total (n=l 76) 
80.46 ± 19.97 
79.25 ± 23.52 
86.17 ± 21.59 
80.84 ± 21.13 
80.99 ± 19.06 
3.10 ± 1.01 
2.48 ± 1.06 
18.43 ± 3.81 
80.99 ± 19.39 
79.85 ± 22.16 
86.36 ± 21.43 
81.50 ± 20.29 
81.51±18.87 
3.11±1.05 
2.55 ± 1.11 
18.27 ± 3.76 
79.77 ± 20.77 
78.46 ± 25.29 
85.92 ± 21.91 
79.98 ± 22.27 
80.31±19.38 
3.10 ± 0.97 
2.38 ± 0.99 
18.64 ± 3.90 
.64 
.65 
.88 
.58 
.63 
.94 
.20 
.54 
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Notes. BPI, Brief Pain Inventory, PMI, Pain Management Index, SF-MPQ-2, Short-Form McGill Pain Questionnaire 2; ESAS, 
Edmonton Symptom Assessment Scale; SF-36 PHC, SF-36 Physical Health Component Summary Score; SF-36 MHC, SF-36 
Mental Health Component Summary Score; CES-D, Center for Epidemiologic Studies-Depression Scale; IES Impact of Event 
Scale; PAQ-C, Pain Attitudes Questionnaire, CPAQ, Chronic Pain Acceptance Questionnaire; PASS-20, Short Form Pain 
Anxiety Symptoms Scale; PCS, Pain Catastrophizing Scale; FA CIT-Sp 12, Functional Assessment of Chronic Illness Therapy 
- Spiritual Wellbeing 12; MPI, Multidimensional Pain Inventory; MOS-SS, Medical Outcomes Study Social Support Survey; 
ECR, Experiences in Close Relationships Inventory; KMS, Kansas Marital Satisfaction Scale; SD, Standard Deviation 
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Table 2. Candidate correlates of each outcome variable (n=244). 
BPI 
Average 
Pain BPI Pain SF-MPQ-2 SF-MPQ- 2 SF-MPQ- 2 SF-MPQ-2 
Intensity Interference Continuous Intermittent N europathic Affective 
Age (years) .006 -.010 -.064 -.071 -.086 -.034 
Sex -.082 -.121 -.046 -.138 -.118 -.131 
English primary language -.140 -.133 -.046 -.145 -.098 -.123 
Marital Status .009f -.027 f -.012 f .025 f -.040f -.035 f 
Education -.027 f -.109 f -.021 f -.009 f .027f -.075 f 
BMI .101 .064 .095 .151 .141 .047 
Primary tumor type ~ .874 1.079 .937 .814 .826 .448 
Cancer duration (months) .068 .069 .116 .071 .206** .123 
Pain duration (months) -.049 .030 .055 .016 .126 .139 
Chronic Non-Cancer Pain .110 .060 .206** .119* .121 .155 
Count analgesics taken .063 .174** .104 .050 .103 .097 
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Polypharmacy .085 .107 .052 .061 .036 .112 
ADS .124 .136 .166* .141 .034 .1s1* 
Chemotherapy, Radiation -.238** -.154 -.1so* -.155 -.064 -.146 
or Hormone treatment 
Non-pharmacological pain -.065 -.049 -.030 -.032 -.036 -.050 
treatment 
Prescribed an opioid .036f .142 f .064f .092 f -.024 f .104 f 
CCI>O .090f .016 f .131 f .lOOf .006f .064f 
KPS -.216** f -.372** f -.269** f -.266** f -.157* f -.280** f 
BPI Average pain 1 .598** .568** .473** .489** .494** 
intensity 
BPI Interference .598** 1 .510** .504** .456** .596** 
SF-MPQ-2 Continuous .568** .510** 1 .575** .581 ** .675** 
SF-MPQ-2 Intermittent .473** .504** .575** 1 .578** .595** 
SF-MPQ-2 Neuropathic .489** .456** .581 ** .578** 1 .555** 
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SF-MPQ-2 Affective .494 ** .596** .675** .595** .555** 1 
ESAS Physical symptoms .326** .502** .35o** .289** .328** .496** 
SF-36 PHC -.220** -.395** -.265** -.321** -.219** -.221** 
SF-36 MHC -.149*b -.335**b -.136*b -.110 -.179**b -.356**b 
CES-D .245** .358** .208** .206** .326** .392** 
IES Avoidance .157 .219**c .062 .205**c .155 .244** 
IES Intrusion .176* f .292** f .180* f .210**f .254** r .381**f 
P AQ-C Stoicism .061 .001 .078 .115 .146 .090 
P AQ-C Cautiousness -.028 f .063 f -.009 f .040f .064f .lOOr 
CP AQ Activity -.155 -.349** -.072 -.112 -.060 -.155 
Engagement 
CP AQ Pain Willingness -.160** -.281 ** -.152 -.237** -.188* -.313** 
PASS-20 Fear .192*d .298**d .184*d .144 .265**d .403**d 
PASS-20 Escape- .063 .235**d .072 .163 .124 .193*d 
Avoidance 
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P ASS-20 Physiological .l 76*d .342**d .174*d . l 77*d .284**d .321 **d 
Anxiety 
P ASS-20 Cognitive .154 f 335** f .177* f .220** f .210** f .313**f 
Anxiety 
PCS Rumination .21 f*e .306**e .155 .276**e .291 **e .384**e 
PCS Magnification .186*e .224**e . l 85*e .174*e .207**e .401 **e 
PCS Helplessness .244**e .326**e .l 89*e .256**e .319**e .42o**e 
PCS Total .243** .324** .194* .267** .311 ** .442** 
F ACIT-Sp-12 Mean/Peace -.213**b -.279**b -.085 -.147 -.163 -.218**b 
FACIT-Sp-12 Faith -.031 .010 .080 -.043 .089 .127* 
MPI Punishing .063 .139 .115 .098 .1ss* .067 
MPI Solicitous .028 .081 .122 .034 -.033 .118 
MPI Distracting .001 -.070 .091 .005 .073 .110 
MOS-SS Average# -.089 -.056 -.018 -.058 -.090 .007 
family/friends 
MOS-SS Emotional 
Information 
MOS-SS Tangible 
MOS-SS Affectionate 
MOS-SS Positive Social 
Interaction 
ECR Avoidance 
ECRAnxiety 
KMS 
-.083 
-.036 
-.058 
-.055 
.121 
.066 
-.077 
-.075 
-.034 
-.095 
-.113 
.153 
.113* 
-.079 
-.032 
-.006 
-.044 
.006 
.069 
.095 
-.043 
Values are Pearson's Correlation coefficients or Spearman's Rho 
-.062 
-.021 
-.100 
-.053 
.064 
.111* 
.074 
-.083 
-.014 
-.122 
-.081 
.125 
.186* 
-.033 
-.064 
-.019 
-.035 
-.069 
.129 
.262** 
.040 
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* p :S .01; ** p :S .001, bolded coefficients were retained for inclusion in the Multivariate models in the second step of correlate 
selection. 
Notes. BPI, Brief Pain Inventory; SF-MPQ-2, Short-Form McGill Pain Questionnaire 2; IES Impact of Event Scale; ADS, 
Anticholinergic Drug Scale; CCI, Charlson Comorbidity Index; KPS, Karnofsky Performance Status Scale; ESAS, Edmonton 
Symptom Assessment Scale; SF-36 PHC, SF-36 Physical Health Component Summary Score; SF-36 MHC, SF-36 Mental 
Health Component Summary Score; CES-D, Center for Epidemiologic Studies-Depression Scale; PAQ-C, Pain Attitudes 
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Questionnaire, CPAQ, Chronic Pain Acceptance Questionnaire; PASS-20, Short Form Pain Anxiety Symptoms Scale; PCS, 
Pain Catastrophizing Scale; FACIT-Sp 12, Functional Assessment of Chronic Illness Therapy- Spiritual Wellbeing 12; MPI, 
Multidimensional Pain Inventory; MOS-SS, Medical Outcomes Study Social Support Survey; ECR, Experiences in Close 
Relationships Inventory; KMS, Kansas Marital Satisfaction Scale; SD, Standard Deviation 
a Not retained for inclusion. Correlations with BPI Average Pain Intensity 2:.6 
b Not retained for inclusion. Correlation with CES-D 2:.6 
c Not retained for inclusion. Correlation with IES Intrusion 2:.6 
d Not retained for inclusion. Correlations with P ASS-20 Cognitive Anxiety 2:.6 
e PCS subscale intercorrelations 2:.6 therefore PCS Total retained for inclusion. 
f All multivariate models included the variables that differed between older and younger patients at p :S .05. 
~ F-test statistic 
Table 3. Summary chart of significant (p ~ .05) correlates retained in each final multivariate regression model 
BPI Avg 
PI 
SF-MPQ-
2 Cont 
SF-MPQ-
2 Inter 
SF-MPQ-
2 Aff 
BPI Int 
Post-
grad Chronic CCI> 
degree NMP 0 
y 0 y 0 y 0 
+ + 
+ + 
+ + 
#pain 
Cancer meds 
KPS dur taken 
y 0 y 0 y 0 
+ 
. - -·. ---
+ 
CTX/ ESAS IES Rx RT/H Phys SF-36 
opioid T sx PHC CES-D Intrus 
y 0 y 0 y 0 y 0 y 0 y 0 
-- + + + 
+ 
+ 
+ - - + + 
+ + + + 
---
+ + + - + 
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CPAQ PCS 
PW Tot 
y 0 y 0 
-+ 
+ -
Notes: BPI Avg Pl, BPI Average Pain Intensity; SF-MPQ-2 Cont, Inter, NeP, Aff, SF-MPQ-2 Continuous, Intermittent, 
Neuropathic, Affective; BPI Int, BPI Interference; Post-grad degree, post-graduate degree; Chronic NMP, Chronic 
nonmalignant pain; CCI, Charlson Comorbidity Index; KPS, Karnofsky Performance Status Scale; Cancer dur, Cancer 
duration;# pain meds taken, count of analgesics taken; Rx opioid, prescribed an opioid; CTXIRT/HT, chemotherapy, radiation 
PASS-
20Cog 
Ax 
y 0 
+ 
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or hormone treatment; ESAS Phys sx, Edmonton Symptom Assessment Scale Physical symptom severity; SF-36 PHC, SF-36 
Physical Health Component Score; CES-D, Center for Epidemiologic Studies -Depression scale; IES lntrus, Impact of Events 
Scale Intrusion; CPAQ PW, Chronic Pain Acceptance Questionnaire Pain Willingness subscale; PCS Tot, Pain Catastrophizing 
Scale Total; PASS-20 Cog Ax, Pain Anxiety Symptoms Scale-short form Cognitive Anxiety subscale; Y, Younger; 0, Older; 
+, positive relationship;-, negative relationship. 
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Table 4. Multivariate linear regression correlates of Brief Pain Inventory Average Pain 
Intensity 
Younger Older 
B (SE) p B(SE) p SE b-diff 
Post-graduate degree a 1. 743(.481) .298*** 
CCI>O .800 (.396) .163* 
KPS -.040(.018) -.199* 
Chemotherapy/ 
radiation/ hormone -.922 (.337) -.214** -1.677 (.340) -.398*** 1.576 
therapy 
ESAS Physical 
.275 (.107) .219** .219 (.107) .188*** .370 
symptoms 
CP AQ Pain Willingness -.057 (.020) -.260** 
IES Intrusion .050(.023) .088* 
P ASS-20 Cognitive 
Anxiety 
-.069 (.035) -.192* .053 (.028) .159 .005** 
F(6,132) = 6.260,p ~ .0001, F(s,99) = 12.870,p ~ .0001, 
R2 = .222; Adjusted R2 = R2 = .394; Adjusted R2 = 
.186 .363 
a reference category is ~ High School; SE b-diff = SE b-difference; CCI, Charlson 
Comorbidity Index; KPS, Kamofsky Performance Status Scale; ESAS, Edmonton 
Symptom Assessment Scale; CP AQ, Chronic Pain Acceptance Questionnaire; IES, 
Impact of Events Scale; PASS-20, Pain Anxiety Symptoms Scale-short form 
* p ~ .05; ** p ~ .01; *** p ~ .001 
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Table 5. Multivariate linear regression correlates of Short-Form McGill Pain 
Questionnaire-2 Continuous pain qualities 
Younger Older 
B (SE) p B(SE) p SE b-diff 
Chronic nonmalignant 
.887 (.395) .189* pain 
CCI>O 1.227 (.389) .246** 
KPS -.050 (.017) -.238** 
Chemotherapy/ 
radiation/ hormone -.604 (.334) -.138 -1.040 (.363) -.240** .495 
therapy 
ESAS Physical 
.516 (.100) .432*** 
symptoms 
SF-36 PHC -.050 (.023) -.173* 
IES Intrusion .058 (.021) .216** 
_ < F(3,101) = 13.929,p :S .0001, 
F(s,133) - 8.502,p _ .0001, R2= 293. Ad. d R2 = 2 d" d 2 . , JUSte R =.242; A JUSte R = .214 .272 
SE b-diff = SE b-difference; CCI, Charlson Comorbidity Index; KPS, Karnofsky 
Performance Status Scale; ESAS, Edmonton Symptom Assessment Scale; SF-36 PHC, 
SF-36 Physical Health Component Score; IES, Impact of Events Scale; 
* p :S .05; ** p :S .01; *** p :S .001 
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Table 6. Multivariate linear regression correlates of Short-Form McGill Pain 
Questionnaire-2 Intermittent pain qualities 
Younger Older 
B (SE) p B (SE) p SE b-diff 
Post-graduate degree a 1.046 (.471) .166* 
Chronic nonmalignant 
.763 (.488) .166 
pain 
CCI>O 1.087 (.427) .193 ** 
KPS -.054 (.018) -.226 ** 
ESAS Physical symptoms .308 (.108) .264** 
SF-36 PHC -.101 (.025) -.309*** 
CPAQ Pain Willingness -.054 (.020) -.250** 
IES Intrusion .060 (.023) .196** 
_ < F(3,101) = 8.740, p ::S .0001, 
Fcs,m) - 10.641, p _ .0001, R2 = 206. Ad. d R2 = 2 . 2 . , ~uste R =.286; Adjusted R = .259 .1 83 
a reference category is ::S High School; SE b-diff = SE b-diff erence; 
CCI, Charlson Comorbidity Index; KPS, Karnofsky Performance Status Scale; ESAS, 
Edmonton Symptom Assessment Scale; SF-36 PHC, SF-36 Physical Health Component 
Score; CP AQ, Chronic Pain Acceptance Questionnaire; JES, Impact of Events Scale; 
* p ::s .05; ** p ::s .01; *** p ::s .001 
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Table 7. Multivariate linear regression correlates of Short-Form McGill Pain 
Questionnaire-2 Neuropathic pain qualities 
Younger Older 
B(SE) p B (SE) p SE b-diff 
Cancer duration 
.013 (.003) .289*** .005(.003) .174 (months) 
.004* 
Prescribed an opioid -1.515 (.595) -.189** 
ESAS Physical 
.225 (.092) .209* 
symptoms 
SF-36 PHC -.040 (.018) -.166* -.044 (.019) -.219* .026 
CESD .049 (.014) .276*** .039 (.013) .273** .019 
MPI Punishing 
.208 (.107) .146 Responses 
F(6124)= 10.490,p :S .0001, Fc3,100) = 6.580,p :S 
R2 = .337; Adjusted R2 = .0001, R2 = .165; 
.305 Adjusted R2 = .140 
SE b--diff= SE b-difference; ESAS, Edmonton Symptom Assessment Scale; SF-36 PHC, 
SF-36 Physical Health Component Score; CES-D, Center for Epidemiologic Studies-
Depression scale; MPI, Multidimensional Pain Inventory; 
* p :s .05; ** p :s .01; *** p :s .001 
Table 8. Multivariate linear regression correlates of Short-Form McGill Pain 
Questionnaire-2 Affective pain qualities 
Younger Older 
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B (SE) B(SE) SE b-diff 
KPS -.037 (.016) -.162* 
ADS .124 (.070) 0.127 
ESAS Physical 
.319 (.108) .233** .514 (.110) .399*** .154 
symptoms 
SF-36 PHC -.046 (.024) -.152 
CPAQ Pain 
-.045 (.020) -.186* Willingness 
PCS Total .056 (.016) .279*** 
IES Intrusion .047 (.023) .163* .076 (.028) .231 ** .036 
Fcs m) = 15.135,p:::; .0001, 
R2 = .363; Adjusted R2 = 
Fc4 too)= 19.082, p :S .0001, 
R2 = .433; Adjusted R2 = 
.339 .410 
SE b--diff= SE b-difference; ESAS, Edmonton Symptom Assessment Scale; SF-36 PHC, 
SF-36 Physical Health Component Score; CPAQ PW, Chronic Pain Assessment 
Questionnaire; PCS, Pain Catastrophizing Scale; IES, Impact of Events Scale;* p:::; .05; 
** p:::; .01; *** p:::; .001 
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Table 9. Multivariate linear regression correlates of Brief Pain Inventory Pain 
Interference 
Younger Older 
B (SE) p B(SE) 
Post-secondary a -.657 (.364) -.139 
Post-graduate degree a -.954 (.472) -.155* 
p SE b-diff 
KPS -.038 (.017) -.158** -.056 (.019) -.236** .025 
Count analgesics taken .269 (.132) .138* 
Prescribed an opioid 1.340 (.514) .195** 
ESAS Physical 
.261 (.107) .186** .560 (.121) .410*** .161 * 
symptoms 
SF-36 PHC -.081 (.023) -.254*** 
PCS Total .032 (.016) .155* -.060 (.020) -.312** .025** 
IES Intrusion .068 (.022) .230** 
P ASS-20 Cognitive 
.176 (.040) .451 *** Anxiety 
Fcs no)= 12.762,p :S .0001, 
R2 = .440; Adjusted R2 = 
Fcs 98) = 19.058,p::; .0001, 
R2 = .493; Adjusted R2 = 
.405 .467 
a reference category is :S High School; SE b--diff = SE b-difference; KPS, Karnofsky 
Performance Status Scale; ESAS, Edmonton Symptom Assessment Scale; SF-36 PHC, 
SF-36 Physical Health Component Score; PCS, Pain Catastrophizing Scale; IES, Impact 
of Events Scale; PASS-20, Pain Anxiety Symptoms Scale-short form; 
* p::; .05; ** p::; .01; *** p::; .001 
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Figure 1. Predicted values of SF-MPQ-2 Continuous pain qualities in two-way interaction 
between age group and CCI. 
Simple slopes analysis revealed the slope for younger patients was significant (B = -
1.472 (SE= .462), ~ = -.338, t = -3.184,p = .002) while the slope for older patients did 
not reach significance (B = -.107 (SE= .357), ~ = -.024, t = -.299,p = .78). 
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Figure 2. Predicted values of SF-MPQ-2 Intermittent pain qualities in two-way 
interaction between age group and CCI. 
Simple slopes analysis revealed the slope for younger patients was significant (B = -
1.637 (SE= .495), ~ = -.352, t = -3.305,p = .001) while the slope for older patients did 
not reach significance (B = -.365 (SE= .383), ~ = -.078, t = -.953, p = .34 ). 
ESAS Physical 
symptoms 
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PCS Total c: -.020 (.254) BPI Interference 
b2: -.251 (-.234) 
KPS 
Figure 3. Structural Equation model testing the mediation of ESAS Physical symptoms 
and KPS on the relationship between PCS Total and BPI Interference. 
Unbracketed numbers are Standardized Regression weights from bootstrapped estimates 
for older patients, bracketed numbers are Standardized Regression weights from 
bootstrapped estimates for younger patients. Analysis conducted in AMOS (Arbuckle, 
1994) Version 20. 
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BRIDGE FROM CHAPTER 3 TO CHAPTER 4 
Data presented in Chapter 3 suggest that in people with cancer pain, there are no age 
differences in the severity of depressive symptoms. This is consistent with studies of 
people with cancer pain that have demonstrated that older and younger people may be 
equally at risk to experience depressive symptoms (Gagliese, Gauthier, & Rodin, 2007; 
Green & Hart-Johnson, 2010; Kai-hoi Sze, Wong, Lo, & Woo, 2000; Knotkova, Clark, 
Mokrejs, Padour, & Kuhl, 2004; G. M. Williamson & Schulz, 1995), but it is in contrast 
to studies of people with cancer that do not consider pain that have shown that older age 
is associated with less severe depressive symptoms (Compas et al., 1999; Kroenke et al., 
2004; Politi, Enright, & Weihs, 2007; Schroevers, Ranchor, & Sanderman, 2004; 
Vinokur, Threatt, Vinokur-Kaplan, & Satariano, 1990; Wenzel et al., 1999). However, 
there are no studies that have compared the relationship between age and depressive 
symptoms in people who do and do not experience cancer pain. Therefore, Chapter 4 
presents a preliminary analysis of the relationship between age and depressive symptoms 
in women who do and do not experience pain three months after breast cancer surgery. 
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Introduction 
The population is aging (Statistics Canada, 2007). Currently, adults aged 65 and 
older represent 13% of the population, but this is expected to increase to 25% by the year 
2031 (Statistics Canada, 2007) . Although aging is associated with a host of factors, such 
as increased comorbidities and functional limitations, widowhood, loneliness, and social 
isolation, which may operate as risk factors for depressive symptoms (V anltallie, 2005), 
younger age has been associated with greater depressive symptoms (form et al., 2005; 
Kasen, Cohen, Chen, & Castille, 2003; Klerman & Weissman, 1989; Wickramaratne, 
Weissman, Leaf, & Holford, 1989). It has been estimated that the prevalence of major 
depression ranges from 5-10% in the general population, and approximately 5-15% in 
older people (Barkin, Schwer, & Barkin, 2000; Blazer II & Hybels, 2005; Hasin, 
Goodwin, Stinson, & Grant, 2005; Reynolds & Kupfer, 1999). A larger proportion of 
older people may also experience subsyndromal depressive symptoms (Barkin, Schwer, 
& Barkin, 2000; Blazer II & Hybels, 2005; Lebowitz et al., 1997; Reynolds & Kupfer, 
1999; V anltallie, 2005). These seemingly inconsistent findings may be due to cohort 
effects (Kasen, Cohen, Chen, & Castille, 2003) or the shared etiology of depression and 
certain diseases (Alexopoulos et al., 1997), which may be more prevalent in older than 
younger people. 
Aging is also associated with the development of cancer (Canadian Cancer 
Society [CCS], 2013). Depressive symptoms may be prevalent in people with cancer, 
with 0- 58% of patients experiencing depressive symptoms and 0- 38% meeting criteria 
for major depression (Massie, 2004). These wide ranges may be due, in part, to different 
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diagnostic criteria or measurement methodologies and populations studied (Massie, 
2004). Consistent with findings from the general population, in people with cancer, 
greater depression has been associated with younger age (Compas et al., 1999; Kroenke 
et al., 2004; Politi, Enright, & Weihs, 2007; Schroevers, Ranchor, & Sanderman, 2004; 
Vinokur, Threatt, Vinokur-Kaplan, & Satariano, 1990; Wenzel et al., 1999). This has led 
to the suggestion that older people are less psychologically affected by cancer than 
younger people (Blank & Bellizzi, 2008). One possible explanation for these findings is 
that among younger people, cancer is perceived as a lifecourse disruption that is 
inconsistent with normative healthcare expectations or as a threat to the fulfillment of 
goals, whereas among older people, the process of adapting to other age-related health 
issues confers a possible protective advantage (Gagliese et al., 2009; Schulz & 
Heckhausen, 1996; Chapter 3). 
However, in people with cancer pain, age is not associated with depressive 
symptoms (Green & Hart-Johnson, 2010; Kai-hoi Sze, Wong, Lo, & Woo, 2000; 
Knotkova, Clark, Mokrejs, Padour, & Kuhl, 2004; G. M. Williamson & Schulz, 1995; 
Chapter 3). This similar to findings from the chronic nonmalignant pain literature where 
age is not associated with the prevalence or severity of depressive symptoms (Gagliese & 
Melzack, 1997b; Gagliese & Melzack, 2003; Sorkin, Rudy, Hanlon, Turk, & Stieg, 1990; 
Turk, Okifuji, & Scharff, 1995). Possible mechanisms for this remain to be elucidated but 
it may be possible that pain operates as a risk factor for depressive symptoms for both 
older and younger people which may override the usual age-related protective factors. 
Studies comparing the relationship between age and depressive symptoms in people with 
134 
cancer who do and do not experience cancer pain are not currently available. However, 
such studies are needed because it may be inappropriate to generalize from the existing 
literature of people with cancer pain (Green & Hart-Johnson, 2010; Kai-hoi Sze, Wong, 
Lo, & Woo, 2000; Knotkova, Clark, Mokrejs, Padour, & Kuhl, 2004; G. M. Williamson 
& Schulz, 1995; Chapter 3) and people without cancer pain (Compas et al., 1999; 
Kroenke et al., 2004; Politi, Enright, & Weihs, 2007; Schroevers, Ranchor, & 
Sanderman, 2004; Vinokur, Threatt, Vinokur-Kaplan, & Satariano, 1990; Wenzel et al., 
1999) due to cross-study methodological inconsistencies. With the aging population, it is 
necessary that we improve our understanding of the role of pain in the relationship 
between age and depressive symptoms in order to design treatments that effectively 
address the needs of people at different life stages. 
In an effort to clarify the relationship between cancer pain and depression, G .M. 
Williamson and Schulz (1995) evaluated age-related patterns in the mediating role of 
activity restriction. There were no age differences in pain, depressive symptoms or 
activity restriction. However, activity restriction fully mediated the relationship between 
depression and pain in younger, but not older patients (G. M. Williamson & Schulz, 
1995). Although the authors suggested that older patients are less distressed by activity 
restrictions because of lower expectations about functional status and more experience 
with disability, they did not measure expectations of functioning. Chief among the many 
methodological limitations present in this study was the use of non-validated measures to 
assess pain, activity restriction, and comorbidities; therefore, interpretation of this age-
related pattern remains problematic. 
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Breast cancer may represent a particularly suitable setting in which to study these 
relationships. Older age is associated with the development of breast cancer (Howlader et 
al., 2013). Surgical excision of the tumor, which often represents initial treatment, has 
been associated with the development of chronic postoperative pain in 20-60% of women 
(Jung, Ahrendt, Oaklander, & Dworkin, 2003). More than half of these women may 
develop neuropathic pain (Haroutiunian, Nikolajsen, Finnerup, & Jensen, 2013). The 
relationship between chronic breast cancer pain (CBCP) and age has been unclear, with 
studies demonstrating associations with younger (J. Katz et al., 2005; Poleshuck et al., 
2006; W. C. Smith, Bourne, Squair, Phillips, & Chambers, 1999) and older age 
(Masselin-Dubois et al., 2013; Shimozuma, Ganz, Petersen, & Hirji, 1999; Vinokur, 
Threatt, Vinokur-Kaplan, & Satariano, 1990), and others reporting no relationship 
(Carpenter et al., 1998; Kroner, Krebs, Skov, & Jorgensen, 1989). Pain after breast cancer 
surgery (BCS) is associated with greater depressive symptoms (Miaskowski et al., 2012; 
Tasmuth, Blomqvist, & Kalso, 1999). Neuropathic pain, defined as pain or sensory 
symptoms caused by disease or lesions affecting the peripheral and/or central nervous 
systems (Backonja, 2003), may be particularly distressing; it has been associated with 
greater pain intensity, interference, and cancer symptomatology and worse mental health 
quality of life than non-neuropathic cancer pain (Tofthagen & McMillan, 2010). In our 
study of age-related patterns in cancer pain (Chapter 3), we found that depressive 
symptoms were associated with greater neuropathic pain to the same extent in both older 
and younger patients. 
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There are no studies that have examined the relationship between depressive 
symptoms and age in women with and without CBCP. The International Association for 
the Study of Pain suggests that pain that persists for three months or longer may be 
considered chronic (Merskey & Bogduk, 1994 ), and it has been suggested that this time 
point should be used in studies of CBCP in order to facilitate cross-study comparisons 
(Jung, Ahrendt, Oaklander, & Dworkin, 2003). Since some women experience pain and 
some do not experience pain three months after BCS, this time point may be ideal to 
determine whether the presence of pain after BCS impacts on the relationship between 
depressive symptoms and age. The aim of this preliminary study was to investigate the 
moderating role of pain three months after BCS on the relationship between depressive 
symptoms and age. We hypothesized that older age would be associated with fewer 
depressive symptoms in women who were pain-free three months after BCS, but not in 
women who experienced pain three months after BCS. 
Methods 
Participants 
Women undergoing unilateral or bilateral lumpectomy or mastectomy at the 
University Health Network who were recruited between March, 2008 and February, 
2013, for a larger, 2-year prospective study of age-related patterns in pain following BCS, 
were included in this analysis. Exclusion criteria were insufficient English fluency, < 18 
years old, American Society of Anesthesiologists class >3, significant CNS, respiratory, 
cardiac, hepatic, renal or endocrine dysfunction, contraindications to opioids or 
acetaminophen, documented Diagnostic and Statistical Manual-IV Axis I disorder or 
cognitive dysfunction, substance abuse or dependence within one year of the surgery, 
pregnancy or breastfeeding within 3 months, immunization within 1 month, blood 
donation within 2 months, and acute infections, illness, allergic reactions, physical 
injuries or dental work within 2 weeks. 
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Women were recruited approximately one week prior to surgery during a pre-
admission visit at Toronto General Hospital (TGH) or a preoperative patient education 
session at Princess Margaret Cancer Centre (PMH), University Health Network (UHN). 
A research assistant (RA) explained the study, and women provided written informed 
consent to participate. The RA administered the Short Orientation Memory Concentration 
test (SOMC [Katzman et al., 1983]), collected demographic and health history 
information, and administered measures of pain and symptom severity during a brief 
interview at the time of recruitment and by accessing the patient's medical chart. 
Participants were given a questionnaire package to complete at home and return on the 
day of surgery. They received a telephone reminder 1-2 days prior to surgery to return 
their completed questionnaires. On the day of surgery, the RA administered measures of 
pain, physical and psychological functioning. Clinical and surgical information was 
collected by accessing patients' medical charts. Three months following surgery (±2 
weeks), women were telephoned to complete a follow-up assessment. Women completed 
the three month follow-up with the RA at UHN if the assessment coincided with a 
medical appointment; otherwise the assessment was completed via telephone. The RA 
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first administered the SOMC and then measures of pain, symptom severity, and physical 
and psychological functioning, then completed the KPS and updated the CCI. 
Measures 
Cognitive screen. The Short Orientation-Memory-Concentration Test (SOMC 
[Katzman et al., 1983]) is a 6-item measure designed to screen for cognitive impairment 
and orientation to time, person and place, and memory. It has been validated for use 
among older adults (Katzman et al., 1983) and has been used in studies of patients with 
cancer (Rodin et al., 2007). 
Measures of Pain. The Pain History Questionnaire measures patients' history of 
painful conditions. It was used to assess patients' experience with chronic nonmalignant 
pain. Patients were also asked how intense they expected the pain to be immediately after 
surgery, after medication, and one week following surgery on 11-point Numeric Rating 
Scales (NRS). An average of these three questions was calculated. The Short-Form 
McGill Pain Questionnaire (SF-MPQ [Melzack, 1987]) is one of the most widely used 
measures of the multidimensional qualities of pain. It includes 15 items that assess 
Sensory and Affective pain qualities. Higher scores reflect greater Sensory and Affective 
pain. It has been validated for use in people with cancer pain (Jensen, 2003b; Ngamkham 
et al., 2012) and younger and older people with chronic nonmalignant pain (Gagliese & 
Melzack, 1997a). The Neuropathic Pain Questionnaire-short/arm (SF-NPQ [Backonja 
& Krause, 2003]) includes 3 items that assess neuropathic pain qualities. It was validated 
in a large sample of people with diverse pain diagnoses. It differentiates neuropathic from 
non-neuropathic pain with good sensitivity and specificity (Backonja & Krause, 2003), 
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and it has been found to differentiate cancer patients with and without neuropathic pain 
(Mercadante et al., 2009). The Brief Pain Inventory (BPI [Cleeland & Ryan, 1994]) 
includes 4 items that assess the Worst, Least, Average pain intensity in the last 24 hours 
and Current pain intensity on 11-point NRSs anchored with the words "no pain" and 
"pain as bad as you can imagine". The Average pain intensity question was used in this 
analysis. The BPI also includes 7 items that assess interference from pain in general 
activity, mood, walking ability, work, relations with others, sleep and enjoyment of life 
with 11-point NRSs anchored with the words "does not interfere" and "completely 
interferes". A Pain Interference score was calculated from the average of these questions. 
The BPI has good validity in people with cancer pain (Ger, Ho, Sun, Wang, & Cleeland, 
1999; Klepstad, Loge, Borchgrevink, Mendoza, & Cleeland, 2002). Pain intensity at Rest 
(NRS-R) and with movement (NRS-M) were assessed with 11-point NRSs anchored with 
the words "no pain" and "worst possible pain". This response format demonstrates 
equivalent psychometric properties in younger and older people with pain (Gauthier & 
Gagliese, 2011 ). Satisfaction with pain control (SAT) was assessed with an 11-point NRS 
anchored with the words "extremely dissatisfied" and "extremely satisfied". 
Analgesic and pharmacologic treatment. The World Health Organization's 
(WHO) Analgesic Ladder was used to categorize prescribed analgesic medication (World 
Health Organization, 1990). Level 1 consists of non-opioid analgesics (e.g. 
acetaminophen, nonsteroidal anti-inflammatories) and adjuvant medications (e.g. tricyclic 
antidepressants, gabapentin) (Bernabei et al., 1998), Level 2 consists of weak opioids 
(e.g. codeine) and Level 3 consists of strong opioids (morphine). The Anticholinergic 
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Drug Scale (ADS (Carnahan, Lund, Perry, Culp, & Pollock, 2002; Carnahan, Lund, 
Perry, Pollock, & Culp, 2006) measures the cumulative anticholinergic load of 
medications. The total score is a sum of all medications based on a potency rating 
associated with each medication. The ADS has been validated in older people (Carnahan, 
Lund, Perry, Culp, & Pollock, 2002). 
Measures of physical functioning. The Karnofsky Performance Status Scale (KPS 
[Karnofsky & Burchenal, 1949]) measures functional status on a scale ranging from 100 
(no evidence of disease) to 0 (death). It was completed by the RA. It has acceptable 
psychometric properties in people with cancer (Yates, Chalmer, & McKegney, 1980). 
The Charlson Comorbidity Index (CCI [Charlson, Pompei, Ales, & MacKenzie, 1987]) 
measures the presence of 19 co-occurring conditions. Higher scores indicate greater 
comorbid load. It is the most recommended comorbidity scale for use in people with 
cancer (Extermann, 2000a). The RA completed the CCI by reviewing medical charts. The 
Edmonton Symptom Assessment Scale (ESAS [Bruera, Kuehn, Miller, Selmser, & 
Macmillan, 1991]) measures the intensity of 9 cancer-related symptoms with 11-point 
NRSs. It has good validity and reliability in people with cancer (Bruera, Kuehn, Miller, 
Selmser, & Macmillan, 1991). Two factors have been identified. The first factor 
measures physical symptoms (pain, tiredness, nausea, drowsiness, appetite, wellbeing, 
shortness of breath) and the second measures psychological symptoms (depression and 
anxiety) (W. Y. Cheung, Le, & Zimmermann, 2009). The construct validity of the 
psychological symptom factor has been questioned (Richardson & Jones, 2009; 
Teunissen, S. C. C. M, de Graeff, Voest, & de Haes, Jun 2007). We therefore used the 
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average of the physical symptoms (excluding pain) to assess physical symptom severity. 
The SF-12 (J. Ware Jr., Kosinski, & Keller, 1996) is a brief, 12-item measure of physical 
and mental health QOL. It has good psychometric properties in people with cancer 
(Thome & Hallberg, 2004). 
Measures of psychological functioning. The Pain Catastrophizing Scale (PCS 
[Sullivan, Bishop, & Pivik, 1995]) measures ruminative thoughts about pain, 
magnification of the negative implications of pain, and helpless attitudes toward pain 
management. Higher scores reflect greater catastrophizing about pain. It has good 
psychometric properties in people with chronic nonmalignant pain and has been used in 
women with postoperative pain from BCS (Schreiber et al., 2013). The Pain Anxiety 
Symptoms Scale (PASS [McCracken & Gross, 1995]) is a 40-item measure fear of pain, 
physiological anxiety, escape and avoidant thoughts, and cognitive anxiety. Higher scores 
reflect greater pain-related anxiety. It has good validity and reliability (Coons, 
Hadjistavropoulos, & Asmundson, 2004; Roelofs et al., 2004). The Center for 
Epidemiologic Studies - Depression Scale (CES-D [Radloff, 1977]) includes 20-items 
that assess the frequency of depressive symptoms over the past week. Higher scores 
reflect greater depressive symptoms. It has been used extensively and has excellent 
validity and reliability (Beeber, Shea, & McCorkle, 1998; Coyle & Roberge, 1992; 
Gauthier & Gagliese, 2011; Pasacreta, 1997). The State-Trait Anxiety Inventory (STAI) 
includes 20-items that measure dispositional (Trait) anxiety and 20-items that measure 
situation-specific anxiety (State) (Spielberger, 1977). Higher scores reflect greater state 
or trait anxiety. It has excellent psychometric properties in diverse patient populations 
(Julian, 2011) including postoperative patients (Granot & Ferber, 2005). 
Data Analysis 
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Less than 1 % of the sample who completed the three month assessment left one or more 
items missing on one or more measures at this follow-up. Age, and depressive symptoms 
and pain at three months were not associated with missing data (all p ~ .07). As this was a 
preliminary study, we computed scores for women with complete data. Descriptive 
statistics were used to characterize the sample. Bivariate tests of association were 
conducted with Pearson and Spearman's correlations. Fisher's Z-transformations 
compared the strength of correlations between age and depression in those with and 
without pain. Interaction models were fit in order to identify the moderating role of pain 
at three months on the relationship between age and depression. Age was grand-mean 
centered and product terms were calculated with three month pain variables. A stepwise 
order of entry was used with the product term entered in the second step (Aiken & West, 
1991; Holmbeck, 2002). Interactions were investigated graphically by plotting the simple 
slopes of age by pain status at three months (Holmbeck, 2002). 
Results 
Participant Characteristics 
Figure 1 displays the patient flow diagram. Between March, 2008 and February, 
2013, 377 women were approached. One hundred and ninety-three women (51.2%) 
refused to participate. Reasons for refusal included lack of interest (n=66; 34.2% ), lack of 
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time (n = 40; 20. 7% ), being upset or overwhelmed just prior to surgery (n = 22; 11.4% ), 
participation in a conflicting study (n = 13; 6.7%) and living too far from the hospital to 
complete follow-ups (n = 2; 1.0%). An additional 44 women (22.8%) gave no reason for 
refusing to participate. One hundred and eighty-four women (48.8%) agreed to 
participate. After giving informed consent to participate, 9 ( 4.9%) voluntarily withdrew 
their participation and 5 (2. 7%) were excluded because of changes to the date or location 
of surgery. One hundred and seventy women (92.4%) completed the preoperative and OR 
day assessments. Seven (3.8%) subsequently withdrew their participation and 8 (4.3%) 
were excluded. We were unable to contact 31 (16.8%) for the three month follow-up. 
One hundred and twenty-four women (67.4%) completed the three month assessment and 
comprise the sample for this analysis. 
Demographics 
Women who completed the three month follow-up were compared to women who 
withdrew or who were excluded (n=29) and women who were lost to follow-up (n=31) 
on demographic, clinical, and surgical factors. There were no differences between the 
groups (allp ~.07). 
Demographic, clinical, surgical, and preoperative and three month pain, physical 
and psychological characteristics of women who completed the three month assessment 
are presented in Table 2. Women were 52.00 ± 11.39 years old. Procedure was evenly 
split: 55.6% underwent mastectomy and 44.4% underwent lumpectomy. Although 25% 
reported a history of chronic pain, preoperative pain intensity was low: The median on all 
preoperative and OR day measures of pain intensity was 0. 
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Preoperatively, 23 (19.0%) had BPI Average pain intensity 2:3/10, or moderate-to-
severe pain intensity (MSPI [L. 0. Andersen et al., 2009; Jensen, Smith, Ehde, & 
Robinsin, 2001; Masselin-Dubois et al., 2013; Schreiber et al., 2013]), and 7 (5.6%) 
scored 2: cutoff on the SF-NPQ, scores which may indicate the presence of neuropathic 
pain (NeP [Backonja & Krause, 2003; Mercadante et al., 2009]). Forty-five women 
scored 2:16 on the CES-D, scores with may indicate the presence of clinically relevant 
depressive symptoms (Radloff, 1977). 
At the three month follow-up, 25 women (20.2%) had MSPI and 19 (15.3%) had 
NeP. At this follow-up, 24 women (19.4%) scored 2:16 on the CES-D. 
Hypothesis Testing 
In order to test the hypothesis that the presence of pain three months after BCS 
moderates the relationship between age and depressive symptoms, BPI Average pain 
intensity, BPI Pain Interference, SF-NPQ and SF-MPQ Sensory and Affective subscales 
data were dichotomized as follows: 
1) BPI Average pain intensity= 0/10 vs. >0/10; 
2) BPI Average pain intensity <3/10 vs. 2:3/10 (MSPI); 
3) BPI Average Pain Interference= 0/10 vs. >0/10; 
4) BPI Average Pain Interference <3/10 vs. 2:3/10; 
5) SF-NPQ below cutoff vs. at or above SF-NPQ cutoff (NeP); 
6) SF-MPQ Sensory= 0/33 vs. >0/33; 
7) SF-MPQ Affective =0/12 vs. ~0/12. 
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These cut-offs were selected based on inspection of the raw data and studies 
identifying cutoffs for moderate-to-severe average pain intensity in women with breast 
cancer (Masselin-Dubois et al., 2013; Schreiber et al., 2013) . These pain groups were 
used in subsequent analyses. 
Age was negatively correlated with preoperative CES-D (r = -.23,p = .01) and 
three month CES-D (r = -.24, p = .008). Table 3 presents correlations between pain 
groups, age, and CES-D at three months. Age was not correlated with pain groups (all p 2: 
.14). Pain at three months was correlated with three-month CES-D (all r 2: .31) but not 
preoperative CES-D (all r :S.16). 
The strength of the bivariate correlations between age and CES-D were compared 
across pain groups with Fisher's Z-tests (Table 4). The correlation between age and 
CES-D was significantly stronger in women without MSPI than women with MSPI (p = 
.05). In women without MSPI, age was negatively correlated with depressive symptoms 
(r = -.29,p =.004), but in women with MSPI, age and CES-D were not correlated (r = -
.Ol,p = .95). In this pain group, although the interaction was nonsignificant (B = .19 (SE 
= .21), ~ = .19, t = -.88,p = .38), inspection of the slopes revealed that, consistent with 
our hypothesis, in women without MSPI, depression was associated with younger age, 
while in women with MSPI, depression was not associated with age (Figure 2). 
There was a significant interaction between age and three month SF-NPQ in 
relation to 3-month CES-D scores (B = -.63 (SE= .24), ~ = -.66, t = -2.65,p = .009). 
Counter to our hypothesis, in women with NeP, depression was associated with younger 
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age. However, in women without NeP, depression and age were not associated (Figure 
3). There were no other significant interactions based on pain group (all p 2:.5) 
We also tested the moderating role of preoperative pain on the relationship 
between age and three month CES-D using the same pain groupings described above for 
preoperative pain measures. None of the interactions were significant (all p 2:.5), 
suggesting that pain three months after BCS, but not preoperative pain, moderates the 
relationship between age and depressive symptoms. 
We explored demographic, clinical, surgical, and preoperative and three-month 
pain interference and qualities, and physical, and psychological differences between older 
and younger women with and without (1) MSPI and (2) NeP at 3 months, in separate 
analyses. Due to the distribution of the data, age groups were defined based on the 25th 
and 75th percentile (Field, 2009; McCluskey & Lalkhen, 2007; Tabachnick & Fidell, 
2012). Although this likely resulted in decreased power to detect a difference, this 
analysis simply represents a preliminary exploration of differences between the youngest 
and oldest women with and without pain and provides an idea about the variability of the 
data across groups. Thirty-four women aged 59-81 comprised the older group and thirty-
four women aged 27-44 comprised the younger group. Analyses were conducted using i 
tests with Yates' correction for small cell sizes, one-way ANOV As, and Kruskal-Wallice 
nonparametric tests. A Bonferroni correction was applied to the omnibus tests of 
significance to control for multiple comparisons (adjusted a= .05150 = .001). Planned 
pairwise comparisons of nonparametric data between younger and older women with 
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pain (either MSPI or NeP) and younger and older pain-free women were conducted with 
Mann-Whitney U tests with a Bonferroni corrected alpha (adjusted a = .0512 = .025). 
To test (1) age group differences in women with and without MSPI at 3 months, 
four groups were formed. There were twenty-four (70.6%) younger women without 
MSPI (Y-noMSPI), 10 (29.4%) younger women with MSPI (Y-MSPI), 29 (85.3%) older 
women without MSPI (0-noMSPI) and 5 (14. 7%) older women with MSPI (0-MSPI). 
Preoperative expectations of pain after surgery differed across age and pain 
groups (F(3,64) = 6.95,p < .001). Post-hoc pairwise comparisons revealed that Y-MSPI 
and Y-noMSPI had higher expectations of pain after surgery than 0-noMSPI (p:::; .008; 
Figure 4). 
Three month ESAS Physical symptom severity differed across age and pain 
groups (F(3,64) = 7.58,p < .001). Post-hoc pairwise comparisons revealed that Y-MSPI 
had greater ESAS symptom severity than Y-noMSPI and 0-noMSPI (p:::; .01; Figure 5). 
Three month STAI-S total also differed across age and pain groups (F(3,64) = 
6.50,p < .001). Post-hoc pairwise comparisons revealed that Y-MSPI had greater STAI-S 
total scores than Y-noMSPI and 0-noMSPI (p:::; .02; Figure 6). 
The Kruskal-Wallice omnibus tests of group differences in three-month SF-MPQ 
Sensory, SF-MPQ Affective, and BPI Interference scores were significant (all p :::; . 001) 
but planned pairwise comparisons ofY-MSPI vs. 0-MSPI and Y-noMSPI vs. 0-noMSPI 
were nonsignficant (all p 2: .10) 
To test (2) age group differences based on three-month NeP, four groups were 
formed. There were 30 (88.2%) younger women without NeP (Y-noNeP), 4 (11.8%) 
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younger women with NeP (Y-NeP), 31 (91.2%) older women without NeP (0-noNeP), 
and 3 (8.8%) older women with NeP (0-NeP). The only factor that differed across groups 
was preoperative expectations of pain after surgery (F(3,64) = 7.219,p < .001). Post-hoc 
tests revealed that Y-NeP and Y-noNeP had higher expectations of pain after surgery 
than 0-noNeP (p :S .01; Figure 7). There were no differences between 0-NeP and the rest 
of the groups (allp >.51). 
Discussion 
In this preliminary investigation of the relationship between depressive symptoms 
and age in women with and without pain three months after BCS, 20% of the women 
experienced moderate-to-severe pain intensity and 15% experienced neuropathic pain at 
three months. Age was not associated with pain at three months. Three further 
noteworthy findings are evident. First, we found partial support for our hypothesis that 
pain three months after BCS moderates the relationship between depressive symptoms 
and age. Specifically, in women with moderate-to-severe pain intensity, depressive 
symptoms and age were not associated, but in women with mild or no pain, depressive 
symptoms were associated with younger age. However, in contrast, depressive symptoms 
were associated with younger age only in women with neuropathic pain, but not in 
women without neuropathic pain. Second, the physical and psychological impact of 
having moderate-to-severe pain intensity was not age related: Older and younger women 
with pain intensity within this range did not differ in the severity of other cancer 
symptoms or state anxiety. Third, high preoperative pain expectations were associated 
with moderate-to-severe pain intensity and neuropathic pain at three months in both older 
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and younger women. These preliminary data provide important directions for future 
research, including the need to address excessively high preoperative pain expectations 
among older and younger women. 
This is the first study to demonstrate that pain moderates the relationship between 
age and depression in a sample of people with and without cancer-related pain. 
Specifically, in women with moderate-to-severe pain intensity three months after BCS, 
age was not associated with depressive symptoms, but in women mild or no pain, 
younger age was associated with higher depressive symptoms. These findings are 
consistent with studies of people with cancer pain that have shown that age is not related 
to depressive symptoms (Green & Hart-Johnson, 2010; Kai-hoi Sze, Wong, Lo, & Woo, 
2000; Knotkova, Clark, Mokrejs, Padour, & Kuhl, 2004; G. M. Williamson & Schulz, 
1995; Chapter 3), and with studies that do not consider pain that have shown that younger 
age is associated with greater depressive symptoms (Campas et al., 1999; Kroenke et al., 
2004; Politi, Enright, & Weihs, 2007; Schroevers, Ranchor, & Sanderman, 2004; 
Vinokur, Threatt, Vinokur-Kaplan, & Satariano, 1990; Wenzel et al., 1999). 
Intriguingly, the reverse was true with respect to neuropathic pain. In women with 
neuropathic pain, younger age was associated with higher depressive symptoms, whereas 
in women without neuropathic pain, age was not associated with depressive symptoms. 
Thus, there is some evidence to support the idea that cancer pain may override protective 
factors that may be present in older people (Gagliese, Gauthier, & Rodin, 2007) but this 
may not be true in the context of neuropathic pain. Mechanisms underlying these 
differences are beyond the scope of this preliminary study and remain to be elucidated. 
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Neuropathic pain has been associated with greater pain intensity, interference, and cancer 
symptom severity, and worse mental health quality of life than non-neuropathic pain 
(Mercadante et al., 2009; Tofthagen & McMillan, 2010). It may also be refractory to 
treatment (Dworkin et al., in press; Mercadante & Portenoy, 2001). In the general 
population, age differences in the correlates of depression have been reported (Regan, 
Kearney, Savva, Cronin, & Kenny, 2013). The presence of chronic nonmalignant pain 
was a common correlate of depression in both older and middle-aged people. 
Neuropathic pain was not measured. It might be possible that the present finding reflects 
an age-related pattern in a correlate of depressive symptoms in women with breast 
cancer, however, this requires replication, therefore remains highly speculative. 
Pain-related interference did not moderate the relationship between age and 
depressive symptoms. However, in a previous study of cancer patients, an age-related 
pattern in the role of activity restriction in the relationship between pain and depression 
was reported (G. M. Williamson & Schulz, 1995). Specifically, G.M. Williamson and 
Schulz (1995) found that activity restriction fully mediated the relationship in younger 
patients, but only partially mediated the relationship in older patients. This is consistent 
with a previous study of people with chronic nonmalignant pain, where pain interference 
and life control mediated the relationship between pain and depression for younger, but 
not older people (Turk, Okifuji, & Scharff, 1995). Several issues prevent the integration 
of the findings from the present study with those of G.M. Williamson and Schulz (1995). 
Primarily, age-related equivalence in the validity and reliability of the measures used in 
that study is unknown. It is therefore difficult to know whether the age-related patterns in 
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activity restriction model are due to actual age-related patterns, or differences in the way 
the measures operated in each age group. Furthermore, it is unclear if their measure of 
activity restriction is specific to cancer, pain, or more general activity. They did not test 
the role of pain in the relationship between age and depressive symptoms. 
Based on their findings, G.M. Williamson and Schulz (1995) suggested that older 
people have lower expectations of functional ability and are therefore less distressed by 
activity restriction than younger people; however, they did not measure this. Studies 
comparing expectations of functioning and their relationship to depressive symptoms in 
older and younger people with cancer pain are not available. Outside of the context of 
cancer, only 13% to 20% of older people have attributed functional limitations to aging, 
and depressive symptoms did not differ between those who held this attribution and those 
who did not (Sarkisian, Liu, Ensrud, Stone, & Mangione, 2001; J. D. Williamson & 
Fried, 1996). Interestingly, older people with chronic nonmalignant pain were not more 
likely than younger people to attribute pain to aging (Gagliese & Melzack, 1997b). Other 
potentially important factors which have not been considered but which may account for 
the age-related pattern in the activity restriction model may be retention or replacement 
of important activities or activity modification (Duke, Leventhal, Brownlee, & Leventhal, 
2002; Gagliese et al., 2009; P.A. Parmelee, Harralson, Smith, & Schumacher, 2007). 
Taken together with the existing literature demonstrating no age differences in depressive 
symptoms in people with cancer pain (Green & Hart-Johnson, 2010; Kai-hoi Sze, Wong, 
Lo, & Woo, 2000; Knotkova, Clark, Mokrejs, Padour, & Kuhl, 2004; G. M. Williamson 
& Schulz, 1995; Chapter 3), these converging lines of evidence do not support the 
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activity restriction model but instead support the hypothesis that the presence of pain 
equalizes the risk for depressive symptoms in younger and older people with cancer. If 
this is true, unresolved, intense pain may represent an especially critical risk factor for 
depression among older women after BCS. However, because this is a preliminary study, 
more research is needed to compare the two models before drawing firm conclusions. 
The relationship between pain intensity and interference may be nonlinear (Paul, 
Zelman, Smith, & Miaskowski, 2005; Serlin et al., 1995). Mild pain (pain intensity of 
~4/10 on an NRS) has been associated with minimal pain interference, whereas 
moderate-to-severe pain (>4/10) has been associated with much greater levels of pain 
interference and compromised QOL (Paul et al., 2005; Serlin et al., 1995).These 
"cutpoints" were established in heterogeneous samples of cancer patients at different 
disease stages. It has also been shown that cutpoints may vary across patient populations 
(Jensen et al., 2001). The identification of cutpoints has clinical relevance because it may 
be possible for healthcare providers to make treatment decisions based on patients' 
reports of pain intensity that improve functioning and QOL (Jensen et al., 2001). In the 
present analysis, the relationship between age and depressive symptoms was not 
moderated by pain using a cutpoint of >Oil 0 on an NRS of average pain intensity, but 
there was an effect when a cutpoint of2'.:3/10, moderate-to-severe pain, was used. Women 
reporting this level of average pain intensity had much higher depressive symptoms than 
women reporting less intense pain, regardless of age. Although there is no established 
cutpoint for clinically significant pain after BCS that is consistently used across studies, 
two recent studies using this cutpoint have demonstrated that women who experience 
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greater pain intensity report worse psychological wellbeing than women with less intense 
pain (Masselin-Dubois et al., 2013; Schreiber et al., 2013). Taken together with the 
present study, it may be possible that this cutpoint has clinical relevance for women three 
months after BCS, however future research is needed to validate cutpoints for clinically 
significant pain in this population. 
Consistent with the findings in Chapter 3, we did not find support for the 
suggestion that older people are less psychologically affected by cancer than younger 
people (Blank & Bellizzi, 2008), in the context of cancer pain. Although these analyses 
were exploratory, it appears that the impact of moderate-to-severe pain intensity three 
months after BCS is not age-related. Pain qualities, pain interference, severity of other 
cancer symptoms and state anxiety appear to be just as bad for older and younger women 
with pain after BCS. Chronic pain after BCS has been associated with impaired physical 
functioning, increased anxiety and pain catastrophizing, and reduced quality of life 
(Carpenter et al., 1998; Deimling, Stems, Bowman, & Kahana, 2005; Macdonald, Bruce, 
Scott, Smith, & Chambers, 2005; Schreiber et al., 2013). However, these findings are 
derived from retrospective analyses and studies comparing the impact of chronic pain 
after BCS in older and younger women are not available. This is the first study to 
consider the potential for age-related patterns in the impact of pain three months after 
BCS using a prospective design, but studies with larger sample sizes are required. 
Whereas a number of biomedical and psychological pre- and postoperative risk 
factors for the development of pain after BCS have been identified (K. G. Andersen & 
Kehl et, 2011 ), this is the first study to identify preoperative pain expectations as a 
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predictor of moderate-to-severe pain intensity and neuropathic pain three months after 
BCS. Having lower preoperative expectations of pain seemed to operate as a protective 
factor for the development of pain, particularly for older women. Higher preoperative 
pain expectations have also been associated with greater acute postoperative pain in 
women with breast cancer (Montgomery, Schnur, Erblich, Diefenbach, & Bovbjerg, 
2010) and greater postoperative pain in other patient populations (Wallace, 1985). 
Interestingly, older age has been associated with lower preoperative pain expectations 
(Gagliese, Jackson, Ritvo, Wowk, & Katz, 2000; Schnur et al., 2007) and fewer expected 
side effects of cancer treatment (Hofman et al., 2004). Other predictors of preoperative 
pain expectations have included preoperative distress, trait anxiety, and family history of 
cancer (Schnur et al., 2007). While preliminary, the present findings may have 
implications for preoperative clinical care, specifically the development of preoperative 
interventions that address pain expectations. 
The novelty of this study lies in its prospective design and identification of pain 
outcome-specific relationships between age and depressive symptoms. The design of this 
study improves on prior studies of pain after BCS which have been retrospective, with 
assessments occurring years or decades after surgery (Macdonald, Bruce, Scott, Smith, & 
Chambers, 2005; Reyes-Gibby, Morrow, Bennett, Jensen, & Shete, 2010; Schreiber et al., 
2013). Additionally, we included women who reported preoperative pain. This is 
important, as it provides a representative clinical picture of women undergoing BCS and 
enhances the external validity of our findings. Despite these strengths, there are several 
limitations that must be considered. The limited sample size and preliminary nature of 
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this study must be taken into account when interpreting the findings. Additionally, 
although the measure of neuropathic pain used in this study was validated in a large 
sample of people with diverse range of painful conditions (Backonja & Krause, 2003) 
and it has been found to differentiate cancer patients with and without neuropathic pain 
(Mercadante et al., 2009), it requires validation in younger and older women with breast 
cancer. Until it has been validated in this population and age-related factorial invariance 
has been established, age-related patterns detected with this scale must be interpreted 
with caution. 
Some important future directions that derive from these results involve 
determining the trajectory of non-neuropathic and neuropathic pain and depression in 
older and younger women as well as age-related predictors of the development of pain 
three months after BCS with a larger sample size. It will also be important to replicate 
these findings in people with other cancers. Moreover, given the potential importance of 
preoperative pain expectations to long-term postoperative pain outcomes for older and 
younger women, much more research into the predictors of preoperative pain 
expectations is needed, including possible age-related predictors. Related, early research 
has established that preoperative patient preparation, including providing information 
about the procedure, as well as pain and other side effects after the procedure, impacts on 
postoperative outcomes (Egbert, Battit, Welch, & Bartlett, 1994; Suls & Wan, 1989). 
Future research investigating preoperative educational interventions that address pain 
expectations for women undergoing BCS is required. 
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In summary, these findings suggest that having moderate-to-severe pain intensity 
three months after BCS cancels out whatever protective factors exist against depressive 
symptoms in older people without pain. However, the reverse may be true in women with 
NeP; younger women with NeP may be at particular risk for depressive symptoms. One 
potentially mitigating factor for the development of chronic postsurgical pain may be 
lower preoperative pain expectations. While this study requires replication with a larger 
sample size in order to draw definitive conclusions, it provides early but important 
information about the role of pain due to BCS in the relationship between depressive 
symptoms and age. Although most women may be pain-free prior to surgery, a 
significant minority of women may develop chronic pain due to BCS, independent of 
age. With the aging population (Statistics Canada, 2007), and the greater risk for breast 
cancer with increasing age (Howlader et al., 2013), the proportion of older women who 
may require treatment for cancer-related pain and depression will grow. A better 
understanding of depression and pain across the adult life span is necessary in order to 
provide treatment that properly addresses the needs of people at different life stages. 
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Table 1. Measures at each assessment included in this analysis 
Preadmission OR-day 3 months 
po stop 
Pain 
Pain history x 
SF-MPQ x x x 
SF-NPQ x x x 
BPI x x 
NRS-R x x 
NRS-M x x 
SAT x 
Analgesic treatment 
WHO Analgesic x x 
Ladder 
ADS x 
Physical Functioning 
KPS x x 
CCI x x 
ESAS x x x 
SF-12 PHC x x 
Menstrual status x x 
Psychological 
Functioning 
Pain expectations x 
PCS x 
PASS x 
CES-D x x 
STAI-S x x x 
STAI-T x 
SF-12 MHC x x 
Notes. SF-MPQ, Short-form McGill Pain Questionnaire; SF-NPQ, Neuropathic Pain 
Questionnaire short-form; BPI, Brief Pain Inventory; NRS-R and M, Numeric Rating 
Scale Rest and Movement; SAT, Satisfaction with Pain Control; WHO, World Health 
Organization; ADS, Anticholinergic Drug Scale; KPS, Karnofsky Performance Status 
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scale; CCI, Charlson Comorbiditiy Index; ESAS, Edmonton Symptom Assessment Scale; 
SF-12 PHC, SF-12 Physical Health Component Score; PCS, Pain Catastrophizing Scale; 
PASS, Pain Anxiety Symptom Scale; CES-D, Center for Epidemiologic-Studies 
Depression scale; STAI-S, State Trait Anxiety Index- State; STAI-T, State Trait 
Anxiety-Trait; SF-12 MHC, SF-12 Mental Health Component Score. 
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Table 2. Descriptive statistics and preoperative pain, physical and psychological factors 
(n=124) 
Age 
Caucasian ethnicity 
Marital status 
Married/partnered 
Single 
Separated/Divorced 
Widowed 
Missing 
BMI 
Menopausal 
Previous surgeries for breast cancer 
History of chronic nonmalignant pain 
Procedure 
Lumpectomy 
Mastectomy 
Laterality 
Right 
Left 
Bilateral 
Stage (American Cancer Society Staging) 
Stage 0 
Stage 1 
Stage 2 
Stage 3 
Prophylactic 
Missing 
Mean± SD; n (%) 
52.00 ± 11.39 (range 27-81) 
106 (85.5) 
92 (74.2) 
13 (10.5) 
12 (9.7) 
7 (5.6) 
1 (.8) 
26.63 ± 5.58 
73 (58.9) 
55 (44.4) 
31 (25) 
55 (44.4) 
69 (55.6) 
43 (34.7) 
45 (36.3) 
36 (29.0) 
8 (6.5) 
34 (27.4) 
20 (16.1) 
12 (9.7) 
30 (24.2) 
20 (16.1) 
Axillary node dissection 
Missing 
Sentinel node biopsy 
24 (19.4) 
25 (20.2) 
60 (48.4) 
Missing 24 (19 .4) 
freop~rative pain,ttreatmen!/iphystcal andpiychoioiicaTfaciors-~ -
-
ADS (median, IQR) 0 (0, 0) 
WHO Analgesic Ladder 
None 87 (70.2) 
Level 1 26 (21) 
Level 2 2 (1.6) 
Missing 9 (7.3) 
CCI>O 4 (3.2) 
KPS 90.85 ± 9.92 
ESAS Physical symptom severity 1.52 ± 1.17 
SF-12 PHC 52.93 ± 8.83 
NRS-R (median, IQR) 0 (0, .5) 
NRS-M (median, IQR) 0 (0, 2) 
SF-MPQ Sensory (median, IQR) 0 (0, 1) 
SF-MPQ Affective (median, IQR) 0 (0, 0) 
BPI Interference (median, IQR) 0 (0, 1.25) 
SF-NPQ 2'.: cutoff 7 (5.6) 
Pain expectations 3.39 ± 1.90 
PCS Rumination 9.99 ± 4.10 
PCS Magnification 5.81±2.41 
PCS Helplessness 11.32 ± 4.70 
PCS Total 26.91 ± 10.51 
PASS Fear 8.64 ± 6.65 
PASS Escape-Avoidance 20.09 ± 7.78 
PASS Physiological Anxiety 12.00 ± 8.88 
160 
PASS Cognitive Anxiety 
PASS Total 
CES-D 
STAI-S 
STAI-T 
SF-12 MHC 
ORD: ay 
,L '-, 
NRS-R (median, IQR) 
NRS-M (median, IQR) 
SF-MPQ Sensory (median, IQR) 
SF-MPQ Affective (median, IQR) 
SF-NPQ 2: cutoff 
3Morth 
SF-MPQ Sensory: median (IQR) 
SF-MPQ Affective: median (IQR) 
BPI Interference: median (IQR) 
Satisfaction with pain control 
KPS 
Wound healing problems* 
ESAS Physical symptom severity 
SF-12 PHC 
CES-D 
STAI-S 
SF-12 MHC 
* includes necrosis, epidermolysis, and/or infection 
18.76 ± 9.07 
59.50 ± 28.74 
14.55 ± 10.54 
41.66 ± 12.32 
36.01 ± 11.66 
45.23 ± 16.02 
0 (0, 1) 
0 (0, 1) 
0 (0, 1) 
0 (0, 0) 
3 (2.5%) 
0 (0,2) 
0 (0,0) 
.07 (0-1.34) 
8.87 ± 2.25 
91.19 ± 6.01 
3 (2.4) 
1.44 ± 1.23 
45.46 ± 9.48 
8.96 ± 8.21 
30.03 ± 10.67 
53.65 ± 9.61 
Note. BMI, body mass index; ADS, Anticholinergic Drug Scale; WHO, World Health 
Organization; CCI, Charlson Comorbidity Index; KPS, Karnofsky Performance Status 
Scale; ESAS, Edmonton Symptom Assessment Scale; PHC, SF-12 Physical Health 
Component Score; NRS, Numeric Rating Scale; SF-MPQ, Short-Form McGill Pain 
161 
162 
Questionnaire; BPI, Brief Pain Inventory; SF-NPQ, Neuropathic Pain Questionnaire-
short-form; PCS, Pain Catastrophizing Scale; PASS, Pain Anxiety Symptom Scale; CES-
D, Center for Epidemiologic Studies-Depression scale; STAI-S, State Trait Anxiety 
Inventory-State; STAI-T, State-Trait Anxiety Inventory-Trait; MHC, SF-12 Mental 
Health Component Score. 
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Table 3. Correlations between age, pain at three months, and depressive symptoms at 
three months and preoperatively 
Age (years) 3 month Preoperative 
CES-D CES-D 
BPI Average pain intensity >0/10 -.12 .45** .16 
BPI Average pain intensity 2:3110 -.13 .35** .15 
BPI Interference >0/10 -.06 .36** .14 
BPI Interference 2:3/10 -.09 .39** .06 
SF-NPQ -.07 .35** .04 
SF-MPQ Sensory> 0 .003 .31 ** .01 
SF-MPQ Affective> 0 -.03 .43** .04 
**p ~ 0.01 . 
Values are Spearman's rho 
Note. BPI, Brief Pain Inventory; SF-NPQ, Neuropathic Pain Questionnaire short-form; 
SF-MPQ, Short-Form McGill Pain Questionnaire; CES-D, Center for Epidemiologic 
Studies - Depression Scale. 
Table 4. Correlations between age and three month CES-D by pain three months after 
breast cancer surgery 
P* 
BPI Average pain intensity= 0/10; BPI Average pain intensity >0/10; 
n=62 (50%) n = 62 (50%) 
r= -.31, p = .01 r = -.13, p = .30 .30 
BPI Average pain intensity <3/10; BPI Average pain intensity ~3/10; 
n=99 (79.8%) n = 25 (20.2%) 
r = -.29, p = .01 r=-.01, p= .95 .05 
SF-MPQ Sensory= 0/33; SF-MPQ Sensory >0/33; 
n=64 (51.6%) n = 60 (48.4%) 
r = -.28, p = .03 r = -.24, p = .07 .81 
SF-MPQ Affective= 0/12; SF-MPQ Affective >0/12; 
n = 99 (79.8%) n = 24 (19.4%) 
r = -.28, p = .005 r = -.16, p = .44 .60 
SF-NPQ below; SF-NPQ ~ cutoff; 
n = 105 (84.7%) n = 19 (15.3%) 
r=-.15, p= .13 r = -.57, p = .01 .07 
BPI Interference = 0/10; BPI Interference >0/10; 
n = 62 (50.5%) n = 62 (50.0%) 
r = -.25, p = .05 r=-.21, p= .11 .81 
BPI Interference <3/10; BPI Interference ~3/10; 
n = 109 (87.9%) n = 15 (12.1 %) 
r = -.24, p = .01 r = -.21, p = .44 .87 
*P value for Fisher's Z test comparing the strength of correlations between the groups. 
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Note. BPI, Brief Pain Inventory; SF-MPQ, Short-Form McGill Pain Questionnaire; SF-
NPQ, Neuropathic Pain Questionnaire short-form; CES-D, Center for Epidemiologic 
Studies - Depression Scale. 
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Figure 1. Patient flow diagram 
n = 193 {51.2%) refused: 
n= 66 not interested 
n= 40 no time 
n=22 upset/overwhelmed 
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n=l3 participating in another study 
n=6 language barrier 
n = 2 lives too far 
n = 44 no reason 
n = 5 {2.7%) excluded: 
Date/location of surgery changed 
n = 9 {4.9%) withdrew: 
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n=3 disease progression/too ill 
n=2 conflicting study 
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n=l disease progression 
n = 31 {18.2%) lost to follow-up I 
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Figure 2: Interaction between age and three month BPI Average pain intensity in relation 
to three month CES-D total scores. 
Simple slopes analysis revealed the slope for women mild or no pain (BPI Average Pain 
<3/10) three months after breast cancer surgery was significant (B= -.20 (SE= .08), ~ = -
.23, t = -2.50,p = .01) while the slope for women with moderate-to-severe pain intensity 
(BPI Average Pain 2:3/10) was nonsignificant (B = -.02 (SE= .20), ~ = -.02, t = -.09,p = 
.93). 
Notes. BPI, Brief Pain Inventory; CES-D, Center for Epidemiologic Studies Depression 
scale; SD, Standard Deviation 
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Figure 3: Interaction between age and three month SF-NPQ in relation to three month 
CES-D total scores. 
Simple slopes analysis revealed the slope for women with neuropathic pain (SF-NPQ 2: 
cutoff) three months after breast cancer surgery was significant (B= -.74 (SE= .22), ~ = -
.82, t = -3.31,p = .001) while the slope for neuropathic pain-free women (SF-NPQ below 
cutoff) was nonsignficant (B = -.11 (SE= .08), ~ = -.13, t = -l.47,p = .15). 
Notes. SF-NPQ, Neuropathic Pain Questionnaire - short-form; CES-D, Center for 
Epidemiologic Studies Depression scale; SD, Standard Deviation 
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Figure 4. Preoperative pain expectations (pain immediately after surgery, after 
medication, and one week following surgery) of younger and older women with 
moderate-to-severe pain intensity and mild or no pain three months after breast cancer 
surgery. 
*Post-hoc pairwise comparisons between younger women with moderate-to-severe pain 
intensity (BPI Average pain intensity 2:3/10) and younger and older women with mild or 
no pain (BPI Average pain intensity <3/10) (p:::; .01 ). 
Note. BPI, Brief Pain Inventory. 
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Figure 5. Three month ESAS Physical symptom severity scores of younger and older 
women with moderate-to-severe pain intensity and mild or no pain three months after 
breast cancer surgery. 
* Post-hoc pairwise comparisons between younger women with moderate-to-severe pain 
intensity (BPI Average pain intensity ~3/10) and younger and older women with mild or 
no pain (BPI Average pain intensity <3/10) (p:::; .01). 
Note. ESAS, Edmonton Symptom Assessment Scale. 
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Figure 6. Three month STAI-S Total scores of younger and older women moderate-to-
severe pain intensity and mild or no pain three months after breast cancer surgery. 
*Post-hoc pairwise comparisons between younger women with moderate-to-severe pain 
intensity (BPI Average pain intensity 2:3/10) and younger and older women with mild or 
no pain (BPI Average pain intensity <3/10) (p :S .02). 
Note. STAI-S, State-Trait Anxiety Inventory- State scale. 
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Figure 7: Preoperative pain expectations (pain immediately after surgery, after 
medication, and one week following surgery) of younger and older women with and 
without neuropathic pain three months after breast cancer surgery. 
*Post-hoc pairwise comparisons between younger women with neuropathic pain (SF-
NPQ 2: cutoff) and younger and older women without neuropathic pain (SF-NPQ < 
cutoff) (p ~ .01). 
Note. SF-NPQ, Neuropathic Pain Questionnaire - short form. 
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CHAPTERS 
General Discussion and Conclusions 
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Introduction 
The overall aim of this dissertation was to elucidate age-related patterns in the 
multidimensional experience of cancer pain. To date, our understanding of the experience 
of cancer pain across the adult life span has been limited for several reasons. Primarily, 
until very recently, the biomedical model of cancer pain has been the focus of 
investigation (Keefe, Abernethy, & Campbell, 2005; Turk, 2002). Additionally, research 
into age-related patterns in cancer pain has suffered from a number of methodological 
limitations and has narrowly focused on pain as a unidimensional construct. 
Unfortunately, the undertreatment of cancer pain in older people, which was described 
twenty years ago (Cleeland et al., 1994), has not changed (Bernabei et al., 1998; Gao, 
Gulliford, & Higginson, 2011; Higginson & Gao, 2012; Yun et al., 2004). As cancer is a 
disease of older people (Canadian Cancer Society [CCS], 2013), with the aging 
population (Statistics Canada, 2007), the numbers of older people who will need proper 
pain management will grow. We face an emerging healthcare crisis if we do not 
significantly improve our understanding of cancer pain across the adult life span. 
The studies described in this dissertation have begun to improve our 
understanding of the experience of cancer pain across the adult life span. Proper pain 
assessment is fundamentally important to pain management. Consequently, a 
multidimensional measure of cancer pain qualities was validated for use in older and 
younger cancer patients (Chapter 2). This permitted the use of the measure to investigate 
age-related patterns in the multidimensional experience of cancer pain and its correlates 
(Chapter 3). The role of pain in the relationship between age and depression was 
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clarified in a preliminary way (Chapter 4). This final Chapter will attempt to integrate the 
findings of these studies and suggest directions for future research and implications for 
treatment. 
Pain Assessment: Validating the Short-Form-McGill Pain Questionnaire for use in Older 
and Younger People with Cancer 
Pain assessment is a necessary component of pain management, and conversely, 
improper assessment is one of the major contributors to improper pain management 
(Gauthier & Gagliese, 2011). An essential consideration in selecting an assessment tool 
for assessing age-related patterns is whether it can be completed by all age groups 
(Streiner & Norman, 2008). When comparing responses on a tool, it is also essential that 
it measures the same thing the same way across age groups (G. W. Cheung & Rensvold, 
2002; G. W. Cheung & Lau, 2012). This is important, because if an age difference is 
detected, it may be interpreted as a possible age-related effect, rather than as differences 
in the psychometric properties of the tool. Although there are unidimensional measures of 
pain intensity, such as Numeric Rating Scales (NRS), that have been validated for use 
across the adult life span (Gauthier & Gagliese, 2011), multidimensional measures of 
pain quality allow for a more comprehensive assessment of the characteristics of pain 
(Gauthier & Gagliese, 2011). The McGill Pain Questionnaire (Melzack, 1975) is the most 
widely used measure of the multidimensional qualities of pain. It has been recently 
revised and expanded (Dworkin et al., 2009): The Short-Form McGill Pain 
Questionnaire-2 (SF-MPQ-2) includes 11-point NRSs and six new qualities that assess 
neuropathic pain. This is especially relevant to people with cancer, as a substantial 
175 
proportion of patients may experience neuropathic pain (Bennett et al., 2012; Caraceni & 
Portenoy, 1999; Grond, Zech, Diefenbach, Radbruch, & Lehmann, 1996). 
Importantly, older and younger cancer patients were equally able to use the SF-
MPQ-2 (Chapter 2). Consistent with previous studies (Dworkin et al., 2009; Lovejoy, 
Turk, & Morasco, 2012), a four-factor solution emerged, consisting of items assessing the 
Continuous, Intermittent, Neuropathic and Affective qualities of pain. Construct validity 
was very similar across age groups: The same items loaded on the same subscales in the 
same way, although there were somewhat stronger correlations between two of the 
subscales among older than younger patients. Convergent validity was equally good 
across age groups, although the strength of the correlation between the Continuous 
subscale and the measure of mental health quality of life was stronger in older than 
younger patients. However, given the weight of the evidence, despite these small age 
differences, the SF-MPQ-2 is valid for use in younger and older people with cancer pain. 
Interestingly, older and younger patients chose the same number of words overall and the 
same number of sensory words to describe their pain. This is in contrast with studies of 
older patients with chronic nonmalignant pain who chose fewer words than younger 
people to describe their pain (Gagliese & Melzack, 1997a; Gagliese & Melzack, 2003). It 
is possible that the inclusion ofNRSs in the new construction of the SF-MPQ-2 may 
contribute to a different response style among older people or that the characteristics of 
cancer pain override the previously documented parsimonious response style of older 
people. Studies examining the use of the SF-MPQ-2 in older and younger people with 
chronic nonmalignant pain may clarify these inconsistencies. 
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Age-Related Patterns in Cancer Pain 
Consistent with studies of people with chronic nonmalignant pain that have 
shown that older and younger people choose the same words most frequently to describe 
their pain (Gagliese & Melzack, 2003), older and younger patients chose the same words 
- aching pain, tiring-exhausting, sharp pain, and dull pain- most often to describe their 
pain. Also, there were no age differences in the intensity of each selected word (Chapter 
2), or the intensity of pain on average, or interference from pain (Chapter 3), suggesting 
that cancer pain may feel the same, hurt just as much, and interfere in important daily 
activities and psychological wellbeing to a similar extent in older and younger people. 
Taken together, these data refute the claims that older people may be more reluctant to 
report pain (Yong, Bell, Workman, & Gibson, 2003) or less likely to endorse intense pain 
than younger people (Greenwald, 1991; Nicholas, Asghari, & Blyth, 2008; Oberle, Paul, 
Wry, & Grace, 1990). 
Despite these similarities, older people were somewhat less likely to receive an 
opioid prescription than younger people, and there were subtle differences in the 
relationships of pain interference to treatment factors across age groups. Receipt of an 
opioid prescription was associated with higher pain interference in older, but not younger 
patients, whereas taking a greater number of analgesics of any class was associated with 
higher pain interference in younger, but not older patients. These findings suggest that 
healthcare providers may respond to cues differently from older and younger patients. In 
older people, who may be less likely to be prescribed an opioid, greater verbal reports or 
nonverbal displays of pain interference may result in the provision of an opioid. 
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However, in younger people, greater verbal reports or nonverbal displays of pain 
interference may result in the provision of more analgesic treatment overall. Studies 
investigating this possibility are urgently needed to gain a better understanding of the 
underlying causes of the undertreatment of cancer pain in older patients (Bernabei et al., 
1998; Cleeland et al., 1994; Gao, Gulliford, & Higginson, 2011; Higginson & Gao, 2012; 
Yun et al., 2004). 
Consistent with findings from the chronic nonmalignant pain literature (Cook, 
Brawer, & Vowles, 2006; Edwards, 2006; Mcllvane, Schiaffino, & Paget, 2007; Turk, 
Okifuji, & Scharff, 1995), age differences in the correlates of pain outcomes were present 
in the absence of age differences in the outcomes themselves (Gagliese, 2009). The 
presence of comorbidity was associated with greater pain for younger, but not older 
people, while the presence of chronic nonmalignant pain was associated with greater pain 
for older, but not younger people. Other health status factors operated differently across 
age groups in the relationship between pain catastrophizing and pain interference, 
suggesting a supportive context that may be unique to older than younger people and 
which may be consistent with a Communal Coping Model of catastrophizing (Sullivan, 
Thom, Haythomtwaite, Keefe, Martin, Bradley, & Lefebvre, 2001). The possibility that 
healthcare providers might respond differently to older and younger people's pain 
interference cues may have implications for treatment. It is therefore important that we 
gain a better understanding of age-related patterns in the supportive context of cancer 
pam. 
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Depressive symptoms did not differ across age groups. In fact, more than half of 
older and younger people with advanced cancer scored above a cutoff which may 
indicate clinically relevant symptomatology, suggesting that depressive symptoms were 
highly prevalent in this sample, regardless of age. However, distress in the form of 
intrusive thoughts was associated with greater pain among younger but not older people, 
a finding which may be consistent with those of the qualitative study, where younger 
people had difficulty adapting to cancer pain and grieved the loss of their pre-pain selves, 
while older people adapted by accepting pain and retaining or modifying important 
activities (Gagliese et al., 2009). Life span developmental theory suggests that our ability 
to adapt to lifecourse disruptions, such as pain in the context of advanced cancer, is 
affected by a host ofbiopsychosocial factors (Aldwin, Spiro, & Park, 2006). It may be 
that older peoples' prior experience with health limitations confers an adaptive 
advantage, whereas younger people, who may perceive cancer and pain as 
developmentally off-time (Gagliese et al., 2009; Revenson & Pranikoff, 2005), may have 
difficulty adapting. Younger people with comorbidity may have the most difficulty. 
These findings have significant clinical utility and demonstrate that even though older 
and younger people may present with similar ratings of pain, the factors that contribute to 
their overall experience of pain may differ. 
It has been suggested that age should not be a consideration when offering 
multidisciplinary treatments for pain (Sorkin, Rudy, Hanlon, Turk, & Stieg, 1990). 
Indeed, there is evidence that older people may benefit from such treatments (Gagliese & 
Melzack, 1997c). The findings presented in this dissertation present compelling evidence 
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that age should be a factor when tailoring these treatments. However, we have only 
begun to elucidate age-related patterns in the experience of cancer pain. Much future 
research is needed to understand how these treatments should be designed for older and 
younger patients across the cancer continuum. 
The Moderating Role of Pain in the Relationship between Age and Depressive Symptoms 
In studies of cancer patients that do not consider pain, younger age is associated 
with greater depressive symptoms (Campas et al., 1999; Kroenke et al., 2004; Politi, 
Enright, & Weihs, 2007; Schroevers, Ranchor, & Sanderman, 2004; Vinokur, Threatt, 
Vinokur-Kaplan, & Satariano, 1990; Wenzel et al., 1999). As described above, younger 
people may view cancer as developmentally off-time and as a threat to their ability to 
attain life goals, whereas older people may experience a unique adaptive benefit of prior 
experience with health limitations (Gagliese et al., 2009; Schulz & Heckhausen, 1996; 
Chapter 3). However, the presence of cancer pain may operate as a risk factor for 
depressive symptoms to the same extent in older and younger patients (Chapters 3 and 4). 
These findings are consistent with prior studies of people with cancer pain where age has 
not been associated with depressive symptoms (Gagliese, Gauthier, & Rodin, 2007; 
Green & Hart-Johnson, 2010; Kai-hoi Sze, Wong, Lo, & Woo, 2000; Knotkova, Clark, 
Mokrejs, Padour, & Kuhl, 2004; G. M. Williamson & Schulz, 1995). This suggests that 
interventions addressing pain and depressive symptoms are important for patients across 
the adult life span. Interestingly, neuropathic pain may be associated with greater 
depression among younger, but not older people (Chapter 4), which may suggest a 
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possible age-related pattern in the correlates of depressive symptoms related to the pain's 
underlying etiology. This fascinating possibility requires further research. 
Integrating the Findings 
There were no age differences in pain intensity, qualities or interference. 
However, there were age-related patterns in relationships between variables. For 
example, the SF-MPQ Continuous subscale was more strongly associated with mental 
health quality of life in older than younger patients (Chapter 2) and there were several 
age-related patterns in the correlates of cancer pain outcomes (Chapter 3). These data are 
consistent with studies of people with chronic nonmalignant pain that demonstrate that 
even if there are no age differences on factors like pain or depressive symptoms, there 
may be age-related patterns in the relationships between factors (Cook, Brawer, & 
Vowles, 2006; Edwards, 2006; Mcllvane, Schiaffino, & Paget, 2007; Turk, Okifuji, & 
Scharff, 1995). Taken together, these findings strongly suggest the need for the 
development of multimodal age-tailored treatments. In this dissertation, the most salient 
factors that are important to the experience of cancer pain among older and younger 
people have begun to emerge, but more research is needed to identify how to effectively 
tailor treatments. 
It has been suggested that older people are less psychologically affected by cancer 
than younger people (Blank & Bellizzi, 2008). The data presented in this dissertation 
suggest that this is not the case among people with cancer pain. There were no age 
differences in the intensity and prevalence of depressive symptoms among people with 
advanced cancer and pain (Chapter 3), and age was not associated with depressive 
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symptoms in women who reported moderate-to-severe pain intensity three months after 
breast cancer surgery (Chapter 4). These findings present convincing evidence of the 
need to address depressive symptoms and pain in older and younger patients. 
While neuropathic pain was associated with greater depressive symptoms to the same 
extent in older and younger people with advanced cancer (Chapter 3), neuropathic pain 
three months after breast cancer surgery seemed to operate as a risk factor for greater 
depressive symptoms in younger, but not older women (Chapter 4). A number of possible 
explanations for these inconsistent findings may be considered. First, different scales 
were used in each study to assess neuropathic pain. We have shown that the psychometric 
properties of the SF-MPQ-2 are not age-related (Chapter 2). Although the Neuropathic 
Pain Questionnaire-short-form (SF-NPQ [Backonja & Krause, 2003]) used in Chapter 3 
has been shown to discriminate between neuropathic and non-neuropathic cancer pain 
(Mercadante et al., 2009), age-related consistency in its psychometric properties remain 
to be demonstrated. Therefore, it is unclear whether this may account for the 
inconsistencies across studies. It is also unclear whether the same results would have 
been obtained if we had used the SF-MPQ-2 in Chapter 4. 
Cross-study participant differences should also be considered. On the one hand, 
Chapters 2 and 3 reported on men and women with different primary cancers who 
experienced pain for approximately one year. On the other hand, Chapter 4 reported on 
women three months after surgery for earlier stage breast cancer. In other patient 
populations, women may be more likely than men to report neuropathic pain (Fillingim, 
King, Ribeiro-Dasilva, Rahim-Williams, & Riley, 2009; Mogil, 2012). However, in 
182 
people with cancer pain, sex differences in neuropathic pain have not been found (Grand 
et al., 1999). Unfortunately, studies comparing neuropathic pain in men and women 
matched for cancer type are not available; therefore, the relevance of potential sex 
differences remains unclear. Several other possibilities, including gonadal hormone 
effects (Kuba & Quinones-Jenab, 2005; Rehman & Masson, 2005) and different 
manifestations of neuropathic pain across different samples (e.g. postoperative pain vs. 
pain of different etiologies) may render cross-study comparisons inappropriate. 
Substantive Contributions 
The findings from this dissertation improve our understanding of the experience 
of cancer pain across the adult life span and make a significant contribution to the 
literature. The validation of the SF-MPQ-2 was an essential first step in achieving the 
overall aim of the dissertation (Chapter 2). The validation study provides important 
information about the utility of a multidimensional measure of pain qualities in people 
with cancer pain of all ages, which will benefit future research and may improve clinical 
care. There are a number of other novel findings: This dissertation presents the first study 
to demonstrate that the qualities of cancer pain are the same and the intensity of each 
selected quality is the same in older and younger people (Chapter 2). Despite a lack of 
age differences in pain outcomes, consistent with studies of people with chronic 
nonmalignant pain (Cook, Brawer, & Vowles, 2006; Edwards, 2006; Mcllvane, 
Schiaffino, & Paget, 2007; Turk, Okifuji, & Scharff, 1995), there were age-related 
patterns in the correlates of pain that spanned the biopsychosocial spectrum. This study is 
the first to identify different profiles of health status risk factors - e.g. comorbidity 
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among younger, but not older people, and chronic nonmalignant pain among older, but 
not younger people - as risk factors for poor pain outcomes. It is also the first study to 
identify a unique role of health status factors that may impact on the supportive context 
of cancer pain differently for older and younger people. Moreover, despite a lack of age 
differences in cancer pain intensity, qualities, or interference, there may be subtle age 
differences in the way healthcare providers respond to patients' reports or displays of 
pain-related interference (Chapter 3) which may help to explain the pervasive 
undertreatment of pain in older people (Bernabei et al., 1998; Cleeland et al., 1994; Gao, 
Gulliford, & Higginson, 2011; Higginson & Gao, 2012; Yun et al., 2004). Furthermore, 
consistent with the literature (Gagliese, Gauthier, & Rodin, 2007; Green & Hart-Johnson, 
2010; Kai-hoi Sze, Wong, Lo, & Woo, 2000; Knotkova, Clark, Mokrejs, Padour, & Kuhl, 
2004; G. M. Williamson & Schulz, 1995), older and younger people with pain do not 
differ in the severity of depressive symptoms or the prevalence of clinically significant 
levels of depression (Chapters 3 and 4), but there may be something unique about 
neuropathic pain after breast cancer surgery that puts younger but not older women at risk 
for greater depressive symptoms (Chapter 4). 
The studies described in this dissertation substantially improve on the 
methodological limitations of the existing literature. Chapter 3 describes the first study of 
age-related patterns in the experience of cancer pain to adopt a multidimensional 
operationalization of cancer pain, which is important, because and relying on intensity 
alone insufficiently describes this experience (Jensen & Karoly, 2011). Due to the 
inclusion criteria, prevalence was not confounded with intensity, an issue present in some 
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prior studies of age-related patterns in cancer pain intensity (e.g. Jordhoy et al., 2001; 
Mohile et al., 2011; Rustoen et al., 2003; Stuver et al., 2012; G. M. Williamson & Schulz, 
1995; Wilson et al., 2009). This study is also the first to match participants based on sex 
and primary tumor type. These factors have been associated with pain (Dobratz, 2008; 
Fillingim, King, Ribeiro-Dasilva, Rahim-Williams, & Riley, 2009; Grond, Zech, 
Diefenbach, Radbruch, & Lehmann, 1996; Miaskowski, 2004; Vainio & Auvinen, 1996); 
therefore, this is an important methodological strength. Additionally, older people with 
comorbidities have traditionally been excluded from clinical trials (Dale et al., 2012), a 
practice which compromises external validity. The inclusion of people with comorbidities 
and chronic nonmalignant pain (Chapters 2 and 3) and women with pain prior to surgery 
(Chapter 4) enhances external validity and paints a clear picture of patients who are seen 
in everyday clinical practice. 
This dissertation has provided important information clarifying and refining the 
experience of cancer pain in older and younger people. It is clear that the age-related 
patterns in the correlates of cancer pain outcomes span the biopsychosocial spectrum and 
that these factors interact with each other to impact on pain outcomes in different ways 
for older and younger people. For example, certain health status factors, like functional 
status and severity of other cancer symptoms, may operate on the supportive context of 
cancer pain differently for older and younger patients. Other health status factors, like 
comorbid conditions, may also provide unique adaptive advantages for older, but not 
younger patients. It will be important for future studies of age-related patterns in cancer 
pain to consider these complex interactions. 
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Future Directions and Implications for Clinical Care 
The findings described in this dissertation have considerable heuristic value and a 
number of future research directions are evident. Primarily, cancer pain is dynamic and 
may fluctuate as the disease progresses or remits, or as patients proceed through 
treatments, such as surgery, chemotherapy, and radiation (Bruera & Kim, 2003; Burton, 
Fanciullo, Beasley, & Fisch, 2007; McCarthy, Phillips, Zhong, Drews, & Lynn, 2000; 
Paice, 2011; Peng, Wu, Sun, Chen, & Huang, 2006). Longitudinal studies are needed to 
track age-related patterns in the progression of pain throughout the course of treatment or 
as the disease progresses or remits. Dyadic studies that include patients and their 
caregivers are needed to test the potential unique role of health status factors on the 
supportive context of cancer among older patients. Studies are also needed to identify 
whether healthcare providers respond to verbal and/or nonverbal cues differently from 
older and younger patients when making treatment decisions. Such studies would have 
considerable clinical relevance and may further contribute to understanding the 
underlying causes of the undertreatment of cancer pain in older people (Bernabei et al., 
1998; Cleeland et al., 1994; Gao, Gulliford, & Higginson, 2011; Higginson & Gao, 2012; 
Yun et al., 2004). 
It is surprising that comorbidity has been virtually ignored in younger cancer 
patients. Much further work is needed to assess the role of comorbidities, chronic 
nonmalignant pain and other health status factors in the context of cancer pain. Future 
studies may need to expand the conceptualization of burden beyond comorbidity to 
include a more nuanced assessment that includes painful comorbidities (Dominick, Blyth, 
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& Nicholas, 2012), symptom burden and functional status. This may have implications 
for the refinement of frailty definitions, on which consensus remains to be reached 
(Balducci & Extermann, 2000; Hamaker et al., 2012; Ruiz, Reske, Cefalu, & Estrada, 
2013), and Comprehensive Geriatric Assessments, which have yet to be standardized and 
which rarely consider pain (Horgan et al., 2012; Puts et al., 2012). 
High preoperative pain expectations was an important predictor of pain three 
months after breast cancer surgery for both older and younger women (Chapter 4). In 
previous studies, older age has been associated with lower preoperative pain expectations 
(Gagliese, Jackson, Ritvo, Wowk, & Katz, 2000; Schnur et al., 2007). Given this and the 
importance of this preoperative factor to postoperative outcomes for women regardless of 
age, future research is needed to identify age-related predictors of pain expectations and 
to identify interventions to address excessively high expectations of pain prior to surgery 
in older and younger women. 
Conclusions 
This dissertation has demonstrated that cancer pain may feel the same, hurt just as 
much, and interfere with important life activities and wellbeing to the same extent in 
older and younger people. Nonetheless, despite a lack of age differences in cancer pain, 
there may be subtle treatment differences that may contribute to the undertreatment of 
pain in older people. Older and younger people with pain may be equally at risk for 
depressive symptoms. Although there are some similarities, there are also age differences 
in the correlates of pain outcomes which span the biopsychosocial spectrum. These 
findings suggest age-tailored treatments for cancer pain may be warranted and future 
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research is needed to further clarify age-related patterns in the experience of cancer pain 
across the disease continuum. 
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CONSENT FORM - UHN 
TITLE: Biopsychosocial Age Differences in the Experience of Cancer 
Pain 
INVESTIGATOR: Dr. Lucia Gagliese (Telephone: 416-340-4296) 
SPONSOR: Canadian Institutes of Health Research 
You are being asked to take part in a research study. Before agreeing to 
participate in this study, it is important that you read and understand the 
following explanation of the proposed study procedures. The following 
information describes the purpose, procedures, benefits, discomforts, risks, 
and precautions associated with this study. It also describes your right to 
refuse to participate or withdraw from the study at any time. In order to 
decide whether you wish to participate in this research study, you should 
understand enough about its risks and benefits to be able to make an 
informed decision. This is known as the informed consent process. Please 
ask the study doctor or study staff to explain any words you don't 
understand before signing this consent form. Make sure all your questions 
have been answered to your satisfaction before signing this document. 
Background and Purpose 
The purpose of this study is to develop an understanding of thoughts and 
feelings related to pain. We would like to know how people deal with pain 
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and how pain impacts on people's well being. You have been identified by 
your doctor as a potential participant in this cancer study that will examine 
your experience of pain, its impact on your life and how you cope with it. If 
you consent, we will ask you to complete a set of questionnaires. A total of 
300 participants of different ages are planned to take part in this study over 
the next 24 months. 
Procedures 
If you agree to participate in this study, you will be asked some questions 
about your memory. You will be given a questionnaire package that takes 
approximately one ( 1) hour to complete. This questionnaire asks about your 
pain, how your pain impacts on your life, and your general health. Other 
parts of the questionnaire will ask you about personal information, such as 
your marital status and personal relationships. You have the option to 
complete the questionnaires on your own, or with the help from a research 
team member. You may complete the questionnaires at the hospital or if you 
prefer, you may take the questionnaire package home and return them by 
mail once they are completed (we will provide postage and an envelope for 
this purpose). If you do choose to participate and take the questionnaire 
package home, we will telephone you in two weeks to remind you to mail 
your completed questionnaire package. You are under no obligation to 
answer questions that you do not wish to answer, and you may feel free to 
take breaks as required. 
Risks 
There are no known risks to you for participation in this study. The 
researchers involved in this study will make every effort to keep your 
personal information secure. Your information will be stored and protected 
in a locked facility, however your confidentiality cannot be guaranteed. 
Benefits 
This study may not benefit you directly but it may improve future pain 
management for individuals experiencing cancer pain. 
Confidentiality 
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All information obtained during the study is completely confidential. You 
will be identified with a study number. No names or identifying information 
will be used in any publications or presentations. 
Your health record will be reviewed to verify that we have accurate 
information regarding your health history. Certain sections of your chart 
(such as medication records) will be photocopied and included in your 
research chart for reference and evaluation. All of these photocopies will be 
completely confidential and any identifying information will be blacked out. 
Participation 
Your participation in this study is voluntary. You can choose not to 
participate or you may withdraw at any time without affecting your medical 
care. 
Payment 
You will be reimbursed for any additional parking fees or transportation 
costs you might incur as a result of participation in this study. 
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Compensation 
If you become ill or are physically injured as a result of participation in this 
study, medical treatment will be provided. The reasonable costs of such 
treatment will be covered by your health insurance for any injury or illness 
that is directly a result of participation in this study. In no way does signing 
this consent form waive your legal rights nor does it relieve the 
investigators, sponsors or involved institutions from their legal and 
professional responsibilities. 
Questions 
If you suffer any side effects or other injuries during this study, or if you 
have any general questions about the study, please call Dr. Lucia Gagliese at 
416-340-4296. 
If you have any questions about your rights as a research participant, please 
call the University Health Network Research Ethics Board at 416-581-7849. 
They are not involved with the research project in any way and calling them 
will not affect your participation in the study. You may also contact the 
York University Human Participants Review Sub-Committee at 416-736-
5055 (Office of Research Ethics, 5th Floor, York Research Tower) if you 
have questions about your rights as a research participant. 
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Consent 
I have had the opportunity to discuss this study and my questions have been 
answered to my satisfaction. I consent to take part in the study with the 
understanding I may withdraw at any time without affecting my medical 
care. I have received a signed copy of this consent form. I voluntarily 
consent to participate in this study. 
Patient's Name (Please Print) Patient's Signature Date 
I confirm that I have explained the nature and purpose of the study to the 
patient named above. I have answered all questions. 
Name of Person 
Obtaining Consent 
Signature Date 
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CONSENT TOP ARTICIPATE IN A RESEARCH STUDY - MSH 
Title Biopsychosocial Age Differences in the Experience of Cancer Pain 
Investigator Dr. Lucia Gagliese (Telephone: 416-340-4296) 
Co-Investigators Dr. G. Rodin, Dr. C. Zimmermann, Dr. M. Moore, Dr. F. 
Shepherd, Dr. L. Librach 
Sponsor Canadian Institutes of Health Research 
Introduction 
You are being asked to take part in a research study. Before agreeing to 
participate in this study, it is important that you read and understand the 
following explanation of the proposed study procedures. The following 
information describes the purpose, procedures, benefits, discomforts, risks, 
and precautions associated with this study. It also describes your right to 
refuse to participate or withdraw from the study at any time. In order to 
decide whether you wish to participate in this research study, you should 
understand enough about its risks and benefits to be able to make an 
informed decision. This is known as the informed consent process. Please 
ask the study doctor or study staff to explain any words you don't 
understand before signing this consent form. Make sure all your questions 
have been answered to your satisfaction before signing this document. 
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Background and Purpose 
The purpose of this study is to develop an understanding of thoughts and 
feelings related to pain. We would like to know how people deal with pain 
and how pain impacts on people's well being. You have been identified by 
your doctor as a potential participant in this cancer study that will examine 
your experience of pain, its impact on your life and how you cope with it. If 
you consent, we will ask you to complete a set of questionnaires. A total of 
300 participants of different ages are planned to take part in this study over 
the next 24 months from two places. About 100 people will come from 
Mount Sinai Hospital. 
Study Design and Procedure 
If you agree to participate in this study, you will be asked some questions 
about your memory. You will be given a questionnaire package that takes 
approximately one (1) hour to complete. This questionnaire asks about your 
pain, how your pain impacts on your life, and your general health. Other 
parts of the questionnaire will ask you about personal information, such as 
your marital status and personal relationships. You have the option to 
complete the questionnaires with help from a research team member or on 
your own. If you wish to complete the questionnaires on your own, you may 
return them by mail once they are completed (we will provide postage and 
an envelope for this purpose). If you do choose to participate and complete 
the questionnaires on your own, we will telephone you in two weeks to 
remind you to mail your completed questionnaire package. You are under no 
obligation to answer questions that you do not wish to answer, and you may 
feel free to take breaks as required. 
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Risks Related to Being in the Study 
There are no known risks to you for participation in this study. The 
researchers involved in this study will make every effort to keep your 
personal information secure. Your information will be stored and protected 
in a locked facility, however your confidentiality cannot be guaranteed. 
Benefits to Being in the Study 
This study may not benefit you directly but it may improve future pain 
management for individuals experiencing cancer pain. 
Confidentiality 
All information obtained during the study is completely confidential. You 
will be identified with a study number. No names or identifying information 
will be used in any publications or presentations. 
Your health record will be reviewed to verify that we have accurate 
information regarding your health history. Certain sections of your chart 
(such as medication records) will be photocopied and included in your 
research chart for reference and evaluation. All of these photocopies will be 
completely confidential and any identifying information will be blacked out. 
Voluntary Participation 
Your participation in this study is voluntary. You can choose not to 
participate or you may withdraw at any time without affecting your medical 
care. 
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In Case You Are Harmed in the Study 
If you become ill or are physically injured as a result of participation in this 
study, medical treatment will be provided. The reasonable costs of such 
treatment will be covered by your health insurance for any injury or illness 
that is directly a result of participation in this study. In no way does signing 
this consent form waive your legal rights nor does it relieve the 
investigators, sponsors or involved institutions from their legal and 
professional responsibilities. 
Questions About the Study 
If you suffer any side effects or other injuries during this study, or if you have 
any general questions about the study, please call Dr. Lucia Gagliese at 416-
340-4296. 
If you have any questions about your rights as a research participant, please call 
Dr. Ronald Heslegrave, Ph.D., Chair of the Mount Sinai Hospital Research 
Ethics Board (REB) or the Research Ethics office number at 416-586-4875. 
This person is not involved with the research project in any way and calling him 
will not affect your participation in the study. You may also contact the York 
University Human Participants Review Sub-Committee at 416-736-5055 
(Office of Research Ethics, 5th Floor, York Research Tower) if you have 
questions about your rights as a research participant. 
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Consent 
I have had the opportunity to discuss this study and my questions have been 
answered to my satisfaction. I consent to take part in the study with the 
understanding I may withdraw at any time without affecting my medical 
care. I have received a signed copy of this consent form. I voluntarily 
consent to participate in this study. 
Patient's Name (Please Print) Patient's Signature Date 
I confirm that I have explained the nature and purpose of the study to the 
patient named above. I have answered all questions. 
Name of Person 
Obtaining Consent 
Signature Date 
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CONSENT FORM 
TITLE: Age-related patterns in pain following breast cancer surgery. 
INVESTIGATOR: Dr. Lucia Gagliese, Toronto General Hospital 
(Telephone: 416-340-4296) 
You are being asked to take part in a research study. Before agreeing to participate in 
this study, it is important that you read and understand the following explanation of the 
proposed study procedures. The following information describes the purpose, procedures, 
benefits, discomforts, risks and precautions associated with this study. It also describes 
your right to refuse to participate or withdraw from the study at any time. In order to 
decide whether you wish to participate in this research study, you should understand 
enough about its risks and benefits to be able to make an informed decision. This is 
known as the informed consent process. Please ask the study doctor or study staff to 
explain any words you don't understand before signing this consent form. Make sure all 
your questions have been answered to your satisfaction before signing this document. 
Background and Purpose 
Surgery is one of the treatments for breast cancer with removal of local tumour tissue 
(lumpectomy) and of surrounding tissues in which the tumour might be present being the 
most common procedures. There is little information available regarding age, levels of 
pain and analgesic use in women who undergo these types of surgeries. As a patient who 
will have breast surgery, you are being asked if you would like to participate in a study 
that will look at sensitivity to pain and recovery throughout your surgical experience in 
relation to your age. Past research has shown that inflammatory substances ( cytokines) 
and some natural hormones (estrogen and progesterone) produced in your body may 
change how sensitive you are to pain. 250 women will participate from University 
Health Network. This study will last approximately 5 years. Participation for each 
person will last approximately two years in total. 
Procedures 
Preadmission visit 
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If you agree to participate in this study, you will be asked to complete several 
questionnaires about your mood, pain history, medical history, activity levels and overall 
well-being. You will also be asked if you are taking any medications for pain or any 
other reason. 
You will then undergo a functional assessment, which measures shoulder range of 
motion, hand grip strength, and arm circumference. In addition, the research assistant 
will assess your sensitivity to pain (pain threshold) using brief tests of heat, pressure, and 
pricking stimulation. You will be asked to say "stop" as soon as you feel pain. A blood 
sample will be drawn at this time to assess your cytokine levels. You will be given a 
questionnaire package to complete at home and return on the day of surgery. Your 
preadmission visit will take approximately 35 minutes to complete. Similar to your 
surgeon's instructions, we ask that you not eat for 12 hours prior to your surgery and that 
you avoid strenuous physical exercise and alcohol for 2 days prior to surgery. You will 
receive a telephone reminder of these instructions 2 days before your surgery. The results 
of your routine pre-operative blood tests, ordered by your surgeon, also will be reviewed 
and collected for the study. 
Day of surgery 
Before Surgery 
On the day of surgery blood will be drawn to assess cytokine, estrogen and progesterone 
levels. Measures of pain, mood, symptoms, pain medication consumption, and pain 
threshold will be taken. Many of these are similar to those previously completed. 
During Surgery 
Your surgery will be performed as usual under general anesthesia (i.e., you will be asleep 
for the duration of the operation). Information (e.g., medication use, blood loss, surgical 
duration, complications) will be recorded from your medical chart. 
After Surgery 
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Standard of care is not changed if you participate in this study. That means you will 
receive the same pain medicine and other types of care whether or not you participate in 
this study. 
At 6 hours after surgery, you will be asked about your pain level and any side effects you 
may have experienced. Information regarding your pain medication will also be 
collected. This visit will take approximately 10 minutes. 
Following your surgery, at either 24 h, 48 h or 72 hours, you will be asked questions 
about your pain, memory, mood, and well-being, as well as questions regarding your 
satisfaction with your pain treatment. You will be asked to repeat the tests to measure 
your sensitivity to pain. Blood will be taken to measure levels of cytokines, estrogen, 
progesterone and morphine (the medication you will be using to control your pain). All 
medication use will be recorded from your medical chart. This visit will take 
approximately 45 minutes. 
Follow-up 
Follow-up Assessments (1 week, 6 weeks, 3 months, 6 months after surgery) 
Prior to your discharge, we will set up an appointment for the I-week follow-up and you 
will receive a confirmation phone call the day before. The other follow-ups will be 
arranged via telephone calls approximately 2 weeks before the assessment, with 
confirmation the day before. During the follow-up assessments, you will be asked to 
answer questionnaires regarding your pain, mood, memory, general wellness, symptom 
experience, wound healing, and satisfaction with your pain treatment. You will be asked 
to repeat functional assessments and tests to measure your sensitivity to pain. Blood will 
be taken to measure levels of cytokines, estrogen and progesterone. These assessments 
will take approximately 45 minutes to complete. 
We will reimburse you for your travel or parking expenses for each visit to the hospital 
that might be needed for the study. You will be given a questionnaire package to 
complete and return in the mail. Postage will be provided and telephone reminders to 
return the questionnaires will be given at 2 and 4 weeks. If you live outside Toronto, or 
would prefer not to travel to UHN or not to have the Research Assistant visit you, 
telephone assessments consisting of the questionnaire package will be conducted. 
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One and two year assessment 
We will telephone you one and two years after your surgery. You will be asked to 
complete several questionnaires about your memory, mood, pain history, medical history, 
activity levels and overall well-being. You will also be asked if you are taking any 
medications for pain or any other reason. We will coordinate a time to perform the 
functional assessments and tests to measure your sensitivity to pain around your follow-
up medical appointment at UHN. After the physical testing, we will provide you with a 
questionnaire package that you may complete with the help of a research assistant or take 
home to complete. If you prefer to only complete the questionnaires, we will mail you the 
questionnaire package. The questionnaire package asks about your pain, how your pain 
impacts your life and your general health and wellbeing. Other parts of the questionnaire 
will ask you about personal information, such as marital status and personal relationships. 
It takes approximately 45 minutes to one hour to complete. We will provide you a 
stamped and addressed envelope so that you may return your completed questionnaire in 
the mail. We will telephone you in two and/or four weeks to remind you to mail your 
completed questionnaire. You are under no obligation to answer questions that you do not 
wish to answer, and you may feel free to take breaks as required. 
Blood Tests 
Blood sampling may be uncomfortable and cause some bruising. Some people may feel 
dizzy or light-headed when having blood samples taken. 
Pain Sensitivity Testing 
There may be a small amount of discomfort associated with testing your sensitivity to 
pain. None of these tests will cause any damage, and as soon as you report any pain the 
tests will be stopped. 
Benefits 
This study may not benefit you directly but it may potentially improve future pain 
management for patients undergoing surgical treatment for breast cancer. 
Confidentiality 
All information obtained during the study is completely confidential. You will be 
identified with a study number and initials only. No names or identifying information 
will be used in any publication or presentations. 
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Your health record will be looked at to evaluate any side effects of the treatment and to 
verify that we have accurate information regarding your health history and treatment. 
Certain sections of your chart (such as, anesthetic record and medication record) will be 
photocopied and included in your research chart for reference and evaluation. Any 
photocopies made will be confidential and any name or identifying information will be 
blacked out. In addition to the research team, your health record may be accessed by the 
Research Ethics Board for the purposes of verifying the information that is collected and 
ensuring that the study has been carried out properly. 
Participation 
Your participation in this study is voluntary. You can choose not to participate or you 
may withdraw at any time without affecting your medical care. You may be asked to 
withdraw from the study if at any time it is thought to be in your best interest. 
Compensation 
If you become ill or are physically injured as a result of participation in this study, 
medical treatment will be provided. The reasonable costs of such treatment will be 
covered by your health insurance for any injury or illness that is directly a result of 
participation in this trial. In no way does signing this consent form waive your legal 
rights nor does it relieve the investigators, sponsors or involved institutions from their 
legal and professional responsibilities. 
Questions 
If you have any general questions about the study or suffer any side effects or other 
injuries during this study, please call Dr. Lucia Gagliese at 416-340-4296. 
If you have any questions about your rights as a research participant, please call the 
University Health Network Research Ethics Board at 416-581-7849. They are not 
involved with the research project in any way and calling them will not affect your 
participation in the study. 
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Future Contact Consent 
I voluntarily consent to be contacted for future research. 
YES D 
NO D 
Consent 
I have had the opportunity to discuss this study and my questions have been answered to 
my satisfaction. I consent to take part in the study with the understanding I may 
withdraw at any time without affecting my medical care. I have received a signed copy of 
this consent form. I voluntarily consent to participate in this study. 
Patient's Name (Please Print) Patient's Signature Date 
I confirm that I have explained the nature and purpose of the study to the patient named 
above. I have answered all questions. 
Name of Person Obtaining Consent Signature Date 
